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ABSTRACT 
 
Aberrant neurotransmitter function promotes cognitive deficits in schizophrenia. 
These abnormalities in functioning are seen as disruptions in attentional and 
information processing, as well as disruptions in the consolidation and retrieval of 
information. Tasks of attentional salience and memory that are used to model these 
disruptions include the latent inhibition (LI) task of attentional salience, prepulse 
inhibition (PPI) task of sensorimotor gating and an Episodic memory (EM) task, 
which is an index of memory for episodes at a particular point in time. Aberrant 
functioning of candidate genes that are associated with risk for schizophrenia may be 
seen as behavioural alterations in these tasks of schizophrenia relevant phenotypes.  
dopaminergic hyperactivity and hypofunction have been implicated in mediating 
disruptions on these cognitive tasks. Increased transmission in the dopamine system 
in the striatal region promotes schizophrenia symptoms, and indirect dopamine (DA) 
agonist Amphetamine worsens these symptoms in patients, and disrupts 
schizophrenia relevant behaviours on these cognitive tasks.  
We investigated the effects of deletion of two genes relevant to schizophrenia on 
cognitive tasks known to be disrupted in the disorder. The effect of deletion of the 
dopamine D2 receptor (D2R) and trans membrane (TM) domain Neuregulin-1 (Nrg-
1) receptor were investigated in mediating disruptions in cognitive processes in an 
animal model of schizophrenia. The role of the D2R in an attentional model of 
sensorimotor gating was assessed. PPI was attenuated in D2R knock out (KO), in a 
one day sensorimotor gating task. In a one day PPI test protocol, amphetamine 
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disruptions on PPI were spared in D2R WT and KO mice. Following on from 
previous reports of disrupted LI by a single low dose amphetamine injection, 
separated by 24h interval, we established a single vs. two low dose PPI protocol in 
order to facilitate a direct comparison of amphetamine induced disruption in LI with 
PPI. A one injection (prior to test only) vs. two injection (prior to habituation and 
prior to test) task was established. In the two day protocol, a single low dose of 
amphetamine disrupted PPI in D2R KO mice and reduced startle reactivity to the 120 
dB pulse alone trials. Two low dose injections of amphetamine however, do not 
disrupt PPI in D2R KO or their WT littermates, and do not mimic low dose 
amphetamine disruptions in the LI task. These findings demonstrate that prior 
conclusions about the requirement of the D2R for amphetamine effects in PPI does 
not generalise to all dose regimens. 
 Episodic memory was also investigated as a measure of cognitive impairment in 
schizophrenia. D2R KO mice show sex specific dissociations on an EM task. Male 
D2R WT and KO animals show equal exploration of old vs. recent objects on the 
what-when component of the EM task, and female KO animals show enhanced 
memory for old vs. recent objects. Both D2R WT and KO mice show intact memory 
for displaced objects.  
These deficits were also investigated in the TM domain Nrg-1 model. Nrg-1 has been 
implicated as a candidate gene for schizophrenia, and behavioural phenotypes 
assessing its role in cognitive impairment in schizophrenia were established. Intact 
LI is seen in both Nrg-1 WT and Het animals. Nrg-1 TM domain Het mutants also 
show deficits on the schizophrenia relevant PPI task. Nrg-1 Het mutants show 
attenuated % PPI compared to their WT littermates, which reflects interrupted 
sensorimotor gating in schizophrenia. Lastly, we found some evidence that reduced 
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function of TM-domain of the Nrg-1 gene disrupted episodic-like memory (what- 
where-when recognition) in males and improved it in females.  
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Chapter 1: GENERAL INTRODUCTION 
 
1.1WHAT IS SCHIZOPHRENIA? 
 
1.1.1Definition 
 
Schizophrenia is a mental illness that is best defined as a psychiatric disorder of 
perceptual, social and motivational deficits, as well as thinking and cognition. It was 
originally known as Ôdementia praecoxÕ and defined as a progressive syndrome 
(Kraeplin,1919), comprising a group of symptoms with unknown specific 
pathophyisiology, anatomical or molecular basis, that resulted in disease only when 
specific entities contributing to the disease could be identified (Kandel,1991). This 
idea further was refined by (Bleuler,1911) who proposed that schizophrenia entailed 
a splitting of the cognitive aspect of personality both from the emotional and 
affective states. However, signs and symptoms of illness are diverse and can be 
broken down in terms of: symptoms that precede a psychotic fit i.e. prodromal signs, 
symptoms that persist in the psychotic state and lastly, symptoms that occur in the 
non psychotic period (Kandel,1991). These symptoms have now been clearly 
assigned into three categories: positive symptoms (psychotic phase), negative 
symptoms (prodromal/non psychotic phase) and cognitive deficits, all of which are 
abnormalities that are characteristic of the schizophrenic mind. 
1.1.2 Symptomatology underlying schizophrenia 
 
The concordance rates for schizophrenia are about 41-65% in monozygotic twins on 
average and 0-28% in dizygotes (Cardno and Gottesman,2000), and monozygotic 
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twins have a higher genetic predisposition for schizophrenia than dizygotes 
(Kallmann, 1946). Moreover, genetic predisposition for  developing schizophrenia is 
more prevalent in families with a psychotic member (see Fig.1a) where even 
prodromal symptoms have been observed in unaffected relatives of schizophrenic 
patients (Gottesman and Erlenmeyer-Kimling,2001). The positive symptoms of 
schizophrenia consist of hallucinations, delusional thoughts, feelings and actions, as 
well as disordered thoughts, incoherence and disorganized speech. The negative 
symptoms consist of social withdrawal and isolation, flattened affect, alogia, a lack 
of motivation, affective blunting of emotional expression as well as anhedonia in 
experiencing pleasure (Kandel,1991; Andreasen,1995). These symptoms are also 
accompanied by cognitive deficits in working memory, attention, semantic and 
episodic memory (Elvevag and Goldberg,2000).Evidence for cognitive impairment 
such as deficits in executive functioning, cued recall and recognition (Sullivan,1994; 
Joyce, Collinson et al.,1996; Hutton, Puri et al..,1998), may arise from dysfunction in 
specific anatomical areas or pathology (Lennox, Park et al.,2000; Perlstein, Carter et 
al., 2001). This will be discussed later. 
1.1.3 Structural and functional changes governing schizophrenic 
symptoms 
 
The aetiology of schizophrenia consists of dysfunction in structural brain regions and 
functional changes in the brain. Studies mapping neuroanatomical substrates in 
schizophrenia have shown reductions in temporal grey matter particularly in the 
temporal gyrus and cerebellum, in patients who experienced hallucinations 
(Neckelmann,2006). Furthermore reductions in grey matter have also been reported 
in the insula, medial prefrontal, medial temporal and striatal regions, as well as the 
dorso-medial frontal cortex, and lateral and orbital frontal areas (Fornito, Yucel et 
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al.,2009). Consequently, patients with schizophrenia with ventricular enlargement 
show the negative symptoms of illness, whilst patients with smaller ventricles show 
typical positive symptoms (Andreasen, Olsen et al.,1982). Moreover, reductions in 
white matter in the temporo-occipital cortex have been associated with the severity 
of negative symptoms in schizophrenic patients (Foong, Symms et al.,2001), thereby 
suggesting that cortical region changes are closely linked to the negative symptoms 
of schizophrenia. Furthermore, patients with schizophrenia also show a reduction in 
cerebral blood flow in the dorsolateral prefrontal cortex (Weinberger, Berman et al., 
1986) whilst performing tasks related to working memory (Carter, 1998; Ho, 
Wassink et al.,2005) . When tested on the Wisconsin Card Sorting test  (WCST) and 
a simple number matching test, drug naive patients with chronic schizophrenia had 
significantly reduced cerebral blood flow in the DLPFC which was correlated with 
the cognitive task; intact DLPFC functioning was accompanied by better 
performance on the card sort task. This indicates that dysfunction in neural circuitry 
may underlie the symptoms of schizophrenia pathophysiology. 
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Figure 1a Figure depicting heritability in Schizophrenia. Adapted from 
Gottesman, 1991. 
1.1.3.1 Structural changes and cognitive deficits in schizophrenia  
 
Patients with schizophrenia have deficits in the processing of information as well as 
problems with involuntary attention (Braff, 1993). They have difficulty in selecting, 
categorizing and classifying masses of information, as well as deficits in the 
allocation of attention to multiple sources in a coherent manner. These deficits are 
linked to symptomatology of the illness. For instance a study reports that patients 
with negative symptoms showed impaired performance on a delayed match to 
sample task (Pantelis, Stuart et al.,2001). This task requires the participant to match 
the target stimulus to a different configuration of simultaneously presented stimuli of 
an identical pattern. Impairments were also seen on other tasks of fronto striatal 
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function and working memory such as the Cambridge Neuropsychological 
Automated Test Battery, and its component the Tower of London task; this is a 
planning task that incorporates aspects of initial and subsequent thought in task 
performance. Subjects were presented a set of stimuli (balls) at the bottom of a 
computer screen, which they were required to arrange so that the positions of the 
balls matched the configuration of another set of balls presented at the top of the 
screen. The initial position of the balls was changed so that the minimum number of 
solutions consisted of a minimum number of two, three, four or five moves. Planning 
and execution as indexed by initial thinking and subsequent thinking latencies were 
assessed. Patients with schizophrenia and those with frontal lobe lesions both showed 
disruptions on these tasks. Schizophrenic patients were slower at performing this task 
compared to controls and those with ParkinsonÕs, as indexed by longer latencies in 
their subsequent thinking times as compared to their initial thinking times (Pantelis, 
Barnes et al.,1997).  
Deficits in attention also form part of the cognitive impairments implicated in 
schizophrenia. Consequently, studies have looked at deficits in selective attention, 
i.e. the ability to filter out irrelevant information and process what is necessary. 
Schizophrenia patients presented with auditory stimuli both binaurally and 
dichotically showed decreased activation of the auditory cortices  in the right super 
temporal gyrus compared to controls in processing these auditory stimuli, suggesting 
a temporal lobe deficit (O'Leary, Andreasen et al.,1996).  Reductions in the volumes 
of brain tissue in the frontal, temporal, parietal and occipital lobes are also associated 
with cognitive abnormalities in schizophrenia (Andreasen, Flashman et al., 
1994).Thus, implying that  cognitive deficits are accompanied by changes in 
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anatomical regions relevant to cognitive processing of these tasks, accompanied by 
the symptoms of schizophrenia.   
1.1.3.2 The striatal and frontal cortex as anatomically relevant regions for 
schizophrenia 
 
The striatum and frontal cortex have been implicated in neurobiological dysfunction 
underlying schizophrenia symptoms. Studies have employed tests of working 
memory to investigate whether changes in activity in the prefrontal cortex in 
schizophrenia are associated with these cognitive deficits. More specifically, 
activations on the WCST in the mid dorsolateral and mid ventrolateral pre frontal 
cortex (PFC) are seen during the setting of rules to the task but not while 
implementing an action according to these rules. The mid dorsolateral PFC is 
activated in these tasks, and the cortical basal ganglia loop is also activated through 
the mid-ventrolateral prefrontal cortex, caudate nucleus, and mediodorsal thalamus, 
all of which govern the shifting of a  mental state to initiate a new response set  
(Monchi, Petrides et al.,2001). Consequently, in a study  employing the continuous 
performance task (a test of sustained attention) in ultra high risk patients, those with 
early onset and chronic onset of schizophrenia reported diminished activation of the 
frontal regions in the anterior cingulate gyrus, inferior frontal gyrus; and middle 
frontal gyrus (Morey, Inan et al.,2005). Both pre frontal and striatal activations were 
greater in patients with early onset rather than chronic schizophrenia (Morey, Inan et 
al., 2005; Thaden, Rhinewine et al.,2006). Furthermore, these fronto-striatal circuits 
play a role in the shifting of attention and behaviour, particularly in the processing of 
temporal information (Meck and Benson,2002). The authors suggest that PFC is 
involved in mediating deficits in attentional shifting and interval timing behaviour, in 
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mediating tasks of working memory and executive function in schizophrenia, and is 
also a source of altered dopamine neurotransmission in the schizophrenic brain. 
Dopamine 1 receptors (D1R) have also been implicated in mediating working 
memory tasks in the PFC (Sawaguchi and Goldman-Rakic, 1991). A greater 
occupancy of dopamine 2 (D2R) receptors in the striatum is also seen in patients 
undergoing a psychotic episode (Kegeles, Abi-Dargham et al.,2010). Mice over-
expressing D2R in the striatum showed impairments on performance in tasks of 
locomotor activity and sensorimotor gating of information processing. However, 
these mice exhibit altered dopamine transmission in the PFC and showed no deficits 
on the T maze or Morris water maze, indicating intact spatial memory (Kellendonk, 
Simpson et al.,2006).Thus, disruptions in working memory alone may involve the 
D2R (Luciana, Depue et al.,1992). Therefore, the aforementioned studies suggest 
that anatomical changes that are associated with cognitive deficits in schizophrenia 
may be attributed to the neurotransmitter circuit that innervates that anatomical 
region. 
1.1.4 The role of neurotransmitters in illness 
 
The neurobiology underlying schizophrenia is governed by a complex construct that 
is related to alterations in dopamine ,glutamate neurotransmission as well as GABA 
and 5 HT (Flames, Long et al.,2004, Li Woo,2007; Coyle,2004). We will focus on 
the two main hypotheses of schizophrenia in light of dopamine hyperfunction in 
predisposing to positive symptoms of illness, and glutamate hypofunction in 
mediating negative symptoms.
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1.1.4.1 The dopamine hypothesis of schizophrenia 
 
The dopamine hypothesis of schizophrenia, in its simplest form, attributes the 
formation of positive symptom like pathophyisiology of psychosis to an 
overstimulation of dopamine in the brain (Dargham, 2004; Meltzer and Stahl 1976). 
Aberrant salience through the hyper-function of this neurotransmitter promotes 
psychotic like symptoms (Howes and Kapur,2009); Antipsychotics (D2R 
antagonists) are known to selectively block dopamine receptors and are effective in 
the treatment of illness by  decreasing dopaminergic activity (Carlsson and 
Lindqvist,1963;). Dopamine mimetic drugs such as L-DOPA and amphetamine 
induce the positive symptoms of psychosis (Seeman,1987). Dopamine receptors 
comprise of a large family of receptor subtypes that can be classified under the D1 
and D2 receptor families as D1-like or D2-like receptors. The former includes the D1 
and dopamine 5 (D5) receptor, whereas the latter includes the D2, D3 and dopamine 4 
(D4) receptor subfamilies. These two subfamilies differ in their pharmacological and 
structural properties, specifically in their coupling to proteins, where the D1R 
stimulates adenylyl cyclase and the D2R inhibits its activity to produce intracellular 
responses (Jackson and Westlindanielsson 1994; Sibley 1999).  
The key dopamine pathways in the brain comprise of the nigrostriatal tract, the 
mesolimbic tract, the mesocortical tract and the tuberoinfundibular tract. The 
dopaminergic cell bodies in these pathways innervate different brain regions, and 
control a variety of behaviours and functions. For example, the cell bodies of the 
nigrostriatal pathway are located in the substantia nigra and are responsible for 
coordinating motor control via the nervous system, whereas the cell bodies of the 
mesolimbic system are implicated in learning and memory processes. Conversely, 
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the mesocortical system is innervated by cortical dopaminergic and noradrenergic 
fibres and is linked to functions governed by the limbic system (Meltzer and Stahl, 
1976).   
Amphetamine, an indirect dopamine agonist, is commonly used as a pharmacological 
construct to investigate these neural substrates and behaviours relevant to psychosis. 
Amphetamine leads to a dopaminergic efflux in the striatal tracts, although the 
effects of amphetamine are dose dependent. In this dose dependent manner it 
mediates different neural substrates underlying diverse behaviours (Seiden, Sabol et 
al.,1993).  Acute administration of amphetamine worsens symptoms in schizophrenia 
patients (Angrist, Rotrosen et al.,1980; Laruelle, Abi-Dargham et al.,1996).  It also 
disrupts performance in tasks used to mimic cognitive and behaviour deficits in 
schizophrenia in rodent models of inattention i.e. latent inhibition (Weiner, Lubow et 
al.,1988)  and spatial learning on the Morris water maze (Russig, Durrer et al.,2003) 
and sensorimotor gating (Swerdlow, Mansbach et al.,1990), where amphetamine 
induced disruptions on these tasks in rodents directly correlate with deficits in  
humans on these tasks (Gray, Pickering et al.,1992; Braff, David et al.,2001). 
Furthermore, administration of amphetamine in schizophrenic patients and rodents 
produces psychotic symptoms that are reversible by D2R antagonist drugs and 
antipsychotics, and has been used as a pharmacological tool to model tasks involved 
in investigating cognitive impairment in schizophrenia (Weiner, Lubow et al.,1988; 
Weiner, Shadach et al.,1996; Kapur,2003). 
1.1.4.2 The glutamate hypothesis of schizophrenia 
 
Glutamate is the major excitatory neurotransmitter in the central nervous system. The 
glutamate hypothesis of schizophrenia states that a hypofunction in glutamate 
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neurotransmission, via the aberrant functioning of the glutamate receptor N-methyl Ð
D-aspartate (NMDA) predisposes to schizophrenia-like pathophysiology (Goff and 
Coyle 2001; Hashimoto K. 2004). Glutamate receptors consist of the ionotropic 
receptors and the G-protein coupled metabotropic receptors. The ionotropic receptors 
consist of three receptor subunits i.e. the NMDA (that consists of the NR1, NR2A-D 
and NR3-A), AMPA (Glu receptors 1-4) and Kainate receptors (Glu receptors 5-7 
and kainate receptors).  Additionally, the metabotropic glutamate receptors are 
divided into three groups: the group I mGLUR receptors (mGLUR 1, 2), group II 
(mGLUR receptor 2,3) and Group III receptor (mGLUR 4,6,7,8) which are all 
coupled to G proteins. Both the ionotropic and metabotropic glutamate receptors 
have been implicated in memory impairments (Gao et al.,2000, Lisman et al.,1998, 
Krystal et al.,2004). The hypofunctioning of these receptors contributes to the 
behavioural symptoms in schizophrenia (Hirsch, Das et al.,1997). 
 Phencyclidine and Ketamine, both non competitive glutamate antagonists, produce 
schizophrenia like positive and negative symptoms, as well as cognitive dysfunction 
in healthy humans (Snyder,1980;Javitt,1991), and worsen symptoms in 
schizophrenic patients (Newcomer, et al.,1999). Acute administration of PCP and 
Ketamine are associated with the blockade of glutamate receptors, and also with an 
increase in cortical dopamine and glutamate (Moghaddam,1997). Administration of 
these drugs leads to impairments on tests of cognitive functioning in the prefrontal 
cortex and the striatal regions, by increasing dopamine transmission (Deutch, 1987) 
and by NMDA receptor up regulation (Sircar,2003). mGLUR 1 and mGLUR 5 
knockout mice with a blocked glutamatergic tone also show deficits in a task of 
sensorimotor gating (Brody, Conquet et al.,2003). D2R antagonists reverse deficits in 
PPI, but the antipsychotic raclopride has no effect in reversing disrupted PPI in 
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mGLUR deficient knockout mice(Henry, Lehmann-Masten et al.,2002), suggesting 
that metabotropic glutamate receptors mediate deficits in the sensorimotor gating in 
schizophrenia, that are not reversible by  dopamine D2R antagonists/antipsychotic 
drugs. Thus, both the DA and glutamate systems have a complex relationship that 
mediates disruptions on cognitive tasks used to model Schizophrenia 
pathophysiology. Disturbances in one system may affect the functioning of other 
systems i.e. dopamine is known to inhibit glutamate release at the NMDA receptors 
(Jentsch and Roth,1999). These systems interactions in turn are further complicated 
by the inhibitory GABAergic and glutamate interactions and excitatory effects of 
glutamate in the prefrontal cortex (dopamine circuit), the functioning of which 
jointly contribute to schizophrenia pathophyisiology (Coyle,2004). Thus, 
schizophrenia pathophysiology is mediated by complex interactions between the 
dopamine and glutamate systems. 
1.1.5 Methods of modelling schizophrenia  
 
Schizophrenia is a complex disorder that has been investigated by using a variety of 
methods; in vivo, ex vivo and imaging studies in animals and humans. Schizophrenia 
is an illness that is not caused by the aberrant functioning of a single gene, but rather 
is the product of multiple genetic and environmental factors. The use of an 
endophenotype approach i.e. intermediate phenotypes that form the links between 
genetic predisposition and their overt expression of behaviour (Gottesman and 
Gould,2003) , provides clues to the neurobiology of Schizophrenia. Understanding 
the molecular mechanisms implicated in its pathology, including the neurotransmitter 
systems implicated in Schizophrenia and how they predispose to its symptoms, helps 
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establish a framework for this complex disorder (Cannon and Keller,2006), see table 
1.1.  
Animal models have been extensively used to model the symptoms of illness and its 
neurobiology by using approaches such as post mortem techniques and imaging to 
elucidate the role played by specific neurotransmitter systems in mediating these 
symptoms. Similarly behavioural indices mapping onto attentional and cognitive 
deficits as well as negative symptoms have been outlined. These can be measured 
using neuropsychological tasks that are behavioural correlates of the impairments 
inherent in Schizophrenia. For example, specific alleles may predispose to 
dysregulation in neurotransmitter systems i.e. altered glutamate neurotransmission in 
the hippocampus that manifests as disruptions in its behavioural correlate i.e. 
memory (Moghaddam,2003). NMDA receptors are involved in the encoding of long 
term memories that require the hippocampus, and in long term plasticity in the 
dentate gyrus-hippocampal circuit (Steele and Morris,1999). These models 
effectively measure the pathways influenced by aberrant gene function by 
challenging specific glutamate receptor ligands with glutamate agonist/antagonist 
drugs, which in turn promote or impede neurotransmission, and mimic or reverse 
abnormal gene function implicated in Schizophrenia.  
The knock out approach has been extensively used to model human central nervous 
system (CNS) disorders. For example, transgenic mice overexpressing the human 
Tau isoform show age dependent onset and progression of AlzheimerÕs disease 
(Ishirhara, Hong et al.,1999). Other transgenic models of AlzheimerÕs disease 
include mice with mutations in the human amyloid precursor protein, that show 
oxidative brain damage indicative of disease, as seen by impairment on spatial 
learning and memory tasks; phenotypes used to model of memory loss as seen in 
26 
 
AlzheimerÕs (Butterfield, Galvan et al.,2010). Mouse models of other ParkinsonÕs 
disease show that mutations of the LRRK2 gene causes the late onset of disease, and 
transgenic mice bearing these mutations show neuronal degeneration of the 
nigrostriatal dopamine pathway (Ramonet, Daher et al.,2011). This indicates that the 
transgenic approach is useful in elucidating the neurobiology underlying these 
disorders, and modelling disease relevant phenotypes. 
These genetically modified mouse models are of importance as they help in 
identifying both susceptibility and causative genes implicated in these CNS 
disorders, and also help evaluate novel therapeutic drug targets (Morrisette, 
Parachikova et al.,2009). The common idea underlying the disease-common allele 
approach is that disease related mutations in the human genome consist of a single 
nucleotide polymorphism (SNP). However, in light of complex disorders such as 
schizophrenia, it is asserted that the illness is not a consequence of a single mutation 
but of a variation of large segments of DNA involving a number of genes 
(Kellendonk, Simpson et al.,2009). 
 The two transgenic models we have focused on in this thesis include the dopamine 
D2R knockout model and the Neuregulin-1 partial knockdown model. A large 
number of SNPÕs within the Nrg-1 gene have been associated with schizophrenia, 
and schizophrenia relevant phenotypes such as measures of sensorimotor gating and 
hypofrontality (Stefansson et al.,2002, Hall et al.,2006). Knockdown of Nrg-1 ErbB 
receptors, as well as of the transmembrane-like domain, and immunoglobulin-like 
domain have been generated. Hetrozygous Nrg-1 mice, with deletions of the gene are 
hyperactive (OÕ Tuathaigh et al.,2007), but mice with mutations in the Nrg-1 gene 
that is either  ErBB2 receptor coupled or  ErbB3 receptor coupled  do not show this 
phenotype (Golub et al.,2004). 
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Mouse models of the D2R model are centered around the dopamine hypothesis of 
schizophrenia i.e. dopamine 2 receptor transmission promotes schizophrenia-like 
symptoms, where an increased number and density of dopamine 2 receptors are also 
seen in the striatum (Dargham,Rodenheiser et al.,2000). Mice over expressing 
dopamine 2 receptor, show disruptions in prefrontally mediated cognitive 
endophenotypes (discussed later) of working memory and associative learning, that 
are also impaired in patients with schizophrenia, as well as to incentive motivation to 
food reward. Only the latter motivational deficit is reversed on switching off this 
over expression in the D2R mutant (Kellendonk, Simpson et al.,2009). This model is 
useful in understanding the underlying neurobiology of schizophrenia as it indicates 
that the mesostriatal pathways may be involved in mediating cognitive impairment in 
illness, and that blockade of D2 receptors may be beneficial in reversing this 
impairment. 
We investigated the three schizophrenia relevant phenotypes of Latent Inhibition 
(LI), a test of conditioned attention; sensorimotor gating to startle i.e. Prepulse 
Inhibition (PPI) and an Episodic Memory (EM) task. Prepulse Inhibition has face, 
predictive and construct validity (discussed in detail, Refer to Section 1.4.1) and is 
associated with schizophrenia, and can be modelled in mice and rats. Dopamine 
agonists disrupt prepulse inhibition and antipsychotic drugs improve prepulse 
inhibition (discussed in detail, refer to section 1.4.1). With regard to LI, mice have 
been selectively bred (e.g. mice over expressing dopamine 2 receptors, knock out 
mice lacking the dopamine 1 receptor) to respond to antipsychotic drugs that do so 
by blocking dopamine transmission.  
Episodic memory (memory for memory at a particular point in time) disruptions 
have been seen in schizophrenia patients (Park, Pschel et al.,1999; Park, Pschel et 
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al., 2003; Bonner-Jackson, Haut et al., 2005). These memory processes are regulated 
by dopamine; dopamine 2 receptors have been proposed to modulate verbal recall of 
memories (Chen, Kuang Yang et al.,2005).The dopamine 2 receptor is also involved 
in the memory for coding spatial information (Tran, Tamura et al.,2003), indicating 
that a transgenic model of memory would be a good schizophrenia relevant cognitive 
endophenotype. Thus, these models are useful for investigating latent inhibition and 
prepulse inhibition, and episodic memory as they would help elucidate whether 
aberrant gene function disrupts these cognitive endophenotypes, and also provide 
clues about the neurobiology underlying illness (Hitzemann,2000). 
There are a number of advantages of using the transgenic approach, apart from the 
use to investigate cognitive endophenotypes for illness. This includes the 
investigation of a mutated gene in a population with a homogeneous genetic 
background, as well as the ability to study the onset of illness in a controlled 
environment. Additionally, transgenic approaches also make it possible to study the role 
of specific receptors with much higher specificity than pharmacological approaches .A 
disease could also be modelled prior to the onset of its overt symptoms, and its 
functional consequences can be studied (Piccioto and Wickman, 1998). 
As mentioned previously, complex behaviours are attributed to a culmination of 
genetic effects, and although this is a useful rationale to employ the transgenic 
approach, it also acts as a limitation, as the allelic variation and expression levels of 
other genes can influence the phenotypes. If a phenotype is influenced by a number 
of genes, than knocking out a particular gene would lead to compensatory effects on 
the phenotype as a consequence of other genes. Additionally, the knockout approach 
is confounded by the background strain that the mutant is bred on. Some strains such 
as the C 57 show intact spatial memory, whilst others such as the 129/Sv show 
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disruptions on tasks used to model these memories. Some inbred mouse strains also 
show congenital deafness, or sight impairments (Crawley et al.,1997). These issues 
can be overcome by backcrossing with a mouse that has already been behaviourally 
phenotyped, but this might lead to a lethal mutation on the inbred background. It is 
suggested that since inbred strains show disruptions on complex behavioural task, 
utmost care needs to be taken in the strain selected for backcrossing (Piccioto and 
Wickman, 1998). 
Structural changes corresponding to circuits regulated by different neurotransmitters 
are also used to measure these endophenotypes. Other models have investigated the 
effect of aberrant neurotransmitter function using lesion studies i.e. the disruption of 
dopaminergic-glutamatergic actions in mediating abnormal responses to activation of 
mesocortical dopaminergic areas takes place post puberty, following early 
hippocampal insult (Tseng, Lewis et al.,2007). These approaches have been outlined 
in the subsequent sections. 
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Schizophrenia symptoms Tests used to model these 
symptoms 
Neurotransmitter systems that 
can be investigated 
I. Positive symptoms   
Psychomotor activation 
 
 
Hyperlocomotion in response 
to novelty/stress 
Locomotor activity 
Locomotor activity to novelty 
Dopamine, using dopamine 
agonists amphetamine to 
model enhancements in 
locomotor activity (Segal and 
Mandell,1974) 
Glutamate receptor agonists 
and antagonists 
Enhanced sensitivity to 
psychotomimetic drugs 
Augmented locomotor 
responses to NMDA 
antagonists PCP, Ketamine 
(Mohn, Gainetdinov et 
al.,1999) 
Locomotor response to 
amphetamine 
Increased sensitivity to tests of 
other drugs Dizocilpine, PCP 
on PPI 
Glutamate 
II. Negative symptoms   
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Social withdrawal 
Avolition 
Anhedonia  
Decreased interaction with 
juvenile conspecific 
Decreased preference for social 
novelty 
Decreased reinforcing 
properties of reward and drugs 
of abuse 
Altered aggression behaviour 
on resident intruder assay 
For example; mice with 
reduced NMDA receptor 
function show deficits in social 
interaction and motor activity 
(Mohn, Gainetdinov et 
al.,1999) 
Glutamate 
III. Cognitive symptoms   
Decreased working memory 
 
Deficits in executive 
dysfunction 
Memory deficits 
Impaired alterations in the t 
maze, radial arm maze, 
attentional set shifting 
Delayed non match to sample 
task  
Dopamine and glutamate 
agonist and antagonists 
Deficits in 
attention/sensorimotor 
gating/ 
Decreased PPI 
Decreased LI 
Dopamine and glutamate 
agonist and antagonists 
For example, to investigate 
predictive validity of 
antipsychotics (D2R 
antagonists) in the reversal of 
schizophrenia symptoms 
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Table 1.1 Mouse behaviours relevant to modelling symptomatology implicated in 
schizophrenia. Adapted from (Powell and Miyakawa 2006). 
(Weiner and Feldon,1987) or 
PPI disruption (Yee,2004) 
General cognitive deficits Decreased spatial learning in 
the Morris water maze 
Radial arm maze 
Same as the above; for instance 
by using PCP to affect 
glutamate neurotransmission 
and disrupt behaviour (Javitt 
and Zukin,1991) 
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1.1.5.1 Cognitive endophenotypes for illness 
 
Psychiatric disorders are a product of gene by gene interactions, gene by 
environment interactions, and epigenetic factors. These genetic interactions exist at 
multiple levels, and can be simplified by the use of endophenotypes, as they can 
quantify and delineate single gene functions, in a single activation circuit thus 
providing a more informative basis to the investigation of psychiatric illness (see Fig. 
1b).  
A number of alleles have been implicated as candidate genes for schizophrenia. 
These include Dopamine (DA), Neuregulin-1 (Nrg-1), Dysbindin and Disrupted- in -
Schizophrenia (DISC-1) (Harrison and Weinberger,2005) where aberrant functioning 
of these genes is thought to lead to abnormalities that underlie schizophrenia 
pathophyisiology (Gottesman and Gould,2003). Abnormal functioning in each of 
these components can be indexed in behavioural paradigms investigating the 
symptoms of illness. Schizophrenia endophenotypes link genetic associations to 
behaviours, rather than to behaviours themselves (Gould and Gottesman,2006). Thus, 
the allocation of specific gene function that contributes to schizophrenia like can be 
indexed by behavioural measures. In order to study this, ÔknockoutÕ or Ôknock-downÕ 
transgenic mouse models are created, that consist of a mouse strain lacking both 
functional copies of the allele or a certain percentage of the allele through a targeted 
mutation. For example, mice lacking dopamine transporter (DAT) have been used as 
a model of hyperdopaminergia in psychosis, as they show elevated synaptic levels of 
dopamine (Barr, Lehmann-Masten et al.,2004). This excess DA transmission 
promotes disruptions in attentional processing and can be  modelled in the LI task of 
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attentional salience, as a schizophrenia relevant phenotype. Mice with dampened 
DAT function show deficits in sensorimotor gating and hyperactivity to a novel 
environment, which are cognitive endophenotypes of schizophrenia. These deficits 
are reversible upon the administration of a selective serotonin antagonist and D2R 
antagonists that are antipsychotic drugs (Zhuang, Oosting et al.,2001), thus 
demonstrating predictive validity in an animal model of schizophrenia. Thus, mice 
with aberrant gene function relevant to schizophrenia can be generated, and 
abnormalities implicated in cognitive behavioural tasks of relevance to 
schizophrenia, are a good measure, to determine genetic contribution to illness.  
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Fig. 1b Endophenotypes are indexed by single genetic/neurobiological 
antecedents that can be linked to specific neuronal circuitry and delineated in 
terms of specific functioning in their associations with psychosis. Adapted from 
Gould and Gottesman,2006. 
36 
 
 
1.1.5.2 Neural circuits, genes and behaviour 
 
Histological measures are also used to investigate the effects of discrete genetic 
changes that contribute to deficits measurable on behavioural paradigms can be 
investigated in terms of their underlying neurobiology. Altered mRNA levels for 
proteins encoded by genes implicated in schizophrenia have been found (Farh,2005 
and Perkins,2007). The DISC-1 is a candidate gene for schizophrenia that is 
associated with cognitive endophenotypes for schizophrenia (Li, Zhou et al.,2007). 
Animals with disruptions in the DISC-1 gene show deficits in spatial learning as well 
as locomotion and prepulse inhibition. Deletion of the DISC 1 gene that is specific to 
the 129S6/SvEv strain, indicates gross brain morphology is intact in mice 
homozygous for the gene, but abolition in the production of this protein structure 
were seen upon transference of the DISC-1 allele to the C57Bl/6J strain (Koike, 
Arguello et al., 2006).  
Another gene that has been implicated in schizophrenia pathophyisiology includes 
the Dysbindin gene. A reduction of dysbindin-1 mRNA has been implicated in the 
formation of hippocampal synaptic plasticity in the CA3 region in the brains of 
schizophrenic patients (Wicker,2008) and may contribute to schizophrenia 
pathophysiology. Histological measures are also used for exploring protein changes 
is through lesion studies. Consequently, the hippocampus plays a role in 
remembering; in the consolidation and retrieval of memories (Costner, Goldman-
Rakic et al.,2004), where hippocampal lesions disrupt the formation or retrieval of 
associations (For wood, Winters et al.,2005).  More specifically, hippocampal 
damage is thought to affect exploratory preferences in rats and has been implicated in 
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studies of learning and memory. Altered inhibitory glutamate and GABAergic 
mechanisms also mediate neural plasticity in the hippocampus and promote these 
disruptions in behaviour (Impey, Mark et al.,1996; Abel, Nguyen et al.,1997; 
Malenka and Bear 2004; Forwood, Winters et al.,2005) which may be attributed to 
protein changes in the brain. This demonstrates a schizophrenia relevant 
endophenotype, as disruptions of schizophrenia relevant behaviours may be linked to 
changes in glutamate neurotransmission and aberrant gene function. 
 
1.1.5.3 Neurodevelopmental approaches 
 
Another approach to investigate aberrant gene function in Schizophrenia is by 
investigating gene*environment and gene*gene interactions, where, in the former a 
combination of genes and the environment may predispose to behavioural 
abnormalities as indexed by phenotypic measures. These may depend on experience 
at various stages of life, which interacts with a combination of genetic effects in 
predisposing to illness (Waddington, Corvin et al.,2007; Kirby, Waddington et al., 
2009).  
The neurodevelopmental hypothesis of schizophrenia posits that environmental 
insults that promote illness, usually take place in the prenatal or perinatal stages of 
development, where aberrant gene effects at these stages may manifest only at a later 
stage of development(Olney and Farber,1995). There is evidence for schizophrenia 
onset at adolescence(Thomsen,1996; Oise and Rund,1999) as indicated by 
volumetric gray matter changes in the dorsolateral pre frontal cortex during 
adolescence (Thompson, Vidal et al.,2001). These factors are mediated both by the 
environment and time of developmental insult onset at a later stage. The genes 
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implicated in schizophrenia, that have been investigated this neurodevelopmental 
approach include the DISC-1 and Neuregulin-1 genes. A study that has investigated 
the role of the DISC-1 in schizophrenia pathophysiology used DISC-1 knockdown 
mice, which show abnormalities in postnatal mesocortical dopaminergic maturation, 
as a consequence of disturbance to pyramidal neurons that mediate neuronal 
plasticity. This disturbance in brain maturation disrupts a sensorimotor gating in post 
pubertal rats (Niwa, Kamiya et al.,2010).Increasing evidence is emerging for  
mutations in the ErbB4 gene, encoded by Nrg-1, in disrupting developmental 
processes in schizophrenia (Walsh, McClellan et al.,2008). Nrg-1 regulates both 
inhibitory and excitatory neurotransmission in the brain, and alterations in the Nrg-1 
ErbB4 pathway may influence plasticity by altering glutamate and GABAergic 
transmission to contribute to schizophrenia pathophysiology (Mei and Xiong,2008). 
Consequently, infant mice that were administered the Nrg-1β1 (which binds to the 
ErbB4 receptors) in the postnatal period, show impairments on prepulse inhibition, 
latent inhibition and social interactions tasks when tested at adulthood (Kato, Abe et 
al.,2010). The neurodevelopmental hypothesis has also been investigated using 
lesions, to investigate the effects of these lesions on schizophrenia relevant brain 
areas and their effects at maturation. Rats with ibotenic acid lesions in the ventral 
hippocampus on the seventh day of birth, show increased hyperactivity to a novel 
environment in early adulthood following amphetamine administration. Additionally, 
rats lesioned as neonates also show hyperactivity in the forced swim test, which has 
been attributed to increased mesolimbic dopamine responsivity to these lesions 
(Lipska, Jaskiw et al., 1993).   
Other factors that contribute to schizophrenia pathology early on in development 
includes poor maternal nutrition, maternal infection, birthing season, urban births as 
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well as minor physical anomalies (Lewis and Levitt,2002). Consequently, mice 
administered protein regulator, immune challenging agent Polyl:C on gestation day 9 
show deficits in latent inhibition, prepulse inhibition, as well as an enhancement in 
reversal learning and augmented locomotor activity in response to amphetamine, at a 
later stage of development (Meyer, Feldon et al., 2005). Therefore, these data suggest 
that maternal infection at mid gestation can promote deficits post puberty and 
promote schizophrenic pathophyisiology. Thus, neurodevelopmental approaches are 
useful measures of tracking changes at different stages of development, as they help 
delineate the role of environmental insult and their interaction with gene function in 
the course of development from birth to adulthood, where symptoms relevant to 
schizophrenia may only be evident at later stages of maturation. 
1.2 Schizophrenia relevant phenotypes that investigate the dopamine 
hypothesis  
 
The psychotic symptoms of schizophrenia have been attributed to a 
hyperdopaminergic state in the limbic regions; administration of a dopamine agonist 
amphetamine causes psychotic like symptoms that are reversible by neuroleptic 
drugs. Furthermore, the dopamine hypothesis suggests dopamine hypofunction in the 
cortex (Jentsch, Redmond et al.,1997). The imbalance of dopamine as a consequence 
of the deficit of dopamine in the cortical region and an excess in the sub cortical 
regions (Abi-Dargham 2004 ).Consequently, negative symptoms such as avolition to 
the reinforcing properties of rewarding behaviours and both of these models of hyper 
and hypodopaminergia together promote the formation of the positive, negative and 
cognitive symptoms of illness (Davis, Kahn et al.,1991). Dopamine is involved in 
motivational salience of environmental stimuli, where reward associated stimuli are 
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the focus of attention for an animal construct of attention in schizophrenia, and goal 
directed behaviour (Bridge and Robinson, 1998, Howes and Kapur, 2009).  
1.2.1 The role of dopamine D2 receptors in schizophrenia 
 
The D2R plays a role in mediating schizophrenia symptoms (Glut, Forgone et al., 
2003; Debarred, Goya et al.,2004; Lawford, Young et al.,2005). There are an 
increased number of D2R present in the brain compared to other D2-like dopamine 
receptor subtypes (Holmes, Lachowicz et al.,2004); dopamine occupies a higher 
proportion of D2 receptors in the striatal brain regions of schizophrenics as compared 
to controls (Kegeles,Abi-Dargham et al,.;2001 Abi-Dargham, Rodenhiser et 
al.,2000). Overstimulation of dopamine produces DA hyperactivity and increased 
DA transmission in the striatal regions, and hypoactivation, or dampened DA activity 
in the cortical regions. Mice over-expressing D2 receptors in the striatum show 
deficits on a test of working memory as indexed by the delayed non match to sample 
task and attentional set shifting (Kellendonk, Simpson et al.,2006).  
Dysregulation of sub cortical dopamine in the pre frontal cortex  by D1 receptors has 
been implicated in the literature (Weinberger, Berman et al.,1992; Weinberger, 
1993), and mediates the cognitive deficits in schizophrenia.  The hypo activation of 
dopamine in the prefrontal region (Weinberger 1988) increases D2 turn over in the 
sub cortical areas, and DA receptor increases are dampened by D2 receptor 
antagonists/antipsychotic drugs (Deutch 1992). The D1 and D2 receptors modulate 
glutamate neurotransmission via projections to these regions. Reduced PFC activity 
owing to the secondary mechanisms of aberrant NMDA functioning, promotes 
decreased mesocortical DA activity. D2 receptor stimulation inhibits NMDA 
receptor mediated flow of information from the cortex to the striatum, (Laruelle, 
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Kegeles et al.,2003) and D1 receptor stimulation facilitates glutamate 
neurotransmission in the striatum(Centonze, Picconi et al.,2001). Thus, these studies 
suggest that D2 receptors are directly and indirectly (via D1R modulation) involved 
in the regulation of symptoms of illness. Indirect DA agonist Amphetamine induced 
disruption of schizophrenia relavant phenotypes is a model of hyperdopaminergia, by 
altering DA transmission; administration of amphetamine in rodents, induces 
schizophrenia like symptoms, and produces disruptions in schizophrenia relevant 
phenotypes (Centonze, Picconi et al.,2002). This is discussed in the next section. 
1.2.2 Amphetamine induced disruptions in schizophrenia phenotypes 
 
Schizophrenia symptoms are worsened in patients with schizophrenia that use 
amphetamine (Lieberman, Kinon et al.,1990), and in healthy humans administration 
of amphetamine even at low doses produces behaviour that resembles the positive 
symptoms of psychosis (Angrist and Gershon,1970). Amphetamine (AMPH) exerts 
its effect on multiple brain regions including the dopaminergic system (Seiden, Sabol 
et al.,1993; Seeman, Schwarz et al.,2006); PET and single photon emission 
computed tomography (SPECT)  studies show increases in, synaptic dopamine levels 
in the striatal region in humans (Breier, Su et al.,1997) and rats (Wang, Pei et al., 
2010) following amphetamine administration. 
Amphetamine increases extracellular dopamine by vesicular release and reverse 
transport (Jones et al.,1998; Budygin et al.,2004). Amphetamine enters the dopamine 
vesicles and causes displacement of dopamine from the vesicles to the cytoplasm. 
Dopamine is released into the extracellular space by outward transport by the 
dopamine transporter. Via the plasma membrane transporter, the transport of 
dopamine takes place from one side of the plasma membrane to another, increasing 
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the rate of reverse transport, and thereby increasing the amount of extracellular 
dopamine across the plasma membrane (Jones et al.,1998, Floor and Meng,1996). 
Amphetamine induced behaviours in rodents have been used to model the 
dopaminergic hyperactivity associated with schizophrenia (Alexander, Wright et al., 
1996).For instance, amphetamine induced disruptions in D2 receptor wild type and 
knock out models have been used to investigate the role of these receptors in PPI 
(Swerdlow, Mansbach et al.,1990), LI (Solomon and et al.,1981) and locomotor 
activity(Braun and Chase 1986) that are attenuated in schizophrenia.  
 Psychostimulants produce hyperactive and stereotypic (sniffing, licking, biting, head 
movements) behaviours in rodents (Braun and Chase 1986) in a dose dependent 
manner. More specifically, low doses of amphetamine (1mg/kg) disrupt latent 
inhibition and produce locomotor stimulation via the nucleus accumbens or ventral 
striatum (Weiner et al.,1988,Warburton et al. ,1993.Bay-Richter et al. 2008; Gray et 
al.,1991). High doses (5 mg/kg) on the other hand, lead to stereotypy via the dorsal 
striatum and nucleus accumbens (Weiner et al.,1988, Joseph et al.,2000, Gray et al,. 
2005). Previous studies using the task of learned inattention latent inhibition (LI) 
have shown LI disruption by low, but not high doses of amphetamine; that is 
attributed to differential involvement of these doses with the mesolimbic and 
mesotriatal systems. At high doses, amphetamine is thought to predispose to anxiety 
related behaviours in mice (Bia, Grazyna et al.,2007) as well as stereotypy and 
preservative behaviours that create cognitive and affective disturbances (Groves and 
Rebec 1976; Braun and Chase, 1986). These cognitive tasks of relevance to 
schizophrenia have been discussed in more detail in the following sections.
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1.3 Models of cognitive dysfunction implicated in schizophrenia 
 
1.3.1 Latent inhibition and schizophrenia 
 
LI is a retardation in learning to a stimulus, as a consequence of that stimulus being 
previously pre exposed, without any reinforced consequences (Lubow and Moore 
1959; Lubow,1989), and has been observed in a variety of species including mice, 
rabbits, goats and humans (Lubow 1989), see Figure 1c. Psychosis is postulated to be 
a dopamine mediated state of aberrant salience (Kapur, Mizrahi et al.,2005), it is 
suggested that environmental and genetic factors predispose to dysregulated 
dopaminergic firing that promotes an assignment of salience to irrelevant stimuli. In 
order to justify this context-inappropriate salience attribution, schizophrenic patients 
experience hallucinations (distorted perceptions) and hallucinations (false beliefs); 
which thereby acts as a Ôcognitive schemeÕ to guide and process further thoughts and 
action (Kapur, Mizrahi et al.,2005). D2 antagonists block dopamine to dampen the 
irrelevant salience of these symptoms, and serve to improve impaired cognitive 
functioning (Kapur and Mamo,2003; Mishara and Goldberg,2004).  
Thus, LI is used as a model of Ôlearned inattentionÕ i.e. ability to ignore irrelevant 
information, and maintain attention to the relevant stimulus and schizophrenia 
patients show disruptions on LI(Rascle, Mazas et al.,2001). Consequently, this task is 
an index of learning, of the rate at which an organism learns as association between 
the unconditioned stimulus (UCS) and the conditioned stimulus (CS), wherein, the 
Ôto-be-CSÕ  that occurs without consequences over a number of trials is compared 
with a stimulus that has not had the chance to become associated with anything 
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(Oades, R et al.,1997). Conditioning studies that used LI in humans use a variety of 
tasks; eye blink conditioning, electrodermal conditioning and taste aversion 
conditioning (Arwas, Rolnick et al.,1989) to demonstrate the LI effect.  
LI can be indexed as a measure of conditioned emotional suppression of behaviours 
that comprises of three stages; pre exposure (PE), in which a stimulus that is to be 
conditioned (tone) to is presented repeatedly, conditioning where the pre exposed 
stimulus is paired with a reinforcement (foot shock) and a test phase which is 
indexed by the animalÕs learning to suppress licking.
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Fig 1c. Diagrammatic description of the LI protocol, depicting the PE and NPE 
stages. In the PE stage, the animal is conditioned to a tone, whilst NPE stage 
animals receive no tone. Upon conditioning, this tone is paired with a shock. In 
the test phase, the PE group exhibit retarded learning of the tone as a predictor 
of the shock, whilst NPE animals show that this association has been sufficiently 
learnt.
CONDITIONING 
TEST 
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1.3.2 Mechanism of action of amphetamine and amphetamine 
mediated LI disruption in schizophrenia 
 
As previously mentioned, Amphetamine increases extracellular dopamine by 
vesicular release and reverse transport (Jones et al.,1998; Budygin et al.,2004). 
Amphetamine stimulates the transport of dopamine, which permits the movement 
from one side of the plasma membrane to another, increasing the rate of reverse 
transport, and thereby increasing the amount of extracellular dopamine across the 
plasma membrane (Jones et al.,1998; Floor and Meng,1996). By blocking access to 
the transporter, the probability of reverse transport is lowered, thereby increasing 
extracellular dopamine (Carboni et al., 2001).  
Amphetamine induced disruptions on behavioural models relevant to Schizophrenia 
are differentially mediated depending on the dose administered; low doses of 
amphetamine produce hyperactivity and high doses produce stereotypy in rodents 
(Feldon, et al.,1990). Previous studies using the LI task have shown LI disruption by 
low, but not high doses of amphetamine(Weiner,1987; Weiner, Lubow et al.,1988), 
which is attributed to differential involvement of these doses with the mesolimbic 
and mesotriatal systems. The mesolimbic system consists of the nucleus accumbens, 
a major site of termination of this system, along with its afferents and efferentÕs to 
other areas such as the amygdala, the hippocampus and the medial pre frontal cortex, 
and the mesostriatal system consists of the substantia nigra and the striatum. Both of 
these circuits are efferent fiber projections of the ventral tegmental area and jointly 
consist of the dopaminergic pathway. Low doses of amphetamine (1mg/kg) disrupt 
latent inhibition and produce locomotor stimulation via the nucleus accumbens or 
47 
 
ventral striatum (Weiner, Lubow et al.,1988; Gray,1991; Clea, Warburton, Joseph et 
al.,1994). High doses (5 mg/kg) on the other hand, lead to stereotypy via the dorsal 
striatum and nucleus accumbens (Weiner, Lubow et al., 1988; Gray, Joseph et al., 
1995; Joseph, Peters et al.,2000) .However, administration of D1/D2 mixed agonist 
apomorphine, and indirect dopamine agonist, at low and high doses (0.3 and 1.5 
mg/kg) did not produce LI disruptions (Feldon,1991). Consequently, failure of LI 
disruption at a high dose has also been seen (6mg/kg) (Weiner et al.,1987), where 
high doses of apomorphine and amphetamine DA agonists do not alter LI (Feldon, 
Barkai et al.,1990) This suggests that the amphetamine disruption of LI in 
schizophrenia is mediated by a low the dose which is sufficient to produce 
schizophrenia like cognitive deficits. 
1.3.2.1 Disruptive effects of amphetamine are mediated by the injection 
schedule in LI 
 
Different effects of amphetamine administration are seen depending on whether they 
occurred as part of a single PE (PE) session followed by a conditioning (COND) 
session, or as two sessions split by a 24 hour time interval. In a session where each of 
the stages (PE, COND, Test) were separated by 24 hours, acute administration of a 
high dose of amphetamine (6 mg/kg), prior to pre exposure and conditioning did not 
induce LI disruptions in rats (Weiner, Izraeli-Telerant et al.,1987). In the same study, 
chronic exposure to this high dose of amphetamine prior to both stages did not 
attenuate LI. Alternatively, a low dose of amphetamine (1.5 mg/kg) disrupts LI in 
rats when administered in both the PE and COND stages only, indicating that neither 
high doses not chronic exposure to amphetamine is needed to produce this 
disruption(Weiner, Lubow et al., 1988). In the session where PE and COND were not 
separated by a 24h interval, the administration of  a single low dose of amphetamine 
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15 minutes prior to PE, and 15 minutes prior to COND, with a thirty minute interval 
between the PE and COND  sessions did not disrupt LI. However, the same injection 
schedule did disrupt LI when the PE and COND sessions were 24 hours apart 
(Weiner, Lubow et al., 1988). This is corroborated by other studies that suggest that a 
single low dose of amphetamine (0.32 mg/kg, subcutaneously) administered 30 mins 
prior to the PE and COND phases attenuates LI (McAllister,1997). A later study 
showed that amphetamine administered 45-90 mins prior to conditioning, but not 15 
mins prior to conditioning, also abolishes LI(Young, Moran et al.,2005). These 
studies indicate that amphetamine mediated disruption of LI are 1) sufficiently 
induced by low doses of amphetamine and 2) dependent on the injection schedule 
adopted.  
1.3.2.2 Mechanisms for amphetamine disruption of LI: the ÔswitchingÕ model 
of LI 
 
The ÔswitchingÕ model asserts that there are two models of LI i.e. one of LI 
disruption and one of abnormally persistent LI. LI is an acquisition deficit, which is 
characterized by an inability in acquiring the CS (tone) Ð reinforcement (shock) 
association as a consequence of non-reinforced procedures, thereby, decreasing the 
associability of the CS (tone) in predicting the reinforcer. However, LI disruption is 
not only dependent on the PE phase. Rather, according to the switching model, LI is 
a selection problem that involves learning conflicting contingencies i.e. a pre 
exposed phase accompanied by no reinforcement, and the conditioned phase 
accompanied by a reinforcer. The acquisition of information takes place in the PE 
and its expression in the COND. The cognitive switching phenomenon involves 
learning both the ability to ignore, and an inability to ignore, where certain 
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combinations in the number of PEÕs, number of conditioning sessions or context 
changes causes control rats to switch attentional mechanisms according to the 
appropriate stimulus-reinforcer contingency (Weiner 2003). 
 This model has been used to investigate the amphetamine induced disruption of LI 
and the neuroleptic reversal of amphetamine induced disruption of LI, in addition to 
LI potentiation by antipsychotic drugs (see Table 1.2). Furthermore, APDÕs block D2 
receptors in the cortical regions, and mesolimbic DA system is critical in attribution 
of salience to DA (Kapur and Mamo 2003). APDÕs reverse amphetamine induced 
disruption of LI, under a low number of stimulus PEÕs, which does not lead to LI in 
control animals, as opposed to sufficient numbers of PEÕs which yield robust LI in 
control animals. This is dependent on the PE and COND parameters employed 
(Weiner 2003). APDÕs haloperidol (0.1 mg/kg), clozapine (5mg/kg) and Ritanserin 
(.6 mg/kg) administered in PE and/or COND, do not facilitate low level LI (40 PE). 
Using 5 conditioning trials and 40 PEÕs however, haloperidol and clozapine only 
facilitated the emergence of LI. Under conditions that did produce LI in controls, 40 
PE and 2 conditioning trials, clozapine and ritaserine abolished LI(Shadach, Gaisler 
et al., 2000). This is consistent with studies in dopamine knockout mouse models, at 
low PEÕs (40) enhanced LI is seen in D1 female KO animals. Alternatively, D2R KO 
animals also show enhanced LI under these low PEÕs, with no LI in WT controls 
(Bay-Richter, O'Tuathaigh et al., 2009). The blockade of the dopamine 
neurotransmission promotes development of LI, and the enhancement of DA 
neurotransmission disrupts LI (Feldon, Barkai et al., 1990). DA agonist amphetamine 
and D2R receptor antagonist Haloperidol differentially mediate the expression of 
information in this switching context; AMPH mediates rapid switching in LI and 
haloperidol retards switching (Weiner,2003). Thus, amphetamine disruption of LI is 
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not only governed by the dose and schedule of amphetamine administration prior to 
PE and COND, but also the number of pre exposures in the LI task. 
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LI effect  Compound Dose Range 
tested 
Dose effective  
Disruption of 
LI 
d-Amphetamine 1 and 4 
mg/kg, s.c.; 
45 min prior 
to training 
4 mg/kg (Solomon and 
et al.,1981) 
  2 injections X 
1 mg/kg, 24 h 
and 15 min 
prior to PE, 
Cond and 
Test 
Abolished LI 
in a single 
session 
(Young 1992) 
  1 mg, i.p.  
different CS 
stimuli used 
1 mg/kg, but 
only with 
flashing house 
light 
(Ruob,Elsner 
et al.,1997) 
  1.5 mg/kg i.p; 
different PE 
durations of 
3, 30 and 150 
mins 
1.5 mg/kg 
only at 30 PE 
duration 
(De la Casa, 
Ruiz et 
al.,1993) 
  .5,1.5, 3 i.p. 
mg/kg 
.5 mg/kg i.p. 
Non 
significant LI 
attenuation 
 
 
(Killcross, 
Dickinson et 
al.,1994) 
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PCP 1 and 5 
mg/kg prior 
to PE, Cond, 
or both 
No effect (Weiner and 
Feldon 1992) 
 
 
 
  2.5 mg/kg i.p. 
(15 min pre 
treatment) or 
8.6 mg/kg i.p 
( 20 h pre 
treatment) 
No effect at 
2.5 mg/kg, 
abolished at 
8.6 mg/kg 
(Turgeon, 
Auerbach et 
al.,1998) 
Reversal of 
amph 
induced 
disruption of 
LI 
Haloperidol 0.2 and 0.5 
mg/kg 
Against 1 
mg/kg i.p. 
Amphetamine 
0.2 and 0.5 
mg/kg 
(Warburton, 
1996) 
 
 
 
 
Clozapine 1-10 mg/kg 
Against1 
mg/kg 
amphetamine 
2 and 5 mg/kg (Moran, 
Fischer et al., 
1996) 
 
Table 1.2 Table showing LI disruption by amphetamine, and its reversal by 
neuroleptics, and neuroleptic induced potentiation of LI. Adapted from (Moser, 
Hitchcock et al., 2000) 
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1.4 PPI and schizophrenia 
 
LI is a task of learned irrelevance that is used to model irrelevant attentional 
information that mimics attentional deficits in schizophrenia. Prepulse Inhibition is 
another attentional cognitive phenotype of relevance to schizophrenia. Rather than 
the ability to allocate attentional processes to ignore irrelevant stimuli, it is used as an 
index to ÔgateÕ or filter information in schizophrenia. PPI is a measure of 
sensorimotor gating where the Acoustic Startle Reflex of an animal (ASR) is 
reduced, when the startling stimulus is preceded by a low intensity prepulse. 
Sensorimotor gating is a means to ÔgateÕ the flow of information received from the 
environment that is processed by the brain, which schizophrenic patients are unable 
to do. More specifically, PPI is a measure of gating attentional and cognitive deficits 
that are present in schizophrenia. Disruption of this process in schizophrenia leads to 
an inability to process the ÒfloodÓ of information and disorganized thoughts that are 
characteristic of the illness (Venables,1960). This measure of assessing startle gating 
possesses continuity across species, and has been observed in mice (Kokkinidis, 
1986; Csomor, Vollenweider et al.,2008; Powell, Zhou et al.,2009), pigs (Lind, 
Arnfred et al.,2004) and humans. Deficits in PPI have been seen in drug nave first 
episode schizophrenics (Ludewig,2003), stable outpatients and inpatients (Parwani, 
Duncan et al.,2000). These deficits have seen as impairments in the inhibitory 
mechanism in the acoustic startle response.  
PPI measures salient sensitivity to a stimulus, and can be used to model sensorimotor 
gating deficits as seen in schizophrenia, on a schizophrenia relevant phenotype, 
disruptions in PPI can be induced by administration of DA agonists, and the ability 
of APDÕs to reverse of these disruptions can be modelled (Swerdlow,2008). PPI has 
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face, construct and predictive validity for illness (Swerdlow,1994). Face validity 
indicates that changes in PPI impairment in Schizophrenia in humansÕ parallels 
changes in PPI in rodent models; dopamine agonist induced disruptions in PPI, 
mimic PPI deficits in schizophrenia patients. This task also has predictive validity, 
where indirect dopamine agonist induced disruptions on PPI are reduced by 
treatment by typical or atypical antipsychotics, but not by psychoactive drugs that 
lack antipsychotic activity (Hoffman and Donovan 1994).Thus, PPI disruption holds 
predictive validity as it predicts the efficacy of antipsychotics (D2R-like antagonists) 
in reversing dopamine agonist mediated disruptions. Lastly, this measure has 
construct validity because disruptions on PPI are produced by dopamine agonists, 
serotonin 5HT-2A agonists and NMDA receptor antagonists which reproduce 
abnormalities implicated in schizophrenia (Geyer,Mark et al.,2001; Swerdlow, 
2008). 
The indirect DA agonist amphetamine facilitates DA release and causes disruptions 
of these gating processes in schizophrenia, and animal models of schizophrenia used 
to index PPI, mimic these amphetamine induced disruptions in PPI (Mansbach, 
Geyer et al.,1988; Ralph, Varty et al.,1999; Sills 1999; Ralph, Paulus et al., 2001; 
Tenn, Kapur et al.,2005). Furthermore, antipsychotic drugs reverse PPI deficits in 
schizophrenia patients (Meltzer, Park et al.,1999; Salimi, Jarskog et al., 2009). 
Typical antipsychotic drugs such as haloperidol and risperidone, atypical 
antipsychotics such as clozapine, and drugs that function as D2R-like antagonists are 
able to reverse PPI deficits in patients with schizophrenia (Hoffman and Donovan 
1994; Geyer,Mark et al.,,2001; Varty, Walters et al.,2001). Thus, PPI is used as a 
cognitive phenotype for illness. 
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1.4.1 Dopaminergic modulation of amphetamine induced disruption of 
PPI 
 
The direct nonspecific dopamine agonist apomorphine and indirect DA agonist 
amphetamine have been shown to disrupt PPI in rats and mice (Mansbach; 1988, 
Davis et al.,1990, Varty et al.,2001). Neither apomorphine (5 mg/kg) nor the more 
selective D1 selective receptor agonist SKF82958 (0.3 mg/kg) altered PPI in D1R 
KO mice, although both compounds disrupt PPI in D2R WT and KO mice, 
suggesting that the D1R alone might modulate PPI in mice. However, the NMDA 
antagonist Dizocilpine (0.3 mg/kg) induces similar PPI deficits in D1R and D2R KO 
mutant mice, confirming that the influences of the NMDA receptor on PPI are 
dependent on both D1Rs and D2Rs in rodents. Thus, both D1Rs and D2Rs modulate 
PPI deficits differently (Williams et al.,2002), suggesting that different drug-receptor 
interactions affect PPI differently in this mouse model. Robust PPI and acoustic 
startle have been seen in D2R, D3R and D4R KO mice (Ralph, Varty et al.,1999). 
However, administration of amphetamine (10 mg/kg), only disrupts PPI in D3 and 
D4 KO mice, but not in D2R KO mice., but amphetamine induced disruption of PPI 
in D2R (+/-) Heterozygous mice is seen(Ralph, Varty et al.,1999). Subsequent 
studies have reported amphetamine induced disruptions in PPI in D1R WT and KO 
mice and in D2R WT, but not D2R KO mice, suggesting that the D2R may not play a 
role in modulating PPI (Ralph-Williams et al.,2002). As reported previously, 
amphetamine (10 mg/kg) failed to disrupt PPI in D2R knock-out mice (Ralph et al., 
1999), supporting a unique role of the D2R in the amphetamine disruption of PPI.  
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1.4.2 Other considerations: The influence of sex and strain on PPI 
 
Sex differences have been seen in studies of PPI and the acoustic startle response 
(ASR). PPI is expressed as a percentage inhibition of the ASR magnitude. In 
humans, the administration of d-amphetamine attenuates the inhibition of the 
prepulse responses in both men and women (Hutchison and Swift 1999). StudiesÕ 
report that women show less prepulse inhibition than men (Kumari, Gray et al., 
2003). Females showed less PPI on a single prepulse paradigm as compared to men, 
but exhibited prepulse facilitation, when inter stimulus interval lasts over 50 msecs) 
on when two sets of prepulses were administered in succession. This effect may be 
mediated by protocol, and may also be subject to oestrogen and menstrual cycle 
changes (Chavez, Gogos et al.,2009).  Menstrual cyclic changes affect mesostriatal 
dopamine activity; an increase in oestrogen levels is accompanied by a reduction in 
prepulse inhibition (Meziane,2007).  
Other studies attribute time of day (circadian rhythms) rather than menstrual cyclic 
changes, in disrupting PPI in a sex specific manner (Adams, Hudson et al.,2008; 
Gogos,2009). In line with this, hormonal fluctuation in the four stages of oestrous 
cycle-proestrous, oestrous, metestrous and diestrous of the menstrual cycle only 
altered PPI magnitude in the BALB/By strain. More specifically, the behaviour of 
the C57 females was consistently stable despite oestrous cycle modulations in PPI 
and other behavioural tests when compared to the BALB/cByJ females (Meziane et 
al.,2007). This suggests sex specific differences in PPI may be strain specific (Paylor 
and Crawley, 1997;Taylor ,Markham,et al.,2011;Kilpatrick et al., 2010).  
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1.4.3 Low and high dose injections as well as aministration schedules 
affect amphetamine induced disruption of PPI 
 
Previous studies show LI disruption by low, but not high doses of amphetamine at a 
24h interval. This is attributed to dose dependent involvement of amphetamine with 
the mesolimbic and mesotriatal systems. The mesolimbic system has been implicated 
in low dose amphetamine mediated disruption of PPI. At low doses, amphetamine is 
coupled to impulse flow, and promotes augmented release of DA in the C57 mouse 
strain (Ventura et al.,2004). At high doses, amphetamine becomes uncoupled to 
impulse flow; and promotes preservative/restricted behaviours in this strain (Ralph et 
al.,2001).Consequently, dopamine depletion by  6-hydroxydopamine lesions in the 
nucleus accumbens, olfactory tubercles and anterior striatum reverse amphetamine 
induced disruption on PPI, but do not disrupt AMPH potentiation of ASR. As the 
ventral striatum is associated with these limbic structures, it is suggested that 
increased mesolimbic DA activity governs AMPH-induced disruption of 
PPI(Swerdlow, Mansbach et al.,1990) .  
Disruptions in PPI are also affected by the time window between administration of 
injections and test sessions. Amphetamine affects the release of dopamine in the 
mesolimbic region between a 1-3 hour time window(Gold, Swerdlow et al.,1988). It 
is seen that amphetamine (0, 0.3, 1, or 3 mg/kg) attenuated PPI when tested 10 mins 
after amphetamine administration, and when the prepulse stimuli were 5 dB above 
65dB of background noise. It is suggested that background noise influences 
amphetamine disruption of PPI; amphetamine dose dependently disrupts PPI when it 
is administered immediately after an amphetamine injection or ten minutes prior to 
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test, when the prepulses need to be at least 5dB above 65 dB background noise (Sills 
1999).Consequently, a 3 mg/kg dose was found to effectively disrupt PPI when 
prepulses were 10db above background noise only.  These disruptions were seen at 
the 10-40 min time window between amphetamine administration and test; at 40-70 
delay between administration and test only a high dose of amphetamine disrupted 
PPI. At a 60-90 min time window between amphetamine administration and test, 
none of the doses of amphetamine disrupted PPI(Sills, Onalaja et al.,1998).Thus, 
longer delays between injection and test prevent amphetamine induced disruptions. It 
is suggested that PPI should be tested within a relatively narrow time window 
between injections and test, as a 40-60 min delay leads to a complete loss in the PPI 
attenuating effect as mediated by amphetamine (Sills,1999).  
Sensitization studies indicate that PPI is also disrupted as a consequence of different 
numbers of injections of amphetamine over a number of days. Following an 
escalated dose regime (3 injections per day X 6 days), where amphetamine 
administration was increased from 1-10 mg/kg, disruptions in PPI were seen (Peleg-
Raibstein, Sydekum et al., 2006). However, escalating doses from 1-3 mg/kg with 3 
injections per day also disrupted PPI (Tenn, Kapur et al.,2005). These sensitization 
studies corroborate previous studies and suggest that low and high doses of 
amphetamine both modulate PPI differently.  
1.5 Memory impairments in schizophrenia 
 
Both LI and PPI are measures of cognitive function that are disrupted in 
schizophrenia and these disruptions may be induced by the aberrant functioning of 
the DA system. Deficits in memory are another subset of these cognitive 
impairments that are modulated by aberrant neurotransmitter function in 
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schizophrenia. Dopamine is involved in the cortical modulation of working memory 
in the PFC as well as in spatial memory, where DA agonists produce deficits in 
spatial memory and amphetamine mediated deficits on recognition memory  are seen 
in rodents (Stefani and Moghaddam, 2002; Bisagno, Ferguson et al.,2003; Castner, 
Goldman-Rakic et al.,2004).  Schizophrenic patients show deficits in multiple facets 
of memory i.e., working memory and memory for cued recall and recognition 
(Sullivan EV 1994; Joyce, Collinson et al.,1996; Hutton, Puri et al., 1998).They also 
show impairments on verbal and non verbal measures of long term memory, logical 
memory(Toulopoulou, Rabe-Hesketh et al.,2003), and episodic memory (Tendolkar, 
Ruhrmann et al., 2002; Bonner-Jackson, Haut et al., 2005).  
Tests for retrospective memory are species specific and have been developed for 
birds, dolphins and rodents. The formation, storage, consolidation and retrieval of 
memories involves multiple substrates(Leavitt and Goldberg 2009), where complex 
interactions between the glutamate and dopaminergic systems mediate the formation 
and storage of these memories (Rushe, Woodruff et al., 1999; Arco and Mora,2009). 
Memories for remembering  Ôwhat, where, and whenÕ (memory for episodes) have 
involved the caching and recovery of food in scrub jays (Clayton and Dickinson 
1998,Dere et al.,2006) as well as food  preference tasks in non human 
primates(Hampton, Hampstead et al.,2005). These models of declarative and 
reference memories place emphasis on hippocampal connections underlying the 
formation of memories(Castner, Goldman-Rakic et al.,2004).  
60 
 
 
1.5.1 The role of dopamine and glutamate neurotransmission in 
mediating memory in schizophrenia 
1.5.1.1 Neuroanatomy of episodic memory 
 
The pre frontal cortex is involved in the encoding and retrieval of memories( Nyberg 
et al. 2003, Israel 2010, Wheeler, Stuss et al. 1997) and contributes to the formation 
of these memories. For instance, the dorsolateral prefrontal cortex (DLPFC) 
integrates information provided by sensory and motor systems in mediating working 
memory and executive functioning, as well as long term memories and encoding. 
Prefrontal dysfunction in an episodic memory task has also been seen in 
schizophrenics ( Ragland, Gur et al., 2001).  Alternatively, the dorsomedial PFC may 
play a distinct in episodic memories by processing information that is relevant to the 
self and self encoded personality, and initiating a concept of memory based on oneÕs 
experience(Brand 2008). Other studies support PFC involvement in mediating 
recognition memory for objects, PET studies have shown decreased cerebral blood 
flow in the PFC during the recognition of new objects and greater increases in 
cerebral blood flow in the left PFC in the recognition of objects that they had 
previously experienced (Heckers, Curran et al., 2000).  
Both prefrontal and hippocampal activation has been seen in a test of episodic 
retrieval in schizophrenia; increased regional cerebral blood flow in the DLPFC and 
reductions in hippocampal activation of the conscious recollection memories has 
been seen in a schizophrenic cohort (Heckers 1998). This suggests, there is a 
dissociation in the encoding and retrieval of memories by the hippocampus and PFC 
in episodic memory (Dietrich 1998;).  
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1.5.1.2 Pharmacology of Episodic Memory: Rodent Studies 
 
Evidence for hippocampal mediation of memories and novelty detection has also 
been reported (Ennaceur, Neave et al.,1997; Mumby,2002,). The hippocampus is 
involved in memories for actions and places that make up discrete events and also in 
the sequential organization of these memories (Eichenbaum,2004). This 
encompasses both semantic and episodic memory, but not the disposition of priming, 
learning of a skill set or conditioning to a test of learning and memory (Squire 1992). 
The hippocampus also incorporates temporal information from the frontal lobes, and 
provides a basis for the episodic memory function. This is demonstrated on a one 
trial paired association task where rats were required to distinguish for food flavour 
(what) and place (where), to determine the correct location of the food, when paired 
with its associate flavour. Hippocampal blockade of glutamatergic NMDA receptors 
affects the memory for paired associates (recall) (flavour-place) but not retrieval. 
However, upon an 8 week training schedule in rats with glutamate AMPA receptor 
blockade, recall was not affected (Day, Langston et al.,2003). Encoding for what-
where glutamate mediated memories in paired associates is found to be impaired 
following hippocampal lesions (Burgess, Maguire et al.,2002). These studies suggest 
glutamate dissociates in mediating memory disruption depending on the components 
of cued recall and memory that are tested.  
Complex interactions between the DA and glutamate systems underlie episodic 
memory deficits in schizophrenia in the hippocampus and cortical regions. The 
hippocampus receives DA enervations from the mesolimbic DA region, and regions 
such as the CA1, are abundant in D1R-like an D2R-like receptors (Csernansky, Kerr 
et al.,1988). The hippocampal and DA relationship is marked by interactions in 
reward mediated behaviour; DA acts as predictor for rewards, both in the unexpected 
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occurrence as well as the omission of a reinforcer in signalling these 
rewards(Schultz,2004) . Thus, in an object recognition /episodic memory task, 
novelty may act as intrinsic reward and motivate exploration (Schott,2008). 
Glutamatergic- dopamine interactions in the mesolimbic regions do not modulate 
these memories alone, but dissociation in the retrieval and encoding of these 
memories is seen in the frontal and striato-limbic regions, owing to altered DA 
transmission. This suggests that disruptions in hippocampus mediated recognition 
memories may be indirectly modulated by dopamine receptor function in the cortical 
regions. 
1.5.2 Episodic memory in DA mutant models 
 
Episodic memory is measured in terms of object discrimination. The typical task of 
object recognition memory consists of one trial object recognition, where rats are 
familiarized with a familiar old object (sample phase) and then tested with a copy of 
this familiar object, along with the addition of a novel object (test phase). Animals 
spend a longer period of time exploring the new object as compared to an old object 
(Ennaceur and Delicious, 1988).Episodic memory in mice however, has been 
measured using a modified version of the object recognition task , that incorporates a 
temporal component This is different from the object recognition task as it 
encompasses when the object was presented at a particular location, at a certain point 
in time. This task of episodic memory measures the what, where and when 
components of memory.  
Additionally, individual components of the memory for ÔwhatÕ, ÔwhenÕ and ÔwhereÕ 
have been assessed as separate tasks to measure memories for object recognition, 
place recognition and recency (Dere et al.,2005,2006;). For example, the object 
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recognition task has been used in rats to explore two equal objects in a two trial 
design (sample trial- test trial) in which animals are presented with a novel object. 
Rodents spend more time exploring the novel object, which thus indicates that a 
familiar object was recognized; this measures the ÔwhatÕ component of memory. 
Another modification of the task measures the memory for a change in place of an 
object. Two familiar objects are presented in one location in the sample trial, and one 
copy of the object is displaced in the test trial. Here, animals spend more time 
exploring the object in the new location than the old location (Bussey, Muir et al., 
1999).Another variation of this task is the memory for temporal order that measures 
the ÔwhenÕ component for two objects that were presented in the past. This consists 
of a two phase sample trial, where two copies of a familiar object are presented (A) 
in the first sample trial, and two copies of a second new object are presented (B) in a 
second sample trial. In the test trial, two copies of each object A and object B are 
presented. Animals spend more time exploring the familiar old object (A) as opposed 
to the newer object (B), based on the regency of  their occurrence (Hansson, 
Howland et al.,2004). 
Both the D1 and D2 receptors have been implicated in memory disturbances in 
schizophrenia (Abi-Dargham, Malawi et al.,2002). The D1 receptor has been 
implicated in working memory and spatial memory deficits (Zahra, Taylor et al., 
1997; Castner, Williams et al.,2000; Abi-Dargham, Malawi et al.,2002). It is also 
involved in both temporal order and place order memory. Administration of a high 
dose of D1-like agonist facilitates memory retrieval, after a 4h delay and the 
administration of both a low and high dose of D1-like agonist impairs memory after 
a short 1h delay in a temporal order recognition memory task (Hotter, Naudon et al., 
2005).  
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A dissociation exists between dopamine receptor subtypes in mediating memory 
processes behaviours; the D2R stimulation spares memory on a delayed alteration 
WM tasks, whereas D1 receptor stimulation promotes disruptions on delayed 
alteration WM and spatial memory tasks in rats(Zahrt, Taylor et al.,1997). It is 
suggested that the D2R affects the consolidation and retrieval of memories by 
increasing D1 receptor turnover in the medial PFC, and thus also promotes 
behavioural inflexibility in attentionally mediated tasks of working memory 
(Kellendonk, Simpson et al.,2006). Switching off the D2 over expression in adult 
animals does not reverse cognitive impairment on working memory tasks, and this 
has been primarily attributed to D1 receptor imbalance in the PFC. This indicates 
that the D2R may indirectly mediate memory disruptions in the consolidation and 
retrieval of delay dependent memories schizophrenia.  
Both the D1R and the D2R are implicated in reward mediated behaviours and spatial 
learning. Pre reward oriented excitatory responses are governed by the D1R and 
mediate reward oriented memory processes, as indicated by mice lacking the D1R 
that show spatial memory and incentive reward related deficits(Tran, Tamura et al., 
2005). This indicates the D1R is required for reward mediated spatial memories. 
D2R KO mice  show slower learning of place recognition and show partial alteration 
in their coding of spatial information to an open field to rewarding stimuli ,as well as 
slower acquisition of place reward associations (Tran, Tamura et al.,2003). 
Additionally, spatial memory deficits have been reported in rats administered a 
DAD2R antagonist raclopride (Wilkerson and Levin 1999) and delay  interval 
dependent disruptions are seen in D2R KO mice(Glickstein, Hof et al.,2002).This 
indicates that D2R is required for spatial memory.
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Neuregulin-1 and cognitive impairment in schizophrenia 
relevant phenotypes 
 
1.6 Neuregulin-1 and schizophrenia 
 
A number of genes that have been implicated in risk for schizophrenia i.e.Nrg-1, 
DISC-1, Catechol-o-methyl transferase (COMT), DA (Holmes, Hollon et al., 2001; 
Shifman 2002; Shen, Lang et al., 2008) and have been investigated in behavioural 
phenotypes relevant to the illness. More specifically, mutant mouse models lacking a 
single or entire functional copy of these gene exhibit behavioural abnormalities that 
are related the characteristics of schizophrenia. These include hyperactivity, isolation 
rearing and sociability, and PPI (Mohn,1999; Geyer, Mark et al.,2001; Clapcote, 
Lipina et al.,2007; O' Tuathaigh, et al.,2007). Studies investigating the role of these 
candidate genes associated with risk for schizophrenia do so using schizophrenia 
relevant phenotypes in animal models of schizophrenia where aberrant gene function 
leads to deficits in cognitive behavioural tasks. We investigated the involvement of 
one such candidate allele, Neuregulin-1 (Nrg-1) as an at risk gene for 
Schizophrenia(Stefansson H. 2002) in mediating schizophrenia like disruptions on 
schizophrenia relevant cognitive tasks.  
 
1.6.1 What is the Neuregulin-1 gene? 
 
Neuregulin-1 (Nrg-1) has been identified as a candidate gene for schizophrenia, 
originally shown by way of a genome wide scan in an Icelandic population, where it 
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was known to map onto the 8p12-p21 locus (Stefansson H. 2002; O'Tuathaigh C.M.P 
2009).This association of Nrg-1 to a high risk for developing schizophrenia has been 
replicated in the Han Taiwanese, Portuguese, as well as the British/Irish population 
(Petryshen, Middleton et al.,; Williams, 2003; Hong, Huo et al., 2004; Hong, Wonodi 
et al., 2008). Nrg-1 is a protein encoded by the Nrg-1 gene which plays a vital role in 
neuronal plasticity and development in the adult brain (Inta, Monyer et al.,2009). It 
has multiple isoforms Nrg types I-VI, that are implicated in schizophrenia 
(Hashimoto, 2004). Nrg-1 type I,II and III are part of an epidermal growth factor like 
domain, which consists of the Immunoglobulin domain (Ig), the trans- membrane 
domain (TM) and proteins that signal through the its receptor; ErbB 2,3,4 receptor 
tyrosine kinases (Corfas, Roy et al., 2004). Nrg-1 signals primarily by being released 
as a soluble protein that binds to the ErbB receptor family, or as a transmembrane 
(TM) protein- like domain which activates the target cell receptors via cell to cell 
contact (Corfas 2004). Preferential binding to the ErbB4 receptor also modulates 
glutamatergic receptor activity where type I,II and III are the major constituents 
(Kwon 2005; Li, Woo et al., 2007).  
1.6.1.1 Nrg-1 and its role in developmental processes 
 
Nrg-1 plays a primary role in regulating key developmental processes which include 
synapse formation, cardiovascular functioning, neuronal migration, myelination, 
dendritic growth as well as long term potentiation, all of which are key processes in 
neuronal development (Harrison and Weinberger 2005; Lemmens, Doggen et al., 
2007; Desbonnet, 2009). The contribution of Nrg-1 in these developmental processes 
indicates that the aberrant functioning of this gene prior to adulthood may manifest 
as impairments at different stages of maturation, and promote disruptions in tasks of 
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social learning, thus mimicking social withdrawal and avoidance behaviours 
characteristic of the negative symptoms of psychosis (Walsh, McClellan et al., 2008). 
Consequently, neonatal mice that were administered the Nrg-1β1 protein (which 
binds to the ErbB4 receptors) show elevations in dopamine and dopamine 
metabolism, as well as impairmentsÕ on PPI, LI and social interaction tasks when in 
adulthood (Kato, Abe et al.,2010). Amongst other behaviours, exploratory 
hyperactivity has also been seen in TM domain heterozygous (+/-) Nrg-1 mice. This 
exploratory activity was inhibited in animals housed in a deprived environment as 
opposed to animals housed in an environmentally rich housing environment (Karl, 
Duffy et al.,2007). Thus, suggesting the involvement of Nrg-1 in Schizophrenia 
relevant phenotypes. 
1.6.1.2 Nrg-1 and phenotypes relevant to schizophrenia 
 
Nrg-1 plays a role in behavioural phenotypes associated with schizophrenia. Nrg-1 
TM domain mice hypomorphic for this gene show hyperactivity, deficits in novel 
object recognition and PPI (Mohn, Gainetdinov et al.,1999; Duffy, Cappas et al., 
2010; Kato, Abe et al.,2010). Consequently, increases in both exploratory activity 
and social dominance related behaviour have also been seen in Nrg-1 TM domain 
animals (O'Tuathaigh, Babovic et al.,2007; Moy, Troy Ghashghaei et al.,2009; 
OÕTuathaigh, Harte et al., 2010). Thus, schizophrenia relevant phenotypes have been 
observed in mice hypomorphic for the Nrg-1 gene. Additionally, mutant mice with 
partial deletions of epidermal growth factor like (EGF) domains show disrupted 
mismatch negativity and reduced sociability, which is a similar behavioural profile to 
the TM domain mice (Duffy, Cappas et al.,2008). This indicates that Nrg-1 and its 
isoforms play a role in schizophrenia phenotypes.  
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Altered Type III Nrg-1 signalling leads to functional deficits that are related to 
schizophrenia. These include dendritic arborization, which promotes abnormal 
cortical plasticity thus leading to altered neural circuit connections (Pederique and 
Farazzi, 2010,Chen et al. 2010). Altered expression of type 1 and type IV isoforms of 
Nrg-1 are seen in schizophrenia, and in alleles implicated at a high risk for 
schizophrenia (Harrison and Law, 2005). Nrg-1/ErbB$ signalling is involved in the 
wiring of cortical inhibitory circuits, and modulates synapse formation in these 
circuits (Rico and Marin,2011). However, little is known about how aberrant TM 
function of Nrg-1 isoforms disrupts different neurotransmitter systems. It is 
suggested that abnormalities in Nrg-1 functioning may lead to altered excitatory or 
inhibitory signalling of glutamate, GABA or acetylcholine receptors, which affects 
neuronal plasticity, and resembles altered cortical connectivity in schizophrenia. For 
Neuregulin is also thought to play a critical role in GABAergic signalling (Russig, 
Murphy et al., 2002; Gajendran, 2009) that may impact cognitive processing and thus 
attribute to schizophrenia-like symptoms (Corfas,2004).   
Enhanced Nrg-1 ErbB4 function blocks NMDA receptor activity in the human PFC 
and rodent cortex (Hahn, Wang et al., 2006), thus modelling NMDA hypofunction 
like phenotype as seen in schizophrenia. Heterozygous (Het) TM domain Nrg-1 mice 
habituate readily to a novel environment compared to their WT littermates, and on 
acute challenge with MK 801 show disruptions on PPI (Duffy, Cappas et al., 2008). 
Nrg-1 also reverses long term potentiation of hippocampal glutamatergic excitatory 
synapses via the activation of dopamine D4 receptors (Kwon, Paredes et al., 2008), 
and The Nrg-1 ErbB4 receptor is implicated in the maturation of glutamatergic 
synapses(Li B Woo,2007).Administration of glutamate antagonists Dizocilpine (MK-
801) or Phencyclidine (PCP) induces reduced sociability and preference for social 
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novelty, in both TM domain Nrg-1 mutant and wild type animals. Alternatively, 
untreated animals showed increases in both exploratory activity and social 
dominance related behaviour (O'Tuathaigh, Babovic et al.,2007; Moy, Troy 
Ghashghaei et al., 2009; OÕTuathaigh, Harte et al.,2010). This indicates that 
glutamate may modulate Nrg-1 mediated disruptions on schizophrenia relevant 
phenotypes. However, these studies do not imply a causal relationship between Nrg-
1 signalling and glutamate and GABA systems. Rather, they suggest a complex 
relationship may exist between Nrg-1 isoforms and inhibitory glutamate and GABA 
signalling, that may not generalise to non ErbB receptor coupled proteins.  
1.7 Nrg-1 and LI 
 
Nrg-1 mediated is involved in the processing of stimulus salience (OÕTuathaigh, 
2003), but Nrg-1 is thought to be involved more in identifying novel and unfamiliar 
stimuli, rather than their discrimination on prior exposure to the stimuli (De 
Leonibus, Verheij et al., 2006). 
Nrg-1 gene has also implicated in modulating cognitive tasks that act as behavioural 
phenotypes of schizophrenia, but disruptions on these tasks as a consequence of 
altered Nrg-1 functioning have not been investigated in attentionally mediated 
cognitive phenotypes of relevance to schizophrenia. 
Nrg-1 Ig domain mice have shown deficits in LI. Ig domain hets show impaired LI as 
compared to their wild type (WT) littermates, but the lack of control groups in this 
study deems it inconclusive (Rimer, Barrett et al.,2005). To date, studies in LI in TM 
domain Nrg-1 mutants have not been carried out.  The Nrg-1 is a relatively novel 
gene, with respect to its association with high risk for schizophrenia, and studies 
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have not looked at the role of all isoforms of the Nrg-1 gene as behavioural correlates 
of schizophrenia pathophysiology. Furthermore, an LI paradigm that uses 
suppression of behaviour as an index of learning has not been employed in these 
mutant mice, and there is no evidence of paradigm specific deficits in LI. This is of 
importance as transgenic lines of the Nrg-1 mouse differ in their phenotype and 
performance on behavioural tasks depending the Nrg-1 isoform mutations; ErbB4 
receptor coupled, or TM domain knockout mice (Mei and Xiong, 2008). 
1.8 NRG-1 and PPI 
 
Reduced PPI has been observed in humans carrying the mutation of the single 
nucleotide polymorphism Rs3924999 of the Nrg-1 gene, where schizophrenic 
patients with abnormal PPI show an over expression of this mutation, as compared to 
controls(Hong, Wonodi et al., 2008).  
A study investigating the PPI deficit in TM domain Nrg-1 mutants, found no effects 
of PCP or MK-801 or amphetamine on PPI or startle habituation or locomotor 
activity in these animals. Only treatment with a 5HT-1a receptor agonist 8-OH-
DPAT disrupted PPI in Nrg-1 Hets (van den Buuse,2009), supporting the lack of a 
generalized impairment in Nrg-1 mutants of different isoforms. However, other 
studies show that MK-801 and PCP attenuate disruptions in PPI dose dependently 
(Yee 2004). Studies have shown PPI deficits in mice lacking glutamate receptors 
(Bubenikova, Vera et al.,2008, Duncan, Moy et al.,2004). However, interaction with 
the glutamate systems is limited to ErbB2,4 receptor Nrg-1 proteins as previously 
mentioned, and little is known about other isoforms. PPI disruptions have not been 
consistently replicated in Nrg-1 mutants. 
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Furthermore, PPI in TM domain mutants is sensitive to changes in protocol; no 
deficits are seen in PPI in Nrg-1 Het mutants compared to their WT littermates; 
however, reduced baseline startle is seen only at  high levels of startle (110db, 115 
db,120 db), in a site specific protocol(Karl 2011). The reliability of the Nrg-1 TM 
domain mutants in mediating PPI task is not clear, as a replication of the original 
study showing disrupted PPI in Nrg-1 mutants(Stefansson H. 2002) has not been 
produced to date. 
1.9 NRG-1 and episodic memory 
 
The role of Nrg-1 in mediating memory disruptions relevant to schizophrenia has 
been investigated in TM domain Nrg-1 mutants. Tests of spatial learning and 
working memory in report intact memory processes in Nrg-1 mutant mice, as 
assessed by the Barnes maze and Y mazes (O' Tuathaigh et al., 2007). Furthermore, 
spatial memory is found to be intact in these Het mutants mice with even better 
retention of spatial memory following brain trauma (Lok,2007). This suggests spatial 
working memory is intact in Het Nrg-1 mice. Other studies also support this notion 
of intact spatial learning and working memory in the Nrg-1 TM domain mutants 
(Duffy, Cappas et al.,2010).Deficits in Het mutants  are only seen on tests of  
contextual fear conditioning, cued aversion and novel object recognition in  these 
mice (Duffy, Cappas et al.,2010). 
 Nrg-1 mutant mice with partial deletions of epidermal growth factor like (EGF) 
domains on all three forms (Type 1,2,3) of the gene show disrupted mismatch 
negativity and reduced sociability(Enrichment, Luminais et al.,2009). To date, TM 
domain Nrg-1 animals show deficits social novelty oriented exploratory 
behaviours(O'Tuathaigh et al.,2006) and novel object recognition (O' Tuathaigh et 
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al.,2008). This indicates Nrg-1 involvement in socially relevant behaviours and 
social novelty.  
Thus, it follows that novelty oriented tasks may be good constructs to test deficits in 
recognition memory in Nrg-1 mutants. A complete test of episodic memory (what, 
where, when) using object recognition has not yet been conducted in TM domain 
Nrg-1 mutants. This is a coherent test of memory that measures the spatio-temporal 
aspects of memory and encompasses the consolidation and recall of memory for an 
object in a particular location and at a particular point in time. Thus, it measures the 
memory for particular episodes that are not governed by semantic rules or knowledge 
but rather the memory for what object was investigated, where it was seen and at 
what point in time it was seen. This would be a good construct of both partial, 
temporal and recognition memory in Nrg-1 mice, as it provides consistent delay 
intervals between phases and adequate training provide robust effects , and act as 
phenotypic indices for episodic memory impairment in schizophrenia. 
1. 10 Other considerations 
 
Sex specific differences in Schizophrenia phenotypes are seen in Nrg-1 TM domain 
mutants. Decreased PCP induced hyper locomotion in male mice Heterozygous for 
the Nrg-1 gene as compared to female Het animals is seen(OÕTuathaigh, Harte et al., 
2010). Furthermore, reductions in preference for social novelty (time spent in 
chamber with stranger 1 or stranger 2) and sociability (preference in time spent in a 
chamber containing a mouse as opposed to an empty chamber) are seen, as well as in 
dyadic social behaviours (time spent in stranger 1 vs. stranger 2 chamber, switched; 
novel chamber- unfamiliar mouse; opposite empty chamber-familiar mouse). Overall 
levels of chamber entries are markedly increased in female Nrg-1 mutants than 
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males. Moreover, locomotion, rearing and exploratory behaviour are attenuated over 
long time intervals, in Nrg-1 mutant mice, as compared to the WTs (OÕTuathaigh, 
Harte et al., 2010). Thus, indicating deficits for schizophrenia relevant phenotypes in 
male mutants Heterozygous for the Nrg-1 gene. The authors propose that shifting of 
exploratory behaviour was increased in female mutants but reduced in male mutants; 
where a reduction in grooming behaviour was observed in the male mutants only. 
Hence, these studies suggest that the partial knockout of a functional copy of the 
Nrg-1 gene, dissociates for behavioural deficits in schizophrenia like phenotypes in 
male Nrg-1 mutants only, where Nrg-1 mediates sex specific dissociations in 
disrupted behaviours as a consequence of the genetic mutation itself. 
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1.11 Thesis Objectives 
 
The studies undertaken in the thesis seek to investigate animal models of attention 
and cognitive deficits implicated in schizophrenia. The role of aberrant 
neurotransmitter function can be tested using transgenic animal models lacking 
functional copies of candidate genes associated with schizophrenia pathophysiology. 
The candidate genes used to investigate cognitive and behavioural impairments in 
schizophrenia consisted of the dopamine D2 receptor (D2R) (-/-) and the Neuregulin-
1 (Nrg-1) (+/-) mutant mouse models. The D2 receptor plays a major role in 
schizophrenia, by affecting both striatal and mesolimbic DA neurotransmission. 
Increased transmission of the dopamine system in the striatal region promotes 
Schizophrenia symptoms, and as indirect DA agonist Amphetamine has been known 
to induce these psychotic like symptoms in healthy humans, and worsen these 
symptoms in schizophrenia patients(Seeman 1987). Moreover, disruptions in 
paradigms of attention and cognition as a consequence of altered DA 
neurotransmission have been seen in tasks of inattention and gating such as Latent 
Inhibition (LI) and Prepulse Inhibition (PPI), and have been used as behavioural 
correlates of schizophrenia. D2R -/- mice show a reduced DA tone and have proved 
to be useful models to understand the function of D2 receptors in behaviours and 
antipsychotic drug effects that are relevant to schizophrenia.  
Disruptions on cognitive tasks have been induced by Amphetamine, which is an 
animal model of hyperdopaminergia. Amphetamine causes an elevation of DA and 
promotes schizophrenia like psychotic symptoms, as a consequence of increased DA 
neurotransmission. Low doses of amphetamine promote psychotic like effects in 
humans and rodents, whereas high doses promote preservative/stereotyped 
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behaviours. Amphetamine induced deficits in cognitive and behavioural tasks have 
been used as pharmacological models of schizophrenia, as these disruptions can be 
reversed by D2 antagonist drugs. High doses of amphetamine promote stereotypy 
and preservative behaviours, and low doses produce psychotomimetic effects in 
humans and rodents. Administration of amphetamine affects attention, sleep and 
sensorimotor gating(Gainetdinov 2001). Studies using dopamine D2 receptor null 
mice suggest that the D2R is necessary for amphetamine-induced disruption of LI 
and PPI (Weiner, Bernasconi et al.,1997; Ralph, Varty et al.,1999). These studies 
suggested that both the number of injections as well as high and low doses of 
amphetamine can have dissociable behavioural and neural effects in these tasks. 
  We investigated whether a single low dose of amphetamine disrupts PPI, and 
whether this is dependent on the amphetamine administration schedule adopted. To 
determine the relevance of this receptor subtype in mediating amphetamine induced 
disruptions in mice, we used ÔknockoutÕ mouse models to elucidate whether 
knocking out the D2 receptor abolished the disruptive effects of amphetamine on 
these tasks. As D2 -/- mice show deficits memory tasks i.e. in spatial memory 
(where) and novel object recognition (what), a test of episodic memory deficits that 
incorporated memory for ÔwhatÕ, ÔwhereÕ and ÔwhenÕ was also established for the 
first time in these mice, thus mimicking episodic memory deficits seen in 
schizophrenia patients.  
We investigated all three schizophrenia relevant tasks in the Nrg-1 mouse model,  as 
Nrg-1 has been associated as a candidate gene for Schizophrenia (Stefansson H. 
2002; Tosato, Dazzan et al.,2005). This is a relatively novel mutation that has been 
associated with schizophrenia and schizophrenia like phenotypes(Gerlai, Pisacane et 
al.,2000), and these behavioural tasks have not been carried out in the TM-domain 
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Nrg-1 Het (+/-) mouse model. Homozygous or complete deletion of the Nrg-1 
receptor is lethal in these mice(Sanchez-Soria and Camenisch 2010), and therefore 
we investigated whether partial ÔknockdownÕ i.e. lacking one functional copy of the 
allele (Heterozygous mice), mimics cognitive deficits in schizophrenia. The tasks 
used are LI, PPI and Episodic memory, which have been repeatedly used in DA 
mutant mouse studies. Using these models, we seek to elucidate whether mutations 
in TM domain of the Nrg-1 gene produces cognitive and attentional deficits in 
behavioural phenotype relevant to schizophrenia. 
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CHAPTER 2 
PREPULSE INHIBITION (PPI) IN D2R WT and KO 
ANIMALS 
2.1 Introduction 
PPI is a measure of sensorimotor gating where the startle reflex of an animal is 
reduced when the startling stimulus is preceded by a low intensity prepulse. It is a 
good test for measuring the processing of information in schizophrenia, as patients 
with schizophrenia show deficits on tasks that require the gating of information 
(Braff 1993).PPI is a robust phenomenon that has been seen in different strains of 
mice and rats(Ralph and Caine,2005). Mice lacking the dopamine transporter show 
deficits in PPI(Ralph, Paulus et al.,2001).Furthermore, decreased startle in PPI in 
D2R KO mice has been seen (Geyer 1999).This indicates that PPI is DA receptor 
dependent. Consequently, the D1 receptor is required for DA agonist induced 
disruptions in PPI, but D2R involvement in these disruptions remains inconclusive 
(Doherty, Masten et al.,2008).However, disruption of PPI by dopamine agonists is 
species specific i.e. non-selective DA agonist Apomorphine disrupts PPI and leaves 
acoustic startle unaffected in rats, where D1R antagonists reverse apomorphine 
induced disruption of PPI. However, D2R antagonist raclopride leaves this unaltered 
(Williams,2002). 
DA releasing drugs like amphetamine disrupt LI and dopamine D2R antagonists 
potentiate LI (Weiner, Feldon et al.,1987; Weiner, Lubow et al.,1988). At low PEÕs 
(40) enhanced LI is seen in D1R female KO animals. D2R KO animals also show 
enhanced LI under these low PEÕs, with no LI in WT controls (Bay-Richter, 
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O'Tuathaigh et al.,2009). Two low doses of amphetamine administered 24 hours 
apart have been shown to disrupt LI in both D2R WT and KO mice.  
 The indirect dopamine agonist amphetamine induces a range of behavioural effects 
that are reversed by antipsychotic drugs e.g. hyperactivity, attentional (LI), prepulse 
inhibition (Kelly, Rubinstein et al., 1998; Ralph, Paulus et al.,2001).Amphetamine 
induced disruption of PPI is prevented in mice lacking the D2R, but not in mice 
lacking the D3 and D4 receptors(Ralph, Varty et al.,1999). High doses of 
amphetamine (10 mg/kg) decrease PPI in both D1R WT and KO mice, and D2R WT 
but not D2R KO mice(Ralph-Williams, Lehmann-Masten et al.,2002). A very high 
dose of amphetamine disrupts PPI; although these effects are prevented in D2R KO 
mice (Ralph et al.,1999).At low doses it promotes disruptions in LI, which are not 
blocked in D2R KO mice (Bay-Richter, O'Tuathaigh et al.,2009).Prior studies in rats 
suggest that amphetamine induced disruption of LI depends on the drug 
administration schedule adopted. A single low dose of amphetamine (1.5 mg/kg) 
administered 15 mins prior to the pre exposure and conditioning stages at a 24h 
interval only, disrupts LI (Weiner, Lubow et al.,1988).The time delay is critical in 
the disruptive effects  of amphetamine on LI as a single low dose injection but not 
two injections given 30 mins prior to PE and 30 min prior to COND disrupts LI. 
Other studies that suggest a single low dose of amphetamine (.32 mg/kg, sub 
cutaneously) 30 mins prior to PE and COND phases attenuates LI(McAllister,1997). 
Consequently, amphetamine administered 45 -90 mins prior to the conditioning 
phase only, but not 15 mins prior to it, also abolishes LI (Young, Moran et al., 2005). 
The following studies investigated whether a low dose of amphetamine disrupts PPI 
in D2R KO and WT animals, and whether like LI the schedule of amphetamine 
administration is important in mediating disruptions in the PPI task. 
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2.2. Materials and Methods 
 
2.2.1 Animals  
The original F2 hybrid strain (129/Sv x C57BL/6J) containing the mutated DRD2 
receptor allele were generated as reported previously (Kelly et al.,1997). The targeted 
gene deletion was constructed in 129/Sv embryonic stem cells and male chimaeras 
mated with C57BL/6 females to produce Heterozygous mutants (DRD2 +/-). Congenic 
DRD1 and DRD2 lines were established by backcrossing heterozygous mutants to 
wild type C57BL/6 for 14 generations. Homozygous KO mice (DRD2 -/-) and 
wildtype (DRD2 +/+) littermates were bred by heterozygous intermatings of the 
congenic Heterozygote mutants imported from Royal College of Surgeons, Dublin, 
Ireland. Congenic strains have significant advantages over mixed background strains 
in reducing inter-animal variability and maximising the specificity of the phenotype to 
the targeted gene (Kelly et al; 1997). DRD1 -/- mice had low body weight and poor 
growth and were weaned later than DRD2 -/- mice to facilitate growth and survival. 
They were given a wet mash diet in the home cages after weaning; this has been 
reported previously in these mice (Doherty et al., 2007).  Male and female KO (n=28) 
mice and wildtype (WT=29) littermates were between 16-24 weeks old prior to being 
used in these experiments. Animals were housed 1-4 per cage under a 12 h light: 12 h 
dark cycle. Mice were housed at constant temperature of 22 degrees and 45% humidity 
controlled environs, with food available freely. Mice were housed 1-4 per cage under a 
12 h light: 12 h dark cycle (lights on 07:00 hrs), constant temperature (20+/-C) and 
humidity (40-60%) with food available ad libitum. Experiments were performed 
during the light period. Mice were subjected to daily water restriction periods of 23 h 
throughout the LI experiments with one hr free access to water in their home cages 
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after the experimental session. All experiments were carried out in accordance with 
local and national rules on animal experimentation, and with appropriate personal and 
project licence authority under the Animals (Scientific Procedures) Act, UK 1986. UK 
home Office Project licence No: 40/2883. 
2.2.2. Behavioural Testing 
2.2.2.1 Drugs 
d-Amphetamine sulphate (Sigma ÐAldrich, Gillingham, UK) dissolved in 0.9% 
saline and administered at a dose of 2.5 mg/kg. Injections of 2.5 mg/kg amphetamine 
or saline were administered intraperitonealy (i.p.) 30 mins prior to behavioural 
testing at a volume of 10 ml/kg. This low dose of amphetamine was based on 
previous LI studies conducted in the laboratory, that sufficiently produced 
disruptions in LI. Animals were administered one single low dose amphetamine 
injection thirty minutes prior to the PE stage and thirty minutes prior to the COND 
stage, that were separated by a 24h interval. Animals were drug naive during the test 
session. 
2.2.2.2 Apparatus 
Two startle chambers (SR-LAB, San Diego Instruments, San Diego, CA) were used 
to measure startle reactivity. Each chamber consisted of a sound attenuated, lighted 
and ventilated cabinet holding a single Plexiglass chamber (5 cm inner diameter). All 
acoustic stimuli were produced by a high frequency loudspeaker mounted inside the 
chamber. In order to ensure consistent stabilimeter sensitivity, a calibration system 
was employed across both chambers. A high frequency loudspeaker produced 
continuous background noise of 65db, in addition to the acoustic stimuli. Vibrations 
of the plexiglass cylinder caused the whole startle response of the animal to be 
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recorded as analog signals, which were then stored by a computer. Eighty four 
readings were taken at stimulus onset, and the during the entire test session. Each 
session had a block of 6 120 db pulses interspersed with 68dB, 72dB, 80dB and 90 
dB prepulses. The SR-LAB calibration unit was used to ensure consistent 
stabilimeter recordings between test chambers over time (Fig. 2.1). Sound levels in 
dB were measured as previously defined (Dulawa et al.,1997). 
 
 
Figure 2.1 A PPI test chamber. The mouse is placed in a plexiglass chamber, 
and the startle response of the animal to a series of loud prepulses is recorded 
within the chamber. 
 
2.2.2.3 Acoustic startle session/ PPI 
The PPI test session consisted of a one day session of startle trials (PULSE ALONE) 
and prepulse trials (PREPULSE+PULSE), intermixed with no-stimulus trials 
(NOSTIM). The pulse alone trial consisted of 40 ms of 120-db pulses of noise. PPI 
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was based on acoustic prepulse intensities that consisted of noise prepulses 68db, 
72db, 80db and 90 db presented for 20 ms (3, 7, 15, 25 dB above 65 db background 
noise). After the mice were placed in the startle chambers, a 65 dB background noise 
level was presented for 10 min acclimation period and continued throughout the test 
session. Each session began with blocks of 6 and ended with another block of 6 
PULSE ALONE trials, which were used for measuring habituation andwere not 
included in the analysis of PPI or mean acoustic startle response. In between these 
two blocks, each trial type (pulse alone, prepulse+pulse for the four prepulse 
intensities) was presented 12 times in a pseudo-random order (see Fig. 2.2). The NO 
STIM trial consisted of background noise only. There was a delay of 7 sec between 
trials. Two startle chambers were used for testing, and each animal was always tested 
in the same startle chamber in the two day session.  
 
 
Figure 2.2 Diagrammatic depiction of the PPI task. The amount of startle to the 
pulse alone, interspersed with prepulses is measured. PPI is measured as 
percentage inhibition of the startle response to the prepulses. 
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2.2.2.4 Data Analysis 
PPI was calculated as a mean percentage score for each prepulse+pulse trial, where 
% PPI= [(Mean of startle to the120 dB pulse- Mean % 68/72/80/90 dB pulse)/(mean 
120 pulse) X100]. The ASR to the 120 dB pulse alone trials (excluding block of 6 at 
beginning and end) was also analyzed. Habituation to the 120dB tone was calculated 
as: (Mean initial 120dB startle-mean 120 dB startle)/ mean initial startle*100 
This habituation was a measure of baseline startle and was based on the initial block 
of six 120 dB pulses at the beginning and block of six pulses at the end of the 
session. All scores were expressed as percentages. 
Percentage PPI was analyzed using ANOVA to compare differences in startle to 
prepulses in WT and KO animals. The computations were carried out using SPSS 
statistical software. % inhibition to each prepulse intensity (68 db, 72 db, 80 db and 
90 db) was the within subjects factor. Genotype (WT/KO) and treatment 
(Amphetamine / SALINE) were between groups factors. Prepulses were not 
administered in a particular sequence, but in a random order in the session. Two 
cohorts of animals were merged in this experiment to create a complete database 
with sufficient sex, genotype and drug matched controls. A repeated measures 
ANOVA indicated no significant effect of cohort on the data sets (p>0.05) 
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2. 3 Results  
Effects of experiment (dataset 1 vs. dataset 2) in D2R WT and KO animals 
A repeated measures ANOVA indicated no significant effect of cohort on the data 
sets (p>0.05) A repeated measures ANOVA showed no significant effect of cohort 
on % PPI [f(1,49)= .011,p>0.05] nor was there a genotype by cohort interaction on % 
PPI [f(1,50)= .071,p>0.05].One animal (KO) was removed from the analysis because 
its level of startle responding was below the minimum 0 on the scale, see Appendix 
2. 
Effects of amphetamine administration on % PPI in D2R WT and KO animals 
A repeated measures ANOVA showed that there was a significant effect of prepulse 
intensity on % PPI[f(3,156)=12.689,p<0.05]. Furthermore, a significant main effect 
of genotype on % PPI was seen [f(1,52)= 6.337,p=.015]. This indicates that %PPI 
was attenuated in D2R KO animals compared to their WT littermates. No significant 
effect of treatment on the % PPI was seen [f(1,52)= 1.126,p>0.05]. Furthermore, no 
genotype by treatment interaction on % PPI was seen [f(1,52=.899,p>0.05] (Fig. 
2.3). 
 
 
85 
 
Genotype
WT saline WT amph KO saline KO amph
M
ea
n
 (
+
/-
 S
E
M
) 
%
 P
P
I
0
20
40
60
80
100
68% pp 
72% pp 
80% pp 
90% pp 
 
 
Figure 2.3 Results indicate that there was a significant main effect  of genotype 
on % PPI. ( 68-90%pp= 68,72,80,90 dB % ppi).  
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Effect of treatment on startle to 120 dB pulses in D2R WT and KO animals 
ANOVA showed that there was no significant effect of genotype on the 120 dB pulse 
alone trials [f(1,29)= 2.655,p>0.05].Thus, indicating no differences in startle to the 
120 dB pulse between D2R KO and WT animals. No significant effect of treatment 
on the startle to 120 dB pulse was seen [f(1,29)=4.031,p>0.05]. 
Furthermore, no genotype by treatment interaction on the startle to 120 dB pulse was 
seen [f(1,29)= 4.012,p>0.05]. This indicates that neither treatment nor genotype 
influenced baseline startle to the 120 dB pulses. 
 
Effect of treatment on ASR on prepulse+pulse trials in D2R WT and KO 
animals 
A repeated measures ANOVA showed that there was a significant effect of prepulse 
intensities on ASR [f(1,156)=9.368,p<0.05].There was no significant effect of 
genotype on ASR [f(1,52)= .766,p>0.05].Thus, indicating no differences between 
D2R KO and WT animals on ASR. No significant effect of treatment on the ASR 
was seen [f(1,52)= 3.043,p>0.05].Furthermore, no genotype by treatment interaction 
on the ASR was seen [f(1,52)=.121,p>0.05] (Fig.2.4).  
 
 
 
87 
 
 
 
Genotype
WT sal KO sal WT amp KO amp
M
ea
n
 (
+
/-
 S
E
M
) 
a
co
u
st
ic
 s
ta
rt
le
 r
es
p
o
n
se
0
20
40
60
80
100
68dBpp 
72dBpp 
80dBpp 
90dBpp 
 
 
Figure 2.4 Data showing a significant ASR in D2 WT (+/+) and KO (-/-) 
animals. There were no differences in ASR between D2 WT or KO animals, 
both in drug naive or drug treated groups. 
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Effect on Habituation 
A significant main effect of genotype on % habituation [f(1,52)= 6.268,p=0.015] was 
seen. Thus, indicating that D2R KO mice habituate differentially to D2R WT mice. 
No significant main effect of treatment on % habituation [f(1,28)=.860,p>0.05] was 
seen (fig 2.5). No genotype by treatment interaction on % habituation was seen 
[f(1,52)=.328,p>0.05].Independent samples t tests indicated that D2R KO animals 
show attenuated %habituation compared to D2R WT (t= 2.338,df=54,p=.023), that 
precluded analysis with amphetamine treatment.  
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Fig 2.5 Data indicating a significant difference of the percentage of habituation 
to the 120 dB pulses in D2R WT and D2R KO animals (p<0.05). Treatment with 
amphetamine did not promote differences in % habituation in either D2R WT 
or KO littermates. 
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2. 4 Discussion 
The results from this study indicated that D2R mutants showed lower levels of % PPI 
compared to their WT littermates. Furthermore, there is a trend for a single low dose 
of Amphetamine treatment to disrupt %PPI in D2R KO animals, but overall there 
was no significant effect of amphetamine treatment on % PPI in WT animals. Results 
do suggest however, that amphetamine can disrupt PPI in the absence of D2R when 
administered at a low dose. Conversely, Ralph et alÕs investigation (1999) showed 
that a high dose of amphetamine prevented PPI disruptions in the D2R KO. The 
present results suggest that this is not the case for a single low dose of amphetamine. 
These findings suggest amphetamine mediated disruption of PPI may be governed by 
D2R dependent mechanisms, but we are unable to make conclusions regarding the 
dependence of amphetamine disruptions in PPI on the D2R, as amphetamine did not 
produce any significant disruption in the D2R KO at a single low dose. Furthermore, 
stable baseline startle responding to the prepulses is seen, in both genotypes. 
However, disruptions in habituation in KO animals were seen compared to their WT 
littermates. 
 D2R KO animals show deficits in habituation compared to their WT littermates, 
with a trend for amphetamine to improve these deficits in both WT and KO animals. 
Schizophrenia is marked by deficits in habituation, and schizophrenic patients show 
impairments in the habituation to startle (Geyer,1987). Previous reports have not 
indicated any habituation deficits in DAD2R KO mice. However, impaired 
habituation in DAT knockdown mice in a locomotor activity were seen to be 
inhibited by amphetamine administration (Zhuang, Oosting et al.,2001). Our results 
demonstrate a similar a trend toward inhibition of impaired habituation by 
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amphetamine. Alternately, it is suggested that impairments in habituation may 
account for hyperactivity. However, D2R KO mice are hypoactive, so differences in 
habituation cannot be attributed to hyperactivity in our cohort. It is suggested that 
differences in the habituation of startle may be mediated by strain, but animals on the 
C 57BL/10J background show high levels of ASR amplitude and low prepulse 
inhibition, but no impairment in either PPI or ASR (Paylor and Crawley,1997; 
Dulawa and Geyer, 2000). Our animals were bred on this background, and although 
they show low levels of prepulse inhibition, and they also show a habituation deficit 
to the 120 dB pulses. This may be independent of the level of prepulse inhibition; if 
animals did not habituate to the 120 dB stimulus, the inhibition to the prepulses 
would not be reduced (refer to definition of PPI in the Introduction). This is 
corroborated by our results that show no difference in baseline startle in the D2R KO 
compared to D2R WT animals, but attenuations in PPI are seen in D2R KO animals. 
Thus, suggesting that habituation may be an independent phenomenon to prepulse 
inhibition.   
There is wider evidence that the behavioural effects of amphetamine depend on the 
dose schedule adopted. More specifically, a single exposure to amphetamine (5 
mg/kg, i.p.) leads to sensitization of locomotor activity(Vanderschuren and Tilders 
1999). Alternatively, multiple daily low amphetamine injections (2.5 mg/kg) 
augment locomotor activity as well as promote increased stereotypy. When tested 
again with the same dose of amphetamine 8 days after long term treatment was 
discontinued, the offset of stereotypy and hyperactivity resembled animals treated 
with short term amphetamine administration (Segal,1996). Other studies corroborate 
this administration schedule dependent role of amphetamine in disrupting 
behaviours; a low dose of amphetamine (1.5 mg/kg) disrupts LI in rats when 
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administered in both the preexposure (PE) and conditioning (COND) stages only, 
indicating that neither high doses not chronic exposure to amphetamine is needed to 
produce this disruption(Weiner, Lubow et al.,1988). In the session where PE and 
COND were not separated by a 24h interval, the administration of a single low dose 
of amphetamine 15 minutes prior to PE, and 15 minutes prior to COND, with a thirty 
minute interval between the PE and COND sessions did not disrupt LI. However, the 
same injection schedule did disrupt LI when the PE and COND sessions were 24 
hours apart (Weiner, Lubow et al.,1988). This indicates that different injection 
schedules interact with the dose of amphetamine administered to modulate behaviour 
differentially. 
We therefore compared one and two administrations of a single low dose of 
amphetamine on PPI, where the two dose task consisted of a single low dose of 
amphetamine administered once prior to habituation and prior to test, and was 
separated by a 24h time interval. Thus, we seek to investigate whether one and two 
injections of a low dose of amphetamine disrupt PPI differentially in D2R WT and 
KO animals. 
2.5 Materials and Methods 
2.5.1 Animals  
Male and female D2R KO (n=22) mice and wild type (WT=17) littermates were 
between 16-24 weeks old prior to being used in these experiments. Refer to previous 
experiment for colony details (Refer to Section 2.2.1). 
2.5.1.2 Behavioural Testing 
The testing protocol was the same as the aforementioned experiment (Refer to page 
176-178). However, prior to testing the animals in the PPI apparatus, animals were 
given a one day habituation session. On day 1, animals were removed from their 
93 
 
home cages and placed in the PPI apparatus for 25 minutes. The house light and 
white noise were turned on. They were left in the startle chamber for the entire 
duration without any pulses. On day 2, they were subjected to the startle session as 
described in the previous experiment i.e. blocs of 120 dB pulses, intermixed with 
prepulses of varying intensities. 
2.5.1.3 Drugs 
d-Amphetamine sulphate was obtained from (Sigma ÐAldrich,Gillingham, UK) 
dissolved in 0.9% saline and administered at a dose of 2.5 mg/kg. Injections of 2.5 
mg/kg amphetamine or saline were administered i.p. thereafter, 30 mins prior to 
behavioural testing at a volume of 10 ml/kg. Animals were injected thirty minutes 
prior to the test session. The dose was the same as in the previous study. On DAY1, 
animals were injected thirty minutes prior to being placed in the PPI boxes. After 
which, they were allowed to habituate to the boxes for a period of 25 minutes. On 
DAY2, animals were again injected thirty minutes prior to being placed in the boxes, 
for a test session of twenty five minutes in total that incorporated 5 minute 
habituation to the 120 dB pulse. 
2.5.1.4 Apparatus 
The apparatus is the same as the previous experiment. 
2.5.1.5 Acoustic Startle Session/ Prepulse Inhibition session 
The startle session is the same as the aforementioned. 
2.5.1.6 Data Analysis 
The data analysis is the same as the prior experiment. 
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2.6 Results 
 
Effects of amphetamine administration on % PPI in D2R WT and KO animals 
A repeated measures ANOVA showed that there was a significant effect of prepulse 
intensities on % PPI [f(3,81)=7.731, p=0.000]. No significant main effect of 
genotype [f(1,27)=.068,p>0.05] or sex [f(1,27)= 4.164,p=0.05]  on %PPI was seen. 
A significant main effect of treatment type [f(2,27)=13.646,p<0.001] on % PPI was 
also seen. A significant interaction of %PPI intensities by treatment type was seen 
[f(6,81)= 2.367, p=.037]. Furthermore, a genotype by treatment type interaction on 
% PPI was also seen [f(2,27)=4.430,p= .023].  Moreover, significant genotype by sex 
by treatment type interaction on %PPI [f(2,27)=4.907,p=.015] was also seen. 
Additionally, a significant genotype by sex interaction on % PPI was seen 
[f(1,27)=18.639, p<0.001].  
In order to explore these interactions further, data was split by genotype, and a 
separate ANOVA was conducted, with treatment and sex as a between groups factor. 
In WT animals, there was no significant effect of prepulse intensities on %PPI 
[f(3,33)=2.593,p>0.05]. A significant main effect of sex was seen 
[f(1,11)=14.008,p=.003] reflecting higher No significant main effect of treatment 
[f(2,11)=2.880,p>0.05] or any interaction between treatment and sex was seen 
[f(6,33)=.973,p>0.05].  In the D2R KO animals, a significant main effect of prepulse 
intensities on % PPI was seen [f(3,48)=6.342,p=.001]. No significant main effect of 
sex was seen [f(1,16)=3.66,p>0.05].  A significant main effect of treatment 
[f(2,16)=15.767,p<0.001] was seen. No interaction between PPI, treatment and sex 
was seen [f(6,48)=.200,p>0.05].  
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In D2R KO animals multiple comparisons (Fishers LSD) indicated a significant 
difference of the effect of a single low dose of amphetamine treatment as compared 
to saline treatment (p=.002). This indicates that a single dose of amphetamine 
disrupts %PPI in D2R KO animals. Post hoc tests indicated no differences % PPI in 
KO animals treated with two doses of amphetamine when compared to their saline 
treated controls (p>0.05) but significant differences on % PPI were seen in D2R KO 
animals treated with a single dose vs a double dose of amphetamine (,p<0.05). (See 
Fig 2.7-2.8). 
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Figure 2.6.Baseline PPI for D2R wild Ðtype controls (+/+) (0.9 % saline; white 
bars) and knock-out(-/-) (0.9 % saline; grey bars) mutant mice. 
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Fig 2.7 Baseline PPI for in D2R wild-type mice with vehicle control (0.9% 
saline; open bars), single low dose amphetamine (2.5 mg/kg; hatched bars) and 
two low doses amphetamine animals (2.5 mg/kg; patterned bars). Post hoc 
Analysis showed that a single low dose of amphetamine disrupts %PPI in D2R 
WT and animals (p<0.05), but two low doses spare these disruptions. 
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Figure 2.8 Baseline PPI for in D2R KO mutant mice with vehicle control (0.9% 
saline; open grey bars) (0.9% saline; open bars), single low dose amphetamine 
(2.5 mg/kg; hatched grey bars) and two low doses amphetamine animals (2.5 
mg/kg; patterned grey bars. Post hoc Analysis showed that a single low dose of 
amphetamine disrupts %PPI in D2R KO animals (p<0.05), but two low doses 
spare these disruptions. 
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Effect of treatment on baseline startle to the 120 dB pulse trials 
A univariate ANOVA indicated no significant main effect of genotype on startle 
magnitude to the 120 db pulse alone trials [f(1,66)= 2.587,p>0.05]. However, a 
significant main effect of treatment on startle magnitude to the 120 db pulse alone 
trials [f(2,66)= 4.610,p=.013] was seen. A significant main effect of sex on startle 
magnitude to the 120 db pulse alone trials [f(1,66)= 4.265,p=.043] was also seen. 
However, no genotype by treatment by sex interaction was seen [f(2,66)= 
.379,p=.686] (Fig. 2.10). 
 
 
Effect of treatment on ASR on prepulse+pulse trials 
A repeated measures ANOVA showed that there was a significant effect of prepulse 
intensities on ASR [f(3,81)= 6.514,p=0.001].Furthermore, no significant effect of 
genotype [f(1,27)= 1.433,p>0.05] or sex [f(1,27)= .316,p>0.05] on ASR was seen. 
Thus, indicating no differences in baseline startle between D2R KO and WT animals. 
There was also no effect of treatment on ASR [f(2,27)= 2.209,p>0.05]. Furthermore, 
no genotype by treatment interaction on the ASR was seen [f(2,27)=.912,p>0.05] 
(Fig. 2.9). 
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Figure 2.9 Data showing a significant ASR in D2 WT (+/+) and KO (-/-) 
animals. There were no differences in ASR between D2 WT or KO animals, 
both in drug naive or drug treated groups. 
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Figure 2.10 Data showing ASR to 120 dB pulses in D2 WT (+/+) and KO (-/-) 
animals. There were a significant main effect of treatment on ASR to the 120 dB 
pulse (p<0.05) in D2R WT or KO animals, but no interaction between genotype 
and treatment (p>0.05). 
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Effect on Habituation 
There was no significant main effect of the to the 120 dB prepulses to % habituation 
[f(11,27)=1.288,p>0.05]. No significant main effect of genotype [f(1,27)= 
1.313,p>0.05] on % habituation was seen. No significant main effect of treatment 
[f(2,27)=3.289,p>0.05] on % habituation  was seen (fig 2.11).  
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Fig 2.11 Data indicating no significant difference of the percentage of 
habituation to the 120 dB pulses in D2R WT or D2 KO animals (p<0.05). 
Treatment with amphetamine did not produce deficits in % habituation in 
either D2R WT or KO littermates. 
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2.7 Discussion  
 
Our results indicated that a single administration of low dose amphetamine disrupted 
PPI in D2R KO while two administrations 24hrs apart prevented disruptions in WT 
and KO mice only. This suggests that the D2 receptor may not be required for 
amphetamine induced disruption of PPI by a single low dose of amphetamine. These 
findings demonstrate that previous findings suggesting that the D2R is required for 
amphetamine effects in PPI does not generalise to all doses, and further that the 
effect of one administration is not necessarily the same as the effect of two 
administrations.  
These data contradict prior studies suggesting that amphetamine disruption of PPI is 
blunted in D2R KO mice (Ralph et al.,1999).As mentioned previously, low doses of 
amphetamine produce disruptions in LI via the mesostriatal areas and high doses 
produce behavioural stereotypy via the mesolimbic region. Sensitization to 
amphetamine disrupts PPI and LI (Tenn, Kapur et al.,2005). This suggests the same 
neural mechanisms may be involved in LI and PPI. The amphetamine induced 
disruption in both these processes might be mediated by a common circuit; the limbic 
system has been implicated in the regulation of PPI. Dose dependent disruptions may 
be mediated differentially by these regions in PPI (Swerdlow, Mansbach et al., 
1990). Sensitization studies provide evidence for differential effects of amphetamine 
on PPI disruption and ASR following multiple in injection schedules at escalating 
doses, which that suggest that different dose schedules govern PPI differently 
(Russig, Murphy et al.,2002). Additionally, it is suggested that indirect agonists 
affect PPI by inhibiting GABA receptors (Swerdlow, Braff et al.,1990), and activate 
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VTA mediated neural circuits. Direct DAD2R agonist Pergolide reduces PPI at low 
doses, and eliminates it at high doses. It is suggested that with increased D2R 
stimulation, the information contained in the prepulse is less vulnerable to 
interference by stimuli in immediate temporal proximity, but more vulnerable to 
interference by stimuli at longer durations(Swerdlow,Geyer et al.,2001). This 
suggests that variations in PPI may be mediated by protocol differences such at the 
time of occurrence of prepulses and prepulse intensity (Karl,2011). 
Our results from experiment 1 and experiment 2 support the importance of protocol 
specificity in mediating PPI. In experiment 1, PPI was seen to be attenuated in the 
D2R KO, but these attenuations in PPI were not seen in experiment 2. Experiment 1 
consisted of a one day PPI test session, which consisted of five minutes of 
habituation to the chamber, which was incorporated into this session. Experiment 2 
consisted of a two day session, where day 1 consisted of habituation to the chambers 
without any stimulus presentations and day 2 consisted of a PPI test session that was 
identical to experiment 1. This suggests that a longer habituation period to the test 
chambers may produce more stable PPI. Baseline acoustic startle responses to the 
prepulses however remain unaffected by the lack of habituation day in experiment 1. 
These findings thus indicate that PPI and ASR may be differently mediated by 
depending on the amount of habituation to the test session. 
Furthermore, no changes in baseline startle and habituation to the 120 dB pulses by 
amphetamine, indicate that disruptive effects on PPI in the test session are not simply 
an artefact of disrupted baseline startle due to stress of injections administered prior 
to this session. Animals do not show the habituation deficits, seen in the previous 
experiment. Other studies report disruptions in the habituation of acoustic startle at 
moderate (5mg/kg) and high (10 mg/kg of d-amphetamine, but not at a low dose (2.5 
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mg/kg) in the NMRI nude mouse strain. This suggests that amphetamine disruption 
of startle habituation may also be dose dependently mediated. However, basal startle 
reactivity to the 120 dB pulse alone trials are affected by amphetamine treatment. 
More specifically, treatment with amphetamine attenuated baseline startle responses 
to the 120 dB pulses. However, no effect of amphetamine treatment was seen on the 
startle magnitude to the prepulse and pulse trials, and this lack of change in the 
startle reflex may be a floor effect (Swerdlow et al.,2000) of amphetamine treatment 
induced disruption in the pulse alone trials. Therefore, the disruption in %PPI may 
not reflect a true disruption of sensorimotor gating and needs to be interpreted with 
caution (see General Discussion). 
 
3.8 Conclusions 
Low dose amphetamine disruption of PPI in D2R animals is dependent on the dose 
schedule and protocol adopted. A baseline PPI phenotype is seen in D2R KO mice, 
in the one day and two day protocol. Alternately, % PPI is attenuated in the D2R KO 
compared to their WT littermates in the one day protocol only. Furthermore, 
dissociation between a single and double dose of amphetamine exists with regard to 
D2R involvement in PPI. The data from our first one day experiment suggested 
attenuated PPI in the D2R KO, and a trend toward amphetamine disruption by a 
single low dose in both D2R KO animals. Our second two day experiment found no 
attenuation in PPI in the D2R KO, however, it was seen that a single low dose of 
amphetamine disrupted % PPI in D2R KO mice, but two injections prevented 
amphetamine mediated impairment in this task in across both genotypes. Taken 
together, our results suggest indicating that a low dose of amphetamine disrupts PPI 
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in the D2R mutant model, in a protocol and drug schedule dependent manner where 
these effects do not generalize to all doses of amphetamine. 
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CHAPTER 3 
EPISODIC MEMORY IN D2R WT and KO 
ANIMALS 
 
3.1 Introduction 
 
In addition to cognitive deficits that span LI and sensori-motor gating, patients with 
schizophrenia also show disturbances in memory. Impaired episodic memory is seen 
in schizophrenia patients and DA agonist amphetamine produces schizophrenia like 
impairments in memory in non human primates (Castner and Goldman-Rakic 2003; 
Castner, Goldman-Rakic et al., 2004).  
Impairments in multiple facets of memory i.e. working memory, spatial memory and 
episodic memory have been well documented in schizophrenia patients (Park, 
Pschel et al.,1999; Tendolkar, Ruhrmann et al.,2002; Park, Pschel et al.,2003; 
Bonner-Jackson, Haut et al.,2005). These memory processes are regulated by 
dopamine; D1 receptors modulate working memory in the PFC(Granon, Passetti et 
al., 2000) and D2 receptors have been proposed to modulate verbal recall of memory 
the striatum (Chen, Kuang Yang et al.,2005).The D2R is also involved in the 
memory for coding spatial information (Tran, Tamura et al.,2003). Spatial memory 
deficits have been reported in rats administered a dopamine D2R antagonist 
raclopride in the radial arm maze test (Wilkerson and Levin,1999), suggesting that 
D2R blockade induces deficits in spatial memory. D2 receptors in the striatum have 
been associated with episodic memory tasks(Cervenka, Bckman et al.,2008), and 
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dopamine stimulation in this region may regulate activity in the hippocampus 
through the ventral tegmental area (VTA) -hippocampal circuits or via ventral 
striatal-thalamic-cortical circuits(Alexander,DeLong et al.,1986). The cortical and 
hippocampal regions are the functional substrates of these memory operations (Rajah 
and D'Esposito,2005).  
D2R KO mice show blunted PFC activation on a spatial working memory task; 
where augmented impairments in spatial memories are seen with increasing delays in 
this task (Glickstein and Schmauss,2002). This suggests that memory disruptions in 
D2R KOÕs are sensitive to long delay intervals in a memory task. However, to date 
episodic memory or novel object recognition has not been investigated in dopamine 
deficient mice, and it is not known if D2R KO induces disruptions on this form of 
memory. 
This chapter seeks to investigate episodic memory in D2R KO mice. We seek to 
investigate episodic memory in the D2R KO mouse model, in a task that establishes 
their memory for ÔwhatÕ, ÔwhereÕ and ÔwhenÕ based object discrimination. This task 
incorporates temporal memory for an object at a particular point in time, and 
memory for spatial displacement of objects (Refer to Section 1.5.2 in the 
Introduction). This task combines recency discrimination for a novel object as well 
as spatial memory for objects based on their occurrence at a point in time, as opposed 
to only novelty based object discrimination. It allows the simultaneous investigation 
of the discrimination for objects depending on the point of time at which they 
occurred, for what an object was, and where it was displaced to, with reference to the 
point in time it occurred at. This task allows the investigation of a novel object not 
only in terms of familiarity discrimination but also in terms of its temporal 
occurrence, and whether animals are able to detect a spatially displaced object based 
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on these recency and novelty driven properties. Thus, novelty and spatial 
displacement object properties individually form constituents of an episodic memory 
for ÔwhatÕ, ÔwhenÕ and ÔwhereÕ, that are governed by the temporal point, at which 
they occurred. . Antipsychotic drugs disrupt spatial memory (memory for where 
only) (Skarsfeldt, 1996) and mice lacking the D2R receptor show impairments in 
spatial memory (where) (Glicksteinet al.,2002). Thus, indicating that the D2R is 
required for intact spatial memory. Furthermore, antipsychotic drugs that are D2R 
antagonists do not improve impairments in episodic memory in schizophrenic 
patients (Goldberg et al.,2007). Thus, we wanted to investigate whether deletion of 
the D2R in KOÕs promotes deficits in an episodic memory task to investigate 
whether this model mimics these APD effects in the episodic memory task and its 
spatio-temporal component that is governed by recency of object occurrence as well 
as its displacement (memory for what-where). 
3.2. Materials and Methods 
3.2.1 Animals  
Dopamine receptor (D2R) wildtype and knockout mice were used in this experiment.  
Male and female KO (n=16) mice and wildtype (WT=16) littermates were between 
16-24 weeks old prior to being used in these experiments. (Refer to Material and 
Methods in Chapter 2 for full details). 
3.2.2. Behavioural Testing 
 
3.2.2.1 Apparatus 
Open Field 
Object exploration was assessed in an open field (8 boxes; 30 cmX 30 cmX 40 cm), 
chamber that consisted of enclosed boxes made out of clear plastic. Two sides of each 
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chamber were covered with black Fablon adhesive plastic, so as to prevent animals in 
each chamber from seeing animals in neighbouring chambers. Multiple spatial cues 
were also provided i.e. the left wall to the chamber was blue; the wall behind the 
chambers was covered in a white sheet with a stripe pattern, and its adjacent wall had a 
large red triangle pasted onto it. A video camera, connected to a video recorder was 
mounted 70 cms above the field to record and store activity videos on computers for 
analysis. Diffuse white light provided illumination in the centre of the chamber. The 
chamber had a closed ceiling, where the activity boxes were kept, and the door was 
closed whilst testing. A fan created white noise and was located at the top right corner 
of the chamber and also acted as a cue. After each trial, the apparatus was thoroughly 
cleaned with a 75% ethanol solution to remove any odour cues. 
 
Fig. 3.1 Mice were placed in open field chambers during the habituation phase, to 
acquaint them to novel objects. 
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Objects 
Two different objects (four copies of each), with varying texture and made of different 
materials were used i.e. a glass conical bottle and a golf ball. The objects were cleaned 
thoroughly with 70 % ethanol solution so that they could not be distinguished by 
odour cues. In the habituation session to a novel object, objects unrelated to those 
presented in the test phase were used (Lego blocks), so that there was no prior 
exposure to a similar object. Pilot studies ensured that the mice could discriminate 
between both objects, and to ascertain that there was no preference for one of these 
objects. 
HANDLING: Day 1-7 
The mice were habituated to the handling procedure prior to the ÔwhatÕ, ÔwhereÕ and 
ÔwhenÕ episodic memory task for seven consecutive days. The animals were picked up 
and released in the open field for an exposure of 1 minute, after which they were 
placed back into their home cage. 
HABITUATION: Day 8-10 
After handling, mice were familiarized to the test apparatus that was devoid of any 
objects for three consecutive days. They received 5 minutes of open field exposure per 
day.  
HABITUATION WITH AND WITHOUT OBJECTS: Day 11-12 
On the following two days, in order to habituate the animals, the mice received 3 more 
daily sessions with exposure for 10 minutes. Two objects were placed in the corners of 
the open field (lego blocks), and each exposure was separated by a 20 minute inter trial 
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interval (fig. 3.1). These objects were not used in the ÔwhatÕ, ÔwhenÕ, and ÔwhereÕ 
object exploration task. 
 
TEST OF MEMORY FOR ÔWHATÕ, ÔWHEREÕ AND ÔWHENÕ PARADIGM IN 
MICE BY COMBINING DIFFERENT VERSIONS OF THE NOVELTY 
PREFERENCE PARADIGM: Day 13 
Each mouse received two sample trials and a test trial. On the first sample trial, mice 
were placed in the centre of the open field that contained four copies of a novel object 
in a triangle shaped configuration; where one object was placed in the centre of the 
northern wall (NC), one at south-west corner of the box (SW), one at the south -centre 
and the last object at the south -east corner of the box (as shown in Fig.3.2). Animals 
were allowed to explore these objects for a period of 10 minutes. After a delay of 50 
minutes, animals received a second sample trial that was identical to the first, except 
the four novel objects were arranged in a different spatial orientation in the open field.  
Objects were arranged in a quadratic formation, where one object was arranged in the 
top left north-west corner (NW), northÐeast (NE), southÐwest (SW) and south-east 
(SE). The objects determined for each mouse were counterbalanced across both 
sample trials. After a second delay of 50 minutes, mice received a test trial identical to 
the second sample trial, where two copies of the old familiar object were places in the 
SW and NE corners, in their stationary (as-before) and displaced (not as-before) 
positions respectively and two copies of the recent object were placed in the NW and 
SE corners. The what-when task shows a preference for the old objects vs the recent 
objects, and the what-where component of the old objects over their subsequent 
locations (stationary and displaced). 
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Old Objects                             Recent Objects                           Discrimination Test 
                                 
            
         
         
 SW              SC          SE                 SW                         SE       SW                              
SE 
 
Fig. 3.2 Schematic drawing of the episodic memory task encompassing the 
ÔwhatÕ, ÔwhereÕ and ÔwhenÕ components. Object locations: NC= north corner, 
SW= south-west, SC= south-centre, SE= south-east, NW= north-west, NE= 
north-east. Adapted from Dere et al. 2005 
 
3.2.2.2 Data Analysis 
 
Data was analysed using mean exploration times in exploring the old and new 
objects and exploration times in exploring the stationary and displaced objects. Two 
repeated measures ANOVAs with object type (old vs recent and stationary vs 
displaced) and genotype and sex as within groups factors were used. Paired t tests 
were also conducted as a post hoc measure to ascertain differences in exploration 
between groups. The Bonferroni correction (α= .0125) was also applied. 
NC NW
W 
NE NE  
NW
NW 
50 min 50 min 
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Additionally, discrimination ratios were also calculated, to obtain a measure of object 
discrimination, which takes into account individual differences, as it measures 
exploration of a preferred object as a proportion of the total amount of exploration 
time, as opposed to total exploration times of all objects (Dix and Aggleton,1998). 
Discrimination ratios (DI) that expressed the preference/discrimination of one object 
as a proportion of the total amount of time spent exploring both objects was 
calculated as follows: 
DI (old vs recent ratio) = Time spent at old object (in seconds)/ Time spent at old 
object+ time spent at recent object (in seconds) 
DI (stationary vs displaced ratio) = Time spent at stationary old object (in seconds)/ 
Time spent at stationary old object+ time spent at displaced old object (in seconds).  
A one way univariate ANOVA was used with DI as the DV and genotype and sex as 
between groupsÕ factors. One sample t tests against a chance level of .5 were also 
conducted on these DIs. The Bonferroni correction was applied (α= .0125) to all t 
tests. Three animals were removed from the analysis based on the lack of exploration 
in each of the sample stages (< 20 sec). See Appendix 3. 
 
3.3 Results 
Recency discrimination: What-when analysis using mean exploration times 
A repeated measures ANOVA showed that there was a significant main effect of the 
familiarity of old and recent objects on the mean amount of exploration  of old 
familiar objects and the recent objects [f(1,55)=5.123, p<0.05]. No significant main 
effect of genotype [f(1,55)= 3.424, p>0.05] or sex [f(1,55)= 1.168, p>0.05] on the 
mean exploration times of the old familiar objects and recent objects was seen. 
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However, a genotype by sex interaction on the exploration of old and recent objects 
[f(1,55)= 7.485, p=.008] was also seen. 
To explore this interaction further, data was split by genotype. In D2R WT animals, 
no significant main effect of the familiarity of old vs recent objects on the 
exploration times of old and recent objects [f(1,27)=.226, p>0.05] was seen. A 
significant main effect of sex was seen [f(1,27)=8.113, p=.008], but no interaction on 
object familiarity and sex was seen [f(1,28)=3.064,p>0.05]. In D2R KO animals a 
significant main effect of the familiarity of old vs recent objects on the exploration 
times of old and recent objects [f(1,28)= 11.505, p= .002] was seen. No significant 
main effect of sex was seen. However, genotype by sex interaction on discrimination 
was seen [f(1,28)= 4.778, p<0.05]. 
 Paired T tests indicated that male WT animals [t= -.658, df=13, p>.0125, two tailed] 
did not differ significantly in their exploration of the old and recent objects, similarly 
to male KO animals [t=.992, df=15, p>.0125, two tailed] that did not exhibit these 
preferences. Female WT animals [t=.027, df=14, p>.0125, two tailed] did not differ 
significantly in their exploration of the old and recent objects either. However, 
female KO [t= 5.185, df=13, p<.0125, two tailed] showed a significant difference in 
exploration of the old objects as compared to the recent objects, indicated by an 
increased preference for the old object. This suggests an enhancement in the 
exploration of old vs new objects in females D2R KO animals. However, 
independent samples t tests indicated no significant differences in exploration of the 
old object between female D2R WT and KO animals [t= -904, df= 13,p>.0125].See 
Fig 3.3 
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Figure 3.3 Graph showing exploration of old vs recent objects in D2R WT and 
KO animals. Male and female WT animals do not exhibit any differences in 
their preference for old rather than recent objects. However, female animals 
KO animals show a difference in exploration of the old objects vs recent objects 
(p<0.05) and this increased preference for the old object is enhanced in the 
female KO.  
 
** 
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Recency discrimination: What When analysis using Discrimination ratios 
Using the DR measure one way between groups ANOVA showed no significant 
main effect of genotype [f(1,55)= 5.479, p>0.05] on the preference (discrimination 
ratios) for the old vs new object. No significant main effect of sex [f(1,55)= 3.426, 
p>0.05] on the preference for the old vs new object, and no significant genotype by 
sex interaction [f(1,55)= .019, p>0.05] was seen. See Fig 3.4 
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Figure 3.4 Graph showing discrimination ratios for old objects vs recent objects 
in male and female D2R WT and KO animals. Only KO female animals show a 
significant exploratory preference for the old objects vs recent objects (p<0.05). 
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What-where analysis using mean exploration times 
A repeated measures ANOVA showed that there was a significant main effect of the 
familiarity of the old displaced and stationary objects on the on the exploration times 
of old displaced vs old stationary objects [f(1,55)= 29.406, p< .001]. A significant 
main effect of genotype [f(1,55)= 7.642, p=.008] on the mean exploration times of 
the old displaced vs stationary objects was seen. Furthermore, a genotype by sex 
interaction [f(1,55)= 6.823, p=.012] was also seen, but no interaction involving 
displacement was significant. This indicates there were no differences in memory 
between sex or genotype (Fig 3.5). 
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Figure 3.5 Graph showing exploration of spatially displaced old vs stationary 
old objects in D2R WT and KO animals. Female animals KO animals show a 
difference in exploration of the old displaced objects vs old stationary objects 
(p<0.05) and this effect is enhanced in the female KO compared to their WT 
littermates. 
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Recency discrimination: What where using discrimination ratios 
A one way between groups ANOVA showed no significant main effect of genotype 
[f(1,55)= .005, p>0.05] or sex[f(1,55)= 1.254, p>0.05] on the preference for 
stationary vs displaced objects. No genotype by sex interaction on the preference for 
stationary vs displaced objects [f(1,55)= 1.046, p>0.05] was seen. One sample t tests 
indicated that WT female animals show a preference in exploration for the stationary 
vs displaced objects [t= -3.470,df=14, p<.0125] as do female KO animals [t= -
4.226,df=13, p<.0125]. Male WT animals do not show a preference in exploration of 
the stationary vs displaced object [t= 1.853,df=13, p>.0125]; but  male KO animals 
[t= 2.470,df=15, p<.0125] did show this preference in exploration. See fig 3.6 
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Figure 3.6 Graph showing discrimination ratios for spatially displaced old vs 
stationary objects in male and female D2R WT and KO animals. Only female 
WT and KO animals and male KO animals show a significant discrimination of 
the displaced objects compared to the stationary objects (p<0.05). 
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3.4 Discussion 
Our results suggest intact spatial memory in D2R WT and KO mice on the what- 
where component of the episodic memory, but no object discrimination on the what -
when recency mediated aspect of object recognition memory. D2R WT and KO 
animals show no differences in the exploration of the recency- oriented memory. An 
enhancement towards preference for the old familiar object over the recent object is 
seen in D2R female KO animals, but we are unable to make a conclusion regarding 
this due to a lack of discrimination in controls. Thus, we are unable to make 
conclusions regarding recency discrimination on the episodic memory task.  
Our results further indicate that D2R deficient female mice show sex specific 
preferential exploration of the what where aspect of the episodic memory task, 
reflecting intact processing of this component of episodic memory. Furthermore, 
both male D2R WT and KO animals show preferential exploration for the old 
displaced object over the old stationary object, reflecting intact memory for 
displacement. Only female D2R WT and KO mice show intact spatial memory in 
their preferences for their memory for a displaced object that was not in its original 
position to when they had previously encountered it, where female KO animals 
showed an enhancement in their exploration of the displaced object as compared to 
their WT littermates. Thus, reflecting enhanced spatial memory for what and where 
in female D2R KO mice only.  
In a recency based task of episodic memory (Dere, Huston et al.,2005) purport that 
rats and mice spend a greater proportion of time exploring the old objects as 
compared to the recent objects, and also spend a greater amount of time exploring the 
spatially displaced object compared to the stationary object. According to this, the 
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more recent object is explored less than the less recent (old familiar) object, as a 
representation of the less recent object still exists in memory. However, tests of novel 
object recognition involve greater preference of the novel object rather than the 
older, familiar one. Here, more exploration of an old familiar object indicates weak 
memory for this object not improved memory. Additionally, it is suggested that 
novelty preference does not wane over multiple exposures or over time (Ennaceur 
and Delacour 1988; Ennaceur 2010) rather, the memory for a familiar stimulus 
decays over time, thus making the older stimulus look novel. This encourages the 
exploration for the old, slightly familiar object as well as the never before seen novel 
object, which is manifest as equal amounts of exploration for each object or a short 
term increase in exploration of the old object. In line with this, D2R WT female mice 
have intact memory for the what and when recency component of the task.  
We conducted a secondary analysis that investigated preferential exploration of the 
old objects vs recent stationary objects, to determine whether exploration was greater 
for novel/ more recent  stationary objects as compared to older, familiar stationary 
objects, and that this exploration was not a consequence of the displacement of the 
older objects (See Appendix 4) This analysis shows that animals spend more time 
exploring  the recent objects as compared to the old objects, which is in line with 
theories of novel object recognition, but not recency based discrimination. Thus, our 
results mimic the pattern proposed by Ennaceur et al., (2010) a lack of exploration of 
the old objects by D2R WT animals may be due to the increased exploration of the 
novel object, which is in line with previous literature.  
 It is suggested that the recency aspect in episodic memory encompasses the memory 
for ÔwhatÕ a specific occasion was in terms of its elapsed time, as opposed to a single 
point in time i.e. ÔwhenÕ (Eacott and Easton,2010), and is not a true measure of 
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episodic memory. It is also suggested that equal amounts of exploration for both the 
old and recent/new objects is not a failure in the ability to discriminate between 
objects (Ennaceur 2010). Rather, animals recognize both objects as familiar or are 
both explored as novel (as previously described), and therefore it is not possible to 
model the ÔwhenÕ aspect. Therefore, the failure to discriminate between objects in 
male animals may have been interpreted differently, where equal or no differences in 
object exploration may not be a true indicator of learning. 
On the measure of spatial memory i.e. the where component, D2R KO female mice 
did not show deficits in their preference for displaced vs stationary objects. Spatial 
memory has been previously assessed more as a measure of working memory by 
using tests such as the T maze, radial arm maze and the delayed matching non 
matching procedure. In our test, the stationary and displaced objects are presented in 
the same locations; in Sample 1, the old familiar objects are present in this location 
and in Sample 2 the recent objects are present in the same location. Thus, the 
context-place association does not change, only the objects do, thus making it 
difficult to ascertain if animals discriminate between object presentations at 
particular points in time. It is also suggested that the spatial displacement element 
involves recall of memories rather than a simple judgement based on familiarity as 
rats manipulate the location of the object compared to what had been previously 
experienced rather than learnt, which cannot be delineated as the temporal element Ð 
spatial element (context-place) does not change, thus, preference for the displaced 
object may be an artefact of place preference, rather than a true discrimination for the 
displaced object.  
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Paradigmatic differences aside, female D2R KOÕs are able to identify the displaced 
object based on their recall of the old objects (enhanced exploration for old objects), 
thus displaying intact episodic memory. 
3.5 Conclusions 
 
D2R WT nor KOÕs showed any preferences in exploration in the what- when aspect 
of the episodic memory task. However, intact spatial memory is seen in D2R WT 
and KO mice. 
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CHAPTER 4 
LATENT INHIBITION IN C 57/BL6J MICE 
4.1 Introduction 
 
The LI paradigm has been extensively used as a model of inattention in 
schizophrenia. LI is a model of attentional salience, which requires an organism to 
ignore irrelevant stimuli. Subsequent non - reinforced  pre exposures to a conditioned 
stimulus retard learning to that stimulus, as opposed to sufficient learning in a non 
pre exposed group. This difference in learning between the pre exposed group that 
shows poorer learning to the stimulus, and the non pre exposed group, that shows 
better learning reflects LI.  
We used a conditioned emotional response paradigm that uses the suppression of 
behaviour to measure LI. The emotional suppression of eating or drinking behaviours 
as a consequence of the tone- shock (CS-US) pairing is used as an index of learning 
behaviour.  An aversive shock is paired to a stimulus, to form a CS-US association, 
in a pre exposed (PE) and non-pre -exposed (NPE) group of animals. The PE phase 
involves pre exposure to a stimulus (tone) in the chamber, and the NPE group 
receives exposure to the chamber only. The conditioned stimulus consists of the tone 
and the unconditioned stimulus of a foot-shock. The test phase consists of the 
suppression of drinking behaviour, which is used as an index for measuring LI, 
where animals that learn the CS-US association (NPE group), and suppress licking 
behaviours as they learn to make the tone shock association and refrain from water 
consumption (Lubow, 2010;Weiner and Shadach,1996; Weiner and Feldon, 
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1992,Lubow, 1959) . However, animals that have been pre exposed to the CS, do not 
exhibit this learning, as they deem the tone as being irrelevant to the shock, and do 
not suppress licking behaviours. This paradigm has been repeatedly used in the 
majority of the literature; both rats and mice show LI (Nakajima, Ka et al., 1999; 
Chang, Meyer et al., 2007; Lipina, Weiss et al., 2007; Lubow 2010) . 
However, in models of conditioned suppression, it is proposed that the aversive 
nature of the stimuli (loudness of tone) and the context (that it is presented in), may 
affect the conditioned emotional behavioural response (Davis 1972). The degree of 
aversiveness of a stimulus promotes a decline in the rate of stimulus responses, as a 
consequence of the stimulus being paired to a strong predictor (Azrin and Hake, 
1969). More specifically, an aversive event (loudness of tone) or novelty (not having 
been pre exposed to the tone) may predispose to an anxiety like emotional state in the 
context the stimulus is presented in (Estes and Skinner,1941) and promotes 
behavioural suppression. Thus, it promotes a lack of responding behaviours in the 
NPE group, not previously exposed to the tone. Exposure to a tone in the test phase 
may deem the tone or context as aversive /novel stimuli to the NPE group, and lead 
to a suppression of behaviour. This mimics the suppression of behaviour as expected 
from NPE group animals in response to the tone shock association in LI. 
Additionally, animals may not form an association between two stimuli as they are 
suppressing behaviour to the stimulus itself, and not as a consequence of the 
associative CS-US properties, thereby promoting an artefactual LI effect, or 
unconditioned suppression.  
In this chapter, the aim of the experiment is to verify that the LI effect occurs due to 
the PE-NPE association to the paired stimuli i.e. LI and is not attributed to the 
aversive/novel properties of the CS (tone) alone. Our paradigm consists of a non 
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contingent tone-shock pairing in the unconditioned suppression non contingent (NC) 
group and paired tone-shock in the NPE group. Animals in the NC group are 
hypothesised to not differ from animals in the PE group, as they do not learn to 
suppress behaviours, owing to a lack of association (non contingent pairing) between 
the tone and shock. Animals in the PE group would be unaffected due to prior pre 
exposure to the tone, and they do not deem it as aversive/ novel and show licking 
behaviours as predicted in LI.  However, animals in the NPE LI group would show a 
suppression of behaviour and differ from the PE group as they have learned to make 
the association in of the tone being able to predict the shock. Thus, indicating that LI 
is not an artefact of the nature of the aversive stimulus or context but a robust index 
of learning an association between contingently presented stimuli, in our hands, and 
as seen in previous studies. This is also a pilot study that differentiates between the 
LI effect and unconditioned suppression, as a pilot LI study in the C57 strain of 
mouse. 
4.2. Materials and Methods 
4.2.1 Animals  
18 naive male C57BL/6 mice obtained from Biomedical Services Unit, University of 
Nottingham Medical School, UK) were used in the study. At the beginning of the 
experiment, animals were 12-28 weeks old and were an average weight of 25-30 
gms. They were housed three per cage, under a 12:12 hour light-dark cycle, 
maintained at constant temperatures and humidity with food available. The 
experiment was conducted in the light phase of the cycle. Mice were placed on a 23 
hr water restriction schedule. All animals were maintained under ad lib food 
(standard chow, Harlan,US), and water was provided ad lib for 1 h per day. They 
were housed in a temperature and humidity controlled environment (22 degrees, 40-
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60%) in the animal housing facility. All experiments were carried out in accordance 
to local and national rules, with appropriate project and personal license authority 
(Animals Scientific Procedures Act, 1986, PPL 40/2883). 
4.2.2. Behavioural Testing 
The LI protocol (Lubow 1959, 2010) comprised of six stages i.e. water restriction, pre-
training, pre-exposure/non-pre-exposure, conditioning, re establishment of drinking, 
and testing. 
WATER RESTRICTION: Day 1-7. Mice were placed on water deprivation schedule 
for 7 days prior to the pre training phase. In this period, the animals received water for 
2 hours per day, every 23 hours. This regime was maintained throughout the 
experiment. 
 PRE-TRAINING: Day 8-13.Water was given in the test apparatus, in addition to the 
daily ration of 1 h delivered in the home cages. Mice were placed in the conditioning 
chambers and allowed to drink freely from a water sipper tube for 15 min. At the end 
of the session the animals received free access to water in their home cages. 
PRE-EXPOSURE: Day 14. After the pretraining phase, mice were placed in the 
conditioning chambers with no water access and preexposed to the 85 dB, CS 60 PEÕs 
X 5 sec (high LI) tones with a 15 sec interstimulus interval. Non-pre-exposed control 
mice were placed in the chambers for the same amount of time but received no pre-
exposures to the CS.  
CONDITIONING: Day 15. Mice were trained with two pairings of the CS with a 
foot-shock as unconditioned stimulus (US; 0.38 mA, 1 s, 2.5 min inter stimulus 
interval) in the NPE (LI). After 5 minutes, two tone-foot-shock pairings were 
presented. Each tone was of 5 seconds duration, and followed by a .38 mA foot-shock. 
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Animals in the NC (non contingent) groups received unpaired tone and shocks (85 dB 
CS, US; .38 mA 1s). There was a 2.5 minute interval between the pairings in the NPE1 
group and the unpaired stimuli in the NC group.  
REBASELINE: Day 16-17. Mice were placed in the conditioning chambers for 15 
minutes and given free access to the sipper tube to re-establish licking in the chamber 
prior to testing. Mice that did not lick consistently were omitted from the experiment 
at this stage.  
TEST PHASE: Day 18. Mice were placed in the conditioning chambers with access 
to the sipper tube. A computer recorded the number of licks and the time to complete 
licks 80-90 (A) and 90-100 (B). After the first 90 licks, the tone conditioned stimulus 
(CS) was presented until the mouse reached lick 100. The measure of conditioned 
suppression was the time taken to complete licks 90-100 in the presence of the CS. A 
suppression ratio (SR) was calculated according to the formula A / (A + B) yielding a 
scale of 0 to 0.5. Low SR indicates good learning while high SR indicates poor 
learning of the association between the tone and foot-shock. LI is seen as higher SR in 
the PE group compared to the NPE group. See Fig 1c in introduction). 
4.2.3 Apparatus 
 
Training and testing was conducted in six identical light and sound attenuating 
conditioning chambers (21.6 cm X 17.8 cm X 12.7 cm, ENV-307W, MED Associates 
Inc., St. Albans, VT, USA). These were composed of Plexiglas walls in the front and 
back of the boxes, and two stainless steel sides. In addition to this, a metal floor grid 
was connected to a shock generator. Each box contained a ventilation fan, mounted the 
chambers to provide an inflow of air, and background noise (69 dB white noise). 
Moreover, a sonalert was mounted on the adjacent wall for delivering the CS (85 dB) 
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(ENV-323AW, Med Associates Inc., St. Albans, VT, USA). Each chamber was 
equipped with a removable drink spout located along the left wall. The lick spout was 
connected to a lickometer (ENV-250, Med Associates Inc., St. Albans, VT, USA) 
which recorded the number of licks made by the animal. The chambers were 
connected to a PC computer that employed MED-PC software (SOF-735, MED 
Associates Inc., St. Albans, VT, USA) to control stimulus presentation and record 
data.  
4.2.3 Data Analysis 
 
A suppression ratio (SR) was calculated, based on Time A and Time B. Time A 
consisted of the time taken to complete licks 80-90 (A) and time B was the time 
taken to complete licks 90-100 (B). After the first 90 licks, the tone Conditioned 
stimulus (CS) was presented until the mouse reached lick 100. The measure of 
conditioned suppression was the time taken to complete licks 90-100 in the presence 
of the CS. A suppression ratio (SR) was calculated according to the formula A / (A + 
B) yielding a scale of 0 to 0.5. A Low SR indicates good learning while high SR 
indicates poor learning of the association between the tone and foot-shock. LI is seen 
as higher SR in the PE group compared to the NPE group.  
A one way ANOVA was conducted to determine whether there was a difference in 
learning (as indexed by a suppression of licking behaviour) in the PE, NPE (paired 
shock and tone) and NC (non contingent shock and tone) groups. Furthermore, post 
hoc tests were conducted to explore whether there was a difference in the SR in the 
PE vs the NPE group, and the PE vs the NC groups. 
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4.4 Results 
 
Differences in Learning in the Pre-Exposed and Non PreExposed Group 
(paired) and Non Contingent Group2 (unpaired) 
 
A one way ANOVA showed that there was a significant effect of exposure on the SR 
[f(2,54)=11.961,p=.001].Furthermore, there was no significant main effect of genotype on 
SR [(2,54)=3.038,p>0.05] . There was a no significant main effect of sex on SR 
[f(2,54)=1.533,p>0.05]. There was also no genotype by exposure by sex interaction [f(2,54)= 
.123,p>0.05]. This indicates that both Nrg-1 WT and HET animals show intact LI. See Fig. 
5.1. 
Post Hoc tests (FisherÕs LSD) indicated that there was a significant difference 
between the PE and NPE group (mean diff. =.191,p=0.019) and between NPE and 
NC groups (mean diff.=.167,p=.029), but not between the PE and NC groups (mean 
diff.=.0235,p>0.05). (See Fig 2.2) 
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Fig.4.2 Mice show a robust LI effect, as indicated by the complete suppression 
of licking behaviour in the NPE group. Animals in the PE group do not learn 
the irrelevance of the tone presented, and thus do not show learning (p<0.05). LI 
is the difference in learning between the NPE group and PE. This is not an 
artefact of the aversive/novel properties of the stimulus alone, but of the CS-US 
association,  as differences in SRs were also seen between the NPE and NC 
group (p<0.05), indicating that only the paired association of stimuli promoted 
associative learning. 
** 
** ** 
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4.5 Discussion 
 
This data indicates that there is a difference in learning to suppress behaviour 
depending whether stimuli are paired or unpaired. In this experiment animals showed 
LI, as indicated by learning of the association to the CS-US contingent stimuli. No 
difference was seen between the PE and NC groups. However, a difference between 
the NC and NPE groups was seen, which jointly indicate that 1) the LI effect is a 
consequence of the learnt association between two paired stimuli, only and not due to 
the nature of the stimulus (unconditioned suppression) and 2) learning only occurred 
in the group that was presented with contingent stimuli and not non contingent 
stimuli, thus indicating LI is a consequence of learning to the CS- US relationship 
only.  In our hands, pre exposure of 60X tone produced a robust LI effect as seen by 
a high suppression ratio in the NPE group and no suppression in the PE group. Our 
findings indicate that LI is a standalone phenomenon of associability that is not an 
artefact of the context or stimulus alone. 
4.6 Conclusions 
 
In this experiment animals showed LI, as indicated by learning of the association to 
the CS-US contingent stimuli only and not due to the nature of the stimulus 
(unconditioned suppression). Thus, LI is a robust phenomenon that relies on learning 
to make an association between the CS-US, rather than the aversive properties of the 
CS alone. 
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CHAPTER 5 
LATENT INHIBITION IN NRG-1 WT AND HET 
MICE 
 
5.1 Introduction 
Nrg-1 has been identified as a candidate gene for schizophrenia (Li, Collier et al., 
2006). An association between the trans membrane domain Nrg-1 gene and 
schizophrenia has been identified (Walss-Bass, Liu et al.,2006) but the functional 
role of the TM-domain of the Nrg-1 gene in mediating cognitive disruptions in 
schizophrenia has not been extensively established. Nrg-1 mice show deficits in 
social interaction and social recognition memories, which are measures of the 
negative symptoms of schizophrenia pathophyisiology (O' Tuathaigh et al.,2007), but 
little is known about its contribution to positive or cognitive symptoms. We seek to 
investigate Nrg-1 as an endophenotype for Schizophrenia; whether it affects the 
entire schizophrenia syndrome or only distinct aspects of the schizophrenia 
phenotype. Using a similar behavioural approach to that used in D2R mutant mouse 
studies, we sought to investigate whether reduced function of the TM domain of the 
Nrg-1 gene, produces schizophrenia like cognitive impairments on measures of 
attention, sensorimotor gating and episodic memory. This experiment investigated 
the behavioural consequences of partially knocking down the Neuregulin-1 gene in 
producing disruptions on the LI task of conditioned inattention. 
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Nrg type 1 immunoglobulin-like (Ig) domain Heterozygous mice show deficits in LI 
compared to their wild type littermates on an ambulatory activity version of the LI 
task (Rimer, Barrett et al.,2005). The LI task consisted of 40 pre exposures to a tone, 
where LI was indexed by a measure of ambulatory activity. PE to a tone made the 
tone less likely to reduce ambulatory activity. However, this study did not have 
appropriate NPE controls and thus remains inconclusive. To date, studies 
investigating LI disruptions in TM domain Nrg-1 mutants  (original strain was a 129 
X C 57 cross) have not been carried out. Nrg-1 has been implicated as an at risk 
allele, that is associated with high risk for schizophrenia (Stefansson,2002), but 
studies have not investigated its role extensively in behavioural phenotypes relevant 
to schizophrenia. Furthermore, an LI paradigm that uses suppression of behaviour as 
an index of learning has not been employed in these mutant mice  
LI is a good paradigm to model the disrupted attentional salience processes in 
schizophrenia, and has received robust validation as a pharmacological model in 
different mutant mouse models of schizophrenia (Bay-Richter et al.,2009; Clapcote 
et al.,2007). However, Neuregulin-1 has not been investigated in cognitive 
phenotypes relevant to schizophrenia pathophyisiology. Therefore we investigated 
whether disruption of the Nrg-1 gene, leads to disrupted LI, as a measure of 
attentional impairments seen in schizophrenia. 
5.2 Materials and Methods 
5.2.1 Animals  
In the study, adult (8-12 weeks old) male and female WT (n=16) and HET (n=15) 
animals were used. Heterozygous Neuregulin 1 ÔknockoutÕ mice were generated and 
imported from the Royal College of Surgeons, Dublin, Ireland. The original C57BL6 
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background strain mouse was backcrossed for 14 generations. These mice were 
originally generated at the Victor Chang Cardiac Institute, University of New South 
Wales, Australia, as described previously(Stefansson ,2002) and maintained on a 
C57BL6 background (14 backcrosses). Heterozygous mutants and wild type (WT) 
mice were generated from Heterozygous breeding pairs and the offspring were 
genotyped using polymerase chain reaction(OÕ Tuathaigh et al.,2007). Mice were 
housed into groups of three to five per cage and maintained on a standard 12 hour 
light: 12 hour dark cycle with ad libitum access to food and water. Mice were housed 
at constant temperature of 22 degrees in 45% humidity controlled environs. All 
experiments were carried out in accordance with and with appropriate personal and 
project licence authority under the Animals (Scientific Procedures) Act, UK 1986. 
PPL No: 40/2883. 
5.2.2 Behavioural Testing 
Refer to Chapter 4 (Section 4.2.2). 
5.2.3 Apparatus  
Refer to Chapter 4 (Section 4.2.3). 
5.2.4 Data Analysis 
Refer to Chapter 4 (Section 4.3). 
 
5.5 Results  
 
A one way ANOVA showed that there was a significant effect of exposure on the SR 
[f (1,54)=11.961,p=.001]. Furthermore, there was no significant main effect of 
genotype on SR [(1,54)=3.038,p>0.05] . There was a no significant main effect of 
sex on SR [f(1,54)=1.533,p>0.05]. There was also no genotype by exposure by sex 
interaction [f(1,54)= .123,p>0.05]. This indicates that both Nrg-1 WT and HET 
animals show intact LI. See Fig. 5.1. 
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Figure 5.1 LI in Nrg-1 WT and HET animals. Both Nrg-1 WT and HET animal 
show LI at 60 PEs (p<0.05)
** 
** 
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The data was also split by sex as sex specific cognitive deficits have been reported in 
previous studies in Nrg-1 mutants in phenotypes of relevance to schizophrenia 
(OÕTuathaigh, 2010). In female animals, a significant effect of exposure on the SR 
was seen [f(1,28)= 5.250, p=.03], indicating that there was a difference between  the 
PE and NPE conditions (LI) in  female animals. There was no significant effect of 
genotype on SR [f(1,28)= .191, p>0.05]. There was no genotype by exposure 
interaction [f(1,28)= .113, p>0.05]. Thus indicating that female HET animals did not 
exhibit differences in LI as compared to female WT animals. In male animals, a 
significant effect of exposure on the SR was seen [f (1,26)= 6.861, p=.015], 
indicating LI in male animals. In males there was a significant effect of genotype on 
SR [f(1,26)= 4.304, p=0.048]. There was no significant genotype by exposure 
interaction was seen [f(1,26)= .747, p>0.05] indicating that there was no 
impairemnet in LI in Nrg-1 Hets (Fig. 5.2). 
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Figure 5.2 Graph expressing SR in the LI effect in Nrg-1 TM domain mutants. 
Split by sex, the analysis shows robust LI in WT male and female animals 
(p<0.05) and in HET female animals (p<0.05), but not in male HET animals 
(p>0.05). 
 
 
 
 
 
** 
** 
** 
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An alternative way of measuring  suppression of licking behaviours is to express it as 
the log10 of the T2 values based on time in seconds in NPE and PE conditions taken 
to resume licking after CS onset (Bay-Richter et al.,2009). 
Using this measure a significant effect of exposure on the time taken to complete 
licks (log10 t times) was seen [f(1,54)= 11.643, p=.001] indicating that there was a 
difference in learning to lick in the PE vs. the NPE groups. There was no significant 
effect of sex [f(1,54)= 4.145, p=.05] or genotype [f(1,54)= 2.108, p>0.05] on log10 
times. However, there was a significant genotype by sex interaction on log10 times 
[f(1,54)= 5.0343, p=.025]. No genotype by exposure by sex interaction was seen 
[f(1,54)= .878, p>0.05] indicating no differences in LI. 
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Fig 5.3 LI in Nrg-1 TM domain mutants as measured by log10 t2 values, 
indicating intact LI in female WT and HET animals (p<0.05). 
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5.6 Discussion 
 
Our results indicate that overall both Nrg-1 WT and HET animals show LI,.Nrg-1 
female WT and HET animals showed intact LI, as did male WT animals.  
 Previous studies have reported sex specific disruptions in TM domain male HET 
mutants. In the Barnes maze, learning is assessed by the latency to reach an escape 
hole and make errors in this process, and tests the ability of the mouse to encode 
information about the escape hole whilst it explores the maze. Male HET animals 
showed a disruption on this task; increased investigation of false escape holes, and a 
larger number of errors were made compared to female mutants(O' Tuathaigh et 
al.,2007). These were attributed to a disruption in attentional processes in the ability 
to encode information. These sex specific dissociations may reflect distinct 
information processing deficits that have been seen in schizophrenic males (Braff, 
Sedro et al., 1999; Roy, Maziade et al.,2001). Nrg-1 may be able to dissociate 
between sexes in behavioural phenotypes of schizophrenia, as has been seen 
consistently in tasks that measure the negative symptoms of schizophrenia. 
The disruptive effects on cognitive tasks of relevance to schizophrenia by Nrg-1 may 
be governed differently by underlying neural mechanisms. The Nrg-1/ErbB4 
receptor mediates the signalling of cortical GABA interneurons (Flames, Long et al., 
2004), and is also involved in glutamatergic neurotransmission (Li B Woo,2007); 
where the frontal-cingulate cortical circuit is implicated in Nrg1 mediated function of 
attentional salience (Flames, Long et al.,2004) . It would be of interest to know 
whether other Nrg-1 isoforms inhibit GABAergic neurotransmission, as this could 
elucidate the mechanisms involved in aberrant Nrg-1 function. Alternately, 
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behavioural alterations on cognitive phenotypes of schizophrenia like behaviour  by 
Nrg-1 isoforms have been attributed to mutations of targeted deletions at specific loci 
(Gerlai, Pisacane et al.,2000), but the exact mechanism by which Nrg1 contributes to 
disruptions in schizophrenia like behaviours is not clear.  
In our study, dampened function of the Nrg-1 receptor leads to sex specific deficits in 
LI that suggests that Nrg1 may mediate cognitive behavioural phenotypes relevant to 
schizophrenia in a distinct sex specific manner. 
5.7 Conclusions 
 
Both WT and KO of the TM domain of Nrg-1 gene show intact LI. 
 
 
 
 
 
 
 
 
146 
 
 
CHAPTER 6 
PREPULSE INHIBITION (PPI) IN NRG-1 WT and 
HET mice 
 
6.1 Introduction 
 
This study carries on from our previous experiments that investigated role of the 
D2R in mediating sensorimotor gating in schizophrenia, as a cognitive 
endophenotype of schizophrenia like pathophyisiology. We investigated whether 
disruption of the TM domain Nrg-1 allele promotes deficits in a PPI task, as a 
cognitive phenotype of relevance to schizophrenia (Geyer et al.,2001).Nrg-1 has 
been associated with PPI. Reduced PPI has been reported in humans carrying the 
Rs3924999 mutation of this gene, and schizophrenic patients with abnormal PPI over 
express this mutation, compared to controls (Hong,Wonodiet al.,2008). 
Schizophrenia like phenotypes that are associated with the Nrg-1 gene vary 
depending on the Nrg-1 isoform that is disrupted. TM domain mice heterozygous for 
Nrg-1 show a hyperactive exploratory phenotype (Karl, Duffy et al.,2007)and Nrg-1 
ErbB4 receptor knockout mice show hyperactivity and impairments in PPI (Wen, Lu 
et al.,2009). Alternately, TM domain Nrg-1 hypomorphs show deficits in PPI that are 
not reversed by clozapine (1 mg/kg) administration (Stefansson,2002), whereas Nrg-
1 Ig domain mutants show a clozapine induced reversal of PPI deficits (Rimer, 
Barrett et al.,2005). 
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Schizophrenia relevant phenotypes are sex specifically mediated by the Nrg-1 gene; 
decreased PCP induced hyperlocomotion is seen in male mice Nrg-1 Het mice but 
not in females (OÕTuathaigh, Harte et al.,2010). Additionally, sub chronic treatment 
with either PCP or MK-801 results in pronounced sensitization in locomotor activity 
in female mutants only. Shifting of exploratory behaviour is also increased in female 
mutants but reductions in grooming behaviour are seen in the male mutants only 
(OÕTuathaigh, Harte et al.,2010). This suggests that the Nrg-1 TM domain allele may 
sex specifically dissociate for schizophrenia relevant phenotypes. 
 The role of the Nrg-1 TM domain gene in mediating PPI is inconclusive. It is 
suggested that PPI and PPI deficits may not be a robust replicable effect in Nrg-1 TM 
domain mutants. Rather deficits in PPI in Nrg-1 TM domain mutants are suggested 
to be protocol and site specific. No deficits in PPI were found in Nrg-1 HET mutants 
compared to their WT littermates; however reduced ASR in Nrg-1 HET animals was 
seen, but only at high levels of startle magnitude (110db, 115 db,120 db) (Karl, 
2011). This disruption in PPI was specific to the intensity of prepulse magnitude 
used and the testing site, as different protocols at different testing sites did not 
establish replicable PPI or PPI disruptions in mutants Nrg-1 HetÕs. The PPI deficit 
that was seen in the original study TM domain Nrg-1 mutants (Stefansson,2002) has 
not been replicated (Boucher, Arnold et al., 2007, Van den Buuse, 2010). 
We wanted to investigate whether the Nrg-1 knock-down mouse model shows 
schizophrenia relevant deficits on a sensorimotor gating task as a consequence of 
aberrant gene function, in mediating disruptions in cognitive phenotypes relevant to 
Schizophrenia. Following on from our Nrg-1 LI data, we also seek to determine 
whether sex specific dissociations are mediated by Nrg-1 on the PPI task of the 
gating of information. 
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6.2 Materials and Methods 
Is the same as previous experiments in Chapter 2. 
6.2.1 Animals  
Animals are the same cohort as Chapter 5.  
6.2.2. Behavioural Testing 
Is the same as previous experiments that employed a two day paradigm in 
Experiment 2, in Chapter 2 (Section 2.5.1.2). 
6.2.2.1 Apparatus 
Is the same as previous experiments, refer to Chapter 2. 
6.2.2.2 Acoustic Startle Session/ Prepulse Inhibition 
Is the same as previous experiments, refer to Chapter 2. 
6.2.2.3 Data Analysis 
Is the same as previous experiments, refer to Chapter 2. 
Percentage PPI was analyzed using a split plot ANOVA to compare differences in 
startle to prepulses in WT and HET animals. The computations were carried out 
using SPSS statistical software. Prepulse inhibition was the within subjects factor, 
with varying startle intensities (68 db, 72 db, 80 db and 90 db), with genotype (WT/ 
HET) as the between groups factor. Prepulses from the aforementioned subset of 
specific intensities were not administered in a particular sequence, but in a random 
order in the session.  
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6. 3 Results  
 
% PPI in Nrg-1 WT and HET animals 
A repeated measures ANOVA showed that there was a significant effect of prepulse 
intensities on % PPI [f(3,162)= 4.442,p=.005] . Furthermore, a significant main 
effect of genotype on % PPI was also seen [f(1,540= 5.722,p=.020]. Moreover, no 
genotype by PPI interaction was seen [f(3,162)= 1.683,p=.730] and no genotype by 
sex by PPI interaction  [f(3,162)=.433,p=.730] was seen. See figure 6.1.  
This indicates that % PPI was disrupted in Nrg-1 HET animals compared to their WT 
littermates.
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Figure 6.1 Diagram showing attenuated % PPI in Nrg-1 HET animals. A main 
effect of genotype was seen. % PPI was attenuated in Nrg-1 HET animals as 
compared to their WT littermates (p<0.05). 
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ASR to the 120 dB pulses in Nrg-1 WT and Het animals 
A univariate ANOVA showed no significant main effect of genotype [f(1,54)= 
2.402,p>0.05] or sex [f(1,54)= 1.295,p>0.05] on the startle to the 120 dB pulses. 
Furthermore, no genotype by sex interaction on the startle to the 120 dB pulses was 
seen [f(1,54)= .242,p>0.05]. 
ASR in prepulse+pulse trials in Nrg-1 WT and Het animals 
A 2X4 repeated measures ANOVA showed that there was a significant main effect 
prepulse intensities [f(3,162)= 7.867,p<0.001. No significant effect of genotype on 
startle magnitude [f(1,162= 1.085,p=.357]was seen. Furthermore, no interaction of 
genotype and sex on startle magnitude [f(3.162)=1.076,p=.361] was seen. (Fig 6.3) 
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Figure 6.3 Graph showing ASR in Nrg-1 WT and Het animals. No significant 
main effects of genotype were seen on % PPI (p>0.05)
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Habituation to the 120 dB pulses 
A univariate ANOVA showed that there was no significant effect of genotype on % 
habituation [f(1,54)= 3.290,p=.075). Furthermore, no significant effect of sex on % 
habituation was seen [f(1,54)= 1.345, p=.251]. No interaction was seen of the effect 
of % habituation on genotype by sex [f(1,54)= 2.764, p=.102].When data was split 
by sex,  no difference of the effect of genotype on PPI was seen in female [f(1,31)= 
.052, p>0.05] or male animals [f(1,23)= 2.667, p>0.05].See Figure 6.5.  
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Figure 6.5 Graph showing habituation to the 120 dB pulses in Nrg-1 WT and 
HET animals. 
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Figure 6.6 Graph showing habituation to the 120 dB pulses in Nrg-1 Wt and 
HET animals. No significant main effect of sex and no sex by genotype 
interaction are seen on habituation (p>0.05). 
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6.4 Discussion 
 
Our results indicate that mutant mice Heterozygous for the Nrg-1 gene a) show 
deficits on the PPI task of sensorimotor gating compared to their WT littermates, and 
b) show robust baseline startle to the prepulses and c) no habituation or habituation 
deficits to the 120 dB pulses. More specifically, Nrg-1 HET mice show attenuated 
PPI as compared to their wild type littermates.  
Previous studies that have looked at PPI in of Nrg-1 TM domain mice report mixed 
results. More specifically, no differences in the baseline startle response, PPI or 
startle habituation in Neuregulin-1 Het mutants has been reported (Van den Buuse 
2009). Our results are consistent with other studies that have reported PPI disruptions 
in both TM domain and ErbB4 hypomorphs (Stefansson,2002). 
The magnitude of PPI and disruptions in PPI are differently mediated depending on 
the protocol used. Different experimental protocols across experiments that produce 
weak or strong PPI, may not affect baseline startle (Swerdlow, Bakshi et al.,1996). In 
line with this, studies have found robust ASR but no PPI in Nrg-1 mutants (Karl 
2011).Our study suggests PPI deficits at 68, 72 and 80 db prepulses in Nrg-1 mutants 
but not at a high intensity 90dB prepulse, and robust ASR.  
Other studies suggest that apart from the requirement of prepulse intensity to be 5-10 
dB above background noise to induce PPI and PPI disruptions (Sills et al.,1999), the 
inter trial interval between prepulses also mediates PPI. Female TM domain Nrg-1 
animals show no alterations in PPI in a fixed inter trial stimulus paradigm, but in a 
variable ISI task they show enhanced PPI. Thus, TM domain Nrg-1 mice also show 
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sex specific dissociations, that are governed by the PPI protocol (Long, Chesworth et 
al.,2010). 
Our results indicate that habituation to the 120 dB pulses in the Nrg-1 mutants is 
independent of PPI and ASR, as disruptions in habituation would also affect the 
magnitude of inhibition to the prepulses. This is corroborated by previous reports that 
indicated lack of habituation on a skin conductance behavioural response protocol 
that is associated with Nrg-1 phosphorylation AKT (marker for psychosis) was 
independent of PPI. In relation to schizophrenia symptoms, weak habituators show 
higher levels of delusions and anxiety as well as lower ratios of phosphorylated 
AKT, compared to strong habituators (Keri, Seres et al.,2011). This suggests that 
deficits in habituation may be associated with distinct positive symptom mediated 
phenotypes of schizophrenia like pathophysiology. 
Our results indicate that disruptions in PPI are seen as a consequence of partially 
dampened Nrg1 functioning. Moreover, these disruptions may be mediated by the 
protocol employed. Nrg-1 may also in mediate distinct sex specific phenotypes of 
schizophrenia like symptoms on specific tasks of attentional salience and novelty (ÔO 
Tuathaigh, 2007) as previously reported, rather than sex specific phenotypes in all 
tasks of cognitive impairment in illness. 
6.5 Conclusions 
 
Nrg-1 TM domain mutants show deficits on the schizophrenia relevant PPI task of 
sensorimotor gating. Nrg-1 HET mutants show attenuated % PPI compared to their 
WT littermates, however, this may be subject to protocol specificity and prepulse 
intensities employed. This data suggests that partial deletion of Nrg-1 leads to  
disruption on  the schizophrenia relevant phenotype of sensorimotor gating.
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CHAPTER 7 
EPISODIC MEMORY TASK IN NRG-1 WT AND 
HET MICE 
 
7.1 Introduction 
 
This chapter explores the effect of reduced Nrg-1 function in an episodic memory 
task. The Nrg-1 gene is involved in the modulation of episodic memory in humans 
(Krug and Nthen 2010) but has not been established in animal models assessing 
episodic memory. Spatial working memory is intact in Nrg-1 TM domain Het 
mutants as indexed by the Barnes and Y mazes (O' Tuathaigh et al.,,2007). Deficits 
in object recognition memory for a novel object have been seen in Nrg-1 TM domain 
Het mutants (Duffy, Cappas et al.,2010). These measures of novelty oriented 
memory and spatial memory suggest Nrg-1 involvement in memories for novelty 
driven memories but not in spatial object recognition. However, these tasks have not 
been extensively established in different Nrg-1 isoforms.   
Nrg-1 mutants show certain sex specific behaviours; decreased PCP induced 
hyperlocomotion is seen in male HET mice but not in female Het mice 
(OÕTuathaigh, Harte et al.,2010). Locomotion, rearing and exploratory behaviour 
were also attenuated in both male and female Het mutants (OÕTuathaigh, Harte et al., 
2010).  
Although the neural circuitry involved in the modulation of memory tasks by the 
Nrg-1 gene are unknown, it is suggested that aberrant Nrg-1 functioning affects both 
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the dopaminergic and glutamate pathways in mediating memory disturbances. Nrg-1 
mediates the consolidation and retrieval of memories in the hippocampus 
(Kempermann, Krebs et al.,2008) and the pre frontal cortex (Krug and Nthen,2010). 
Consequently, it is suggested that dopamine neurotransmission in the mesolimbic 
regions may regulate the modulation of memory in the hippocampus (Dere, Pause et 
al., 2010), particularly if the episodic memory task encompasses a reward related/ 
novelty aspect. Thus, Nrg-1 mediates memories associated with novelty that may be 
affected by dopamine neurotransmission. Additionally, deficits in social learning, in 
Nrg-1 mutants also are attributed to NMDA receptor hypofunction in schizophrenia 
(Enomoto et al.,2007). Thus, Nrg-1 mediated disruptions in schizophrenia relevant 
phenotypes may be governed by complex interactions between dopamine and 
glutamate systems. 
Following on from previous studies that report impairments in object recognition and 
intact spatial memory in Nrg-1 mutants, we seek to investigate whether disruption of 
the Nrg-1 gene leads to impairments on the recency mediated what-when and what-
where object recognition components of an episodic memory task. It should be noted 
however, that the temporal element cannot be removed from the spatial memory 
aspect of this task, and this is not a standalone measure of spatial memory, but rather 
of spatio-temporal memory.  
7.2 Materials and Methods 
Same as previous experiment, refer to Chapter 3. 
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7.2.1 Animals  
Same as previous experiment, refer to Chapter 3. Prior to this experiment, animals 
had undergone the PPI task 3 weeks after the LI study, and the episodic memory task 
4-6 weeks after the PPI task. 
7.2.2. Behavioural Testing 
Same as previous experiment, refer to chapter 3. 
7.2.3 Apparatus 
Same as previous experiment, refer to chapter 3. 
7.2.4 Data Analysis 
Same as previous experiment, refer to chapter 3. 
7.3 Results 
Recency Discrimation: What when analysis using mean exploration times 
A repeated measures ANOVA showed that there was a significant main effect of the 
familiarity of old and new objects in influencing the mean amount of time spent 
exploring the old familiar objects and the recent objects [f(1,27)= 28.905, p<0.001]. 
No significant main effect of genotype on the mean time spent exploring the old 
familiar objects and the recent objects [f(1,27)= .645, p>0.05] was seen. No genotype 
by sex interaction on mean amount of time spent exploring the old familiar objects 
and the recent objects [f(1,27)= .216, p>0.05]was seen.  
To explore Nrg-1 mediated sex specific dissociations as informed by the previous 
literature (OÕ Tuathaigh et al.,2007,), on cognitive tasks as established in previous 
reports, two repeated measures ANOVAÕs split by sex were conducted. In female 
animals, a significant main effect of the familiarity of old and new objects in 
influencing the mean amount of time spent exploring the old familiar objects and the 
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recent objects [f(1,14)= 16.140, p=0.001]. No recency exploration (old vs new times) 
by genotype interaction on the mean amount of time spent exploring the old familiar 
objects and the recent objects [f(1,14)= 3.92, p>0.05] was seen. In male animals, a 
significant main effect of the familiarity of old and new objects in influencing the 
mean amount of time spent exploring the old familiar objects and the recent objects 
was found [f(1,14)= 13.559, p=0.002]. A recency exploration (old vs new times) by 
genotype interaction on the mean mean exploration time [f(1,14)= 5.729, p=.031] 
was seen reflecting memory impairment in the Het males. 
 Paired t tests split by sex were conducted. A significant difference in the amount of 
time male WT animals spent exploring the old objects as compared to the recent 
objects [t= 3.667,df=7, p<.0125] was seen. Furthermore, there was no significant 
difference in the amount of time male HET animals spent exploring the old objects 
as compared to the recent objects [t= 1.999,df=6, p>.0125]. Thus, indicating a 
disruption in the ability to explore the old vs recent objects in male HET animals as 
compared to their WT littermates. Figure 7.1 
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Figure 7.1 Graph showing exploration of old vs recently presented objects in 
Nrg-1 WT and HET animals. Male WT animals show differences in their 
preference for old or recent objects (p<0.05), but male HET animals do not 
indicate a preference for the old object or the recent object as compared to their 
WT littermates. Thus, indicating a subtle deficit in exploratory preferences for 
old vs recent objects in male HET animals. Female HET animals also show a  
enhanced preference in exploration of the old objects over the recent objects 
(p<0.05) in the ÔwhenÕ component but we canÕt make any conclusions as no 
memory is seen in controls. 
** 
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Recency Discrimation: What when analysis using mean discrimination ratios 
A one way between groups ANOVA showed a genotype by sex interaction on the 
preference (discrimination ratios) for the old vs new object [f(1,27)= 4.796, p=.037].  
The data was split by sex. There were no significant differences in female WT or 
HET animals in their preference for the old vs recent objects [f(1,14)= 1.417, 
p>0.05].However, a significant main effect of genotype was seen in male animals 
[f(1,13)= 5.745, p=.032] in their preference for an old vs new object. Thus, 
indicating that male HET animals differed in their preference of old vs new objects 
compared to male WT animals. 
One sample t tests against the .5 chance level were conducted. They indicated that 
WT female animals did not show a preference for old vs new objects [t=.735, 
df=7,p>.0125]. However female Het animals did exhibit this preference [t= 5.026, 
df=7,p<.0125]. Male WT animals also indicated a preference of the old vs new 
objects [t= 3.680, df=7,p<.0125]. However, male HET animals did not show any 
preference [t= 2.286, df=6,p>.0125]. Thus, indicating that male HET animals have 
deficits in their memory for old vs new objects as compared to WT animals. See Fig 
7.2 
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Figure 7.2 Graph showing discrimination ratios of old vs recently presented 
objects in Nrg-1 WT and HET animals. Male WT animals show a preference for 
old vs recent objects (p<0.05), male HET animals do not indicate a preference 
for the old object vs the recent object as compared to their WT littermates. 
Thus, indicating a subtle deficit in male HET animals. Female HET animals also 
show a trend for enhanced preference in exploration of the old objects over the 
recent objects (p<0.05) but no effect is seen in female WT animals. 
** ** 
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Recency discrimination: What where using exploration times 
A repeated measures ANOVA showed that there was no significant main effect of 
the displacement of old objects in influencing the mean amount of time spent 
exploring the old stationary objects and the displaced objects [f(1,27)= 2.172, 
p>0.05]. Furthermore, no significant main effect of genotype [f(1,27)= .208, p>0.05] 
or sex [f(1,27)= 1.034, p>0.05] on displacement was seen. No genotype by sex by 
displacement interaction [f(1,27)= .247, p>0.05]was seen (Fig 7.3). 
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Figure 7.3 Graph showing exploration of stationary or displaced objects in Nrg-
1 WT and HET animals. No significant differences in the exploration of 
stationary or displaced objects were seen in either Nrg-1 WT or HET animals. 
No sex specific differences were found in either genotype (p<0.05). 
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Recency discrimination: What where using discrimination ratios 
One way between groups ANOVA showed no significant main effect of genotype 
[f(1,27)= .139, p>0.05] or sex[f(1,27)= .094, p>0.05] on the preference for stationary 
vs displaced objects. No genotype by sex interaction on the preference for stationary 
vs displaced objects [f(1,27)= .218, p>0.05] was seen. One sample t tests indicated 
that neither WT [t= -1.262, df=15,p>0.05] nor Het [t= -.684, df=14,p>.0125] animals 
showed an increased preference for the displaced vs stationary object  (Fig. 7.4). 
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Fig 7.4 Graph showing discrimination ratios of stationary vs displaced objects 
in Nrg-1 WT and HET animals. No significant differences in the exploration of 
stationary vs displaced objects were seen in either Nrg-1 WT or HET animals. 
No sex specific differences in the discrimination for object displacement were 
seen in either genotype (p<0.05). 
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7.4 Discussion 
 
Our results indicate that Nrg-1 Het animals show impairments in their memory for 
the what when component of the episodic memory task, which was marked by 
increased exploration for an old vs a recent object. No preferential discrimination of 
objects was seen in female WT animals. However, an enhancement for the 
exploration for old vs recent objects is seen in female HET animals, but we are 
unable to make a conclusion regarding this.  It is to be noted, that the standard 
preference for the novel object was not observed in WT mice, as indicated in past 
literature (OÕ Tuathaigh et al.,2008).We cannot draw any conclusions with respect to 
the spatio temporal aspect of this task, as neither WT nor HET animals show any 
preference in exploration of the stationary vs displaced objects. There appears to be a 
trend toward intact spatio-temporal memory in Nrg-1 mutants and this is consistent 
with other studies (Duffy, Cappas et al.,2010), but not significant.  
However, studies that report impairments in object recognition memory in TM 
domain mutants, do so on the rationale that increased exploration of the novel object 
reflects intact memory processes, where exploration of a less novel (old) object 
reflects an impairment in memory for the novel object (O' Tuathaigh 2007; Ennaceur 
2010). However, our task adapted from Dere et al. (Dere, Huston et al.,2005) 
emphasizes on increased exploration of the old object based on recency. As the 
temporal component of recognition memory is always present in our task, it is not 
directly comparable to behaviours on a novel object recognition task, as both objects 
have been exposed prior to test, and are not ÔnovelÕ, but defined in terms of their 
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recency of occurrence. Object exploration is thus defined in terms of recency 
discrimination for the objects, rather than a test of novelty. 
However, it is suggested that novelty preference does not wane over multiple 
exposures or over time (Ennaceur and Delacour,1988; Ennaceur,2010) rather, the 
memory for a familiar stimulus decays over time, thus making the older stimulus 
look novel and facilitates the increased exploration of the older stimulus. Using an 
alternate ÔwhichÕ contextual component, to mark a particular object at a particular 
point in time in an episode could be used in place of the ÔwhenÕ component that 
measures object memory in terms of elapsed time (Ennaceur,2010). However, this is 
inaccurate as it still does not account for increases in exploration of an old object 
over a more recent one, and is not in line with novel object recognition. Additionally, 
the temporal occurrence of these objects may be confounded by place preference of 
the object, because it cannot be segregated from this analysis. Different objects 
(recent objects) are present in locations that were previously occupied by other 
objects (old objects); object B (recent object) occurs in the same place as object A 
(older object), at different points in time. This does not reflect a true, absolute 
temporal measure, or an absolute measure of place preference, as object occurrence 
at particular points in time are confounded by the different objects being present at 
the same locations. 
The lack of exploration on the what where component, may be interpreted as a lack 
of learning in Nrg1 HET mutants (Dere, Huston et al.,2005).  However, it has been 
proposed that equal or no differences in object exploration may not necessarily 
reflect that learning has not occurred; as it can be attributed to the temporary decay 
of memory or interest for a novel object, thus resulting in increased or equal amounts 
of exploration for an old object (refer to aforementioned comment about the waning 
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of a memory trace for the old object) (Ennaceur,2010). However, it is difficult to 
make a firm conclusion about the spatio temporal aspect as our control animals do 
not show significant exploration of displaced vs a stationary object. In the HET 
animals, these results may be confounded either the temporal point at which object 
occurred at object Ðplace object was presented in isolation problem mentioned 
previously. However, there appears to be a trend toward for increased exploration of 
the displaced object as opposed to the stationary object in both WT and KO animals, 
which suggests intact spatio-temporal memory in these mutants. 
7.5 Conclusions 
 
These findings demonstrate that reduced function of TM domain of the Nrg-1 gene 
has sex-specific effects on episodic-like memory impairing the recency based 
discrimination in males and improving it in females. This suggests that the episodic 
memory model may have relevance for investigating memory dysfunction in 
schizophrenia, particularly in the context of sexually dimorphic memory impairment. 
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CHAPTER 8 
GENERAL DISCUSSION 
 
The original objective of this thesis was to investigate the effect of knocking out the 
dopamine D2R in mice on cognitive behavioural phenotypes relevant to 
schizophrenia. D-amphetamine induced disruptions on these cognitive tasks were 
also investigated in both D2R WT and KO animals. Furthermore, the role of another 
candidate gene that had been associated with schizophrenia i.e. the TM domain of the 
Nrg-1 gene was also investigated in cognitive phenotypes relevant to schizophrenia, 
in Nrg-1 Het mice. The dopamine D2R and Nrg-1 receptors are both susceptibility 
genes that have been associated with schizophrenia. Alterations in gene expression 
profiles manifest as deficits on behavioural tasks that are used as indices of 
schizophrenia like phenotypes. The cognitive tasks pertaining to attention i.e. Latent 
Inhibition and sensorimotor gating (PPI) and memory i.e. episodic memory were 
established in these mouse models as behavioural correlates of disrupted cognitive 
processes in schizophrenia. The results of this thesis1)  demonstrate attenuated PPI in 
D2R KO mice as an attentionally mediated cognitive schizophrenia like phenotype; 
2) show dissociable effects of one vs. two low doses of amphetamine in inducing PPI 
disruption in D2R KO and WT mice in a protocol dependent manner; 3) show 
deficits in D2R KO mice on the what-where component of the episodic memory task; 
4) show intact LI in the TM-domain of the Nrg-1 HET mouse, with  sex specific 
deficits in LI in male HET animals; 5) demonstrate attenuated PPI in Nrg-1 HET 
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animals; 6) show dissociable sex specific impairments in Nrg-1 HET animals on the 
what-when aspect of the episodic task.  
8.1 One but not two injections of amphetamine disrupts PPI in D2R 
KO deficient mice 
Two PPI protocols were used to investigate amphetamine mediated disruptions in 
D2R WT and KO mice. The first protocol consisted of a one day test session that 
investigated the effect of the administration of a single low dose injection of 
amphetamine in mediating disruptions in PPI. The second protocol consisted of a two 
day session; day 1 consisted of habituation to the chambers that were devoid of the 
stimuli, and day 2 consisted of the PPI test session. This protocol investigated the 
amphetamine induced disruption of PPI when a single low dose injection of 
amphetamine was administered (d1: saline, d2: amphetamine) as opposed to two 
single low dose injections (d1: amphetamine, d2: amphetamine). This single vs. two 
dose experiment was conducted to investigate whether low dose amphetamine 
mediated disruptions in D2R WT and KO mice are affected by the number of 
administrations of the drug, as seen in other schizophrenia relevant phenotypes. 
As previously reported amphetamine induced disruptions in tasks of cognitive and 
attentional deficits in schizophrenia depend on the drug schedule adopted (Weiner, 
Lubow et al.,1988; Moran,1994). Thus, the one vs. two low dose injection 
experiment was conducted to elucidate whether amphetamine induced disruptions of 
PPI and LI are mediated similarly by the drug administration schedule adopted; to 
investigate whether two single low dose amphetamine injections administered 24h 
apart produce disruptions in PPI as they do in LI. In the first experiment, the protocol 
consisted of a one day test session, where animals were administered a single low 
dose of amphetamine prior to test. It was seen that D2R KO animals showed 
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attenuated % PPI compared to their WT littermates that precluded comparisons with 
treatment.  
A trend toward amphetamine induced disruption of PPI was seen in the D2R KO 
animals, but this was not significant. In the two day paradigm, a single low dose of 
amphetamine disrupted % PPI in D2R KO animals, but two injections did not disrupt 
% PPI in either genotype. Conversely, two injections of amphetamine augmented % 
PPI in the D2R KO compared to animals treated with a single dose, but these 
findings were not significant against D2R KO saline treated controls. 
These results suggest that amphetamine induced disruption of LI and PPI may be 
differentially mediated by the D2R KO depending on the injection schedule adopted. 
As previously mentioned, low doses of amphetamine (1mg/kg) disrupt latent 
inhibition and produce locomotor stimulation via the nucleus accumbens or ventral 
striatum (Weiner et al.,1988,Warburton et al.,1993.Bay-Richter et al. 2008: Gray et 
al. 1991). High doses (5 mg/kg) on the other hand, lead to stereotypy via the dorsal 
striatum and nucleus accumbens (Weiner et al.,1988, Joseph et al. 2000, Gray et al. 
2005). Consequently, low dose amphetamine induced PPI disruption has been 
attributed  to augmented dopaminergic activity in the mesolimbic regions (Swerdlow, 
Mansbach et al.,1990). High doses of amphetamine disrupt PPI in D2R WT mice 
only (Ralph, Varty et al.,1999). At low doses, amphetamine is coupled to impulse 
flow, and promotes augmented release of DA in the C57 mouse strain (Ventura et al., 
2004). At high doses, amphetamine becomes uncoupled to impulse flow; and 
promotes preservative/restricted behaviours in this strain (Ralph et al., 2001). 
Consequently, dopamine depletion in the nucleus accumbens, olfactory tubercles and 
anterior striatum reverse amphetamine induced disruption on PPI. These studies 
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suggest that low and high doses of amphetamine interact with different neuronal 
mechanisms dose dependently to produce specific behavioural alterations. 
A low dose of amphetamine was used in this study to avoid the effect of unknown 
compensatory mechanisms in mediating deficits in PPI in D2R KO animals and 
amphetamineÕs disruptive effects on PPI;. Activation of the serotonergic and 
adrenergic neurotransmitter systems by amphetamine augments motor activity and 
produces alterations in behaviours (Segal and Mandell,2002) at high doses. These 
behavioural alterations are governed by the drug administration schedule as well as 
the dose; accumulation of d-amphetamine in non adrenergic neurons following 
multiple amphetamine administrations promotes a reduction in brain norepinephine 
(adrenergic system neurotransmitter) levels and produces behavioural augmentation 
and stereotypy as a consequence of amphetamine accumulation in the brain (Browne 
and Segal,1977). However, it is suggested that repeated amphetamine administration 
induced behavioural responses may be subject to other factors during testing such as 
the housing environment and isolation rearing (Browne and Segal,1977). Rats were 
socially isolated by being individually housed in the experimental test chambers, and 
were placed in the chambers three days prior to 4 daily injections of saline or d-
amphetamine (2.5 mg/kg). These were then followed by a single administration of 
amphetamine on the fifth injection day. Behavioural augmentation was seen after a 
single injection of d-amphetamine only, and no augmentations were seen in response 
to saline in the five days separating the first and second amphetamine injections. 
No alterations in behaviour were seen in the amphetamine pre treated group 
compared to saline controls, indicating that social isolation factors, acclimatisation to 
test chambers or administration of injections do not affect amphetamine mediated 
augmentation of behaviours.  
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This lack of behavioural augmentation was attributed to state dependency and the 
same injection protocol was further assessed in rats housed in one of three different 
environments; singly housed in test chambers, singly housed in home cages or group 
housed in (6-8 per cage) in home cages. It was seen that pre treatment with 
amphetamine lead to a rapid onset of behavioural augmentation that was independent 
of the environment the animals were housed in, and indicates that behavioural 
augmentation is governed by the number of amphetamine administrations alone. 
This corroborates our findings that suggest drug schedule dependent dissociations 
between one and two low dose mediated disruptive effects of amphetamine. 
Additionally, our findings suggest that prior conclusions about the requirement of the 
D2R for amphetamineÕs effects in PPI may not generalise to all doses, but rather, is 
dependent on the injection schedule adopted.  
 Alternately, it is suggested that amphetamine based disruptions on PPI are also 
governed by the PPI protocol employed. Amphetamine affects dopamine release in 
the mesolimbic region between a 1-3 hour time window (Gold, Swerdlow et al., 
1988). Low dose amphetamine treatment (0, 0.3, 1, or 3 mg/kg) attenuates PPI when 
tested 10 minutes after a single administration, and when the prepulse stimuli are 5 
dB above 65dB of background noise. These disruptions are seen within a narrow 10-
40 min time when amphetamine is administered prior to test, but only high doses 
disrupt PPI when administered at delays of 40-70 minutes prior to test. Low or high 
doses of Amphetamine 60-90 min prior to test, do not disrupt PPI (Sills, Onalaja et 
al.,1998). Our results are consistent with the literature, as our protocol falls within 
this 10-40 min time window and produces PPI disruptions at a low dose in animals 
were tested 30 minutes after amphetamine treatment in both protocols, and where 
prepulses were 3 dB-25 dB, and therefore sufficiently over background noise. This 
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indicates that longer delays between injection and test prevent amphetamine induced 
disruptions in PPI. Additionally, Prepulse magnitudes are required to be sufficiently 
above background noise to influence amphetamine disruption of PPI. Thus, PPI 
disruptions by amphetamine are subject to the task paradigm as well as the injection 
schedule employed.  
PPI studies in Nrg-1 mutants suggest that PPI is mediated by the protocol used (Karl 
et al.,2011). In our initial experiment, attenuated PPI was seen in drug naive D2R 
KO animals in the one day test protocol. However, in the two day protocol, PPI was 
not attenuated in D2R mutants, suggesting that habituation to the test chambers may 
influence PPI magnitude. This suggests that a longer habituation to the test chambers 
may produce more stable PPI. As attenuated PPI is only seen in the D2R mutants 
treated with a single low dose of amphetamine, the two day protocol and drug 
schedule together may mediate PPI and disruptions in PPI.  
However, our analysis of the pulse alone trials suggests that we regard the 
interpretation of sensorimotor gating deficits with caution. Amphetamine treatment 
reduced startle reactivity to the 120 dB pulse alone trials, but left startle to the 
prepulse+pulse trials unaffected. It is suggested that this lack of reduction in the 
prepulse+pulse trials may be a floor effect, of the amphetamine induced disruption of 
the pulse alone trials (Swerdlow et al.,2000). The authors suggest that this floor 
effect may be absolute wherein, the startle magnitude is at its lowest to the pulse 
alone trials, thus leaving the prepulse+pulse trials unaffected; or relative wherein the 
magnitude in the lower range is more resistant to reduction relative to magnitude in 
the higher ranges (Swerdlow et al.,2000). In the one day protocol, amphetamine did 
not affect startle to the pulse alone trials, but there was a trend toward disruption of 
%PPI at the lower prepulse intensities, indicating that there may be a true disruption 
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toward sensorimotor gating. However, in the two day protocol, relative floor effects 
may be seen, as a consequence of attenuated startle reactivity to the 120 dB pulse and 
no change to the startle reactivity to the prepulse+pulse trials. However, different DA 
receptor subtype agonists predispose to genetically mediated differences in startle to 
the pulse alone and pre pule+pulse trials depending on the D1 or D2 receptor that is 
stimulated (Swerdlow et al.,2000) which may account for these amphetamine 
induced disruptions in startle reactivity in the pulse alone trials. However, the data 
must be interpreted with caution with regards to whether amphetamine truly disrupts 
sensorimotor gating or if these attenuations in % PPI may be attributed to relative 
floor effects. 
Thus, amphetamine induced disruption of PPI by a single dose only may be a non 
D2R dependent phenomenon, but disruption of PPI by two doses may require the 
D2R. We conclude that these amphetamine mediated low dose disruptions in PPI are 
differentially mediated by the number of amphetamine administrations as well as the 
protocol employed.  
8.2 D2R mutants show sex specific impairments in the ÔwhatÕ and 
ÔwhereÕ but not the ÔwhatÕ and ÔwhenÕ components of episodic 
memory  
An episodic memory task that assessed the memory for object discrimination as 
indexed by the memory for ÔwhatÕ the object was, ÔwhereÕ it occurred and ÔwhenÕ at 
a point in time it occurred, was conducted in D2R mutants. As previously mentioned, 
impairments in spatial and episodic memory have been well documented in 
schizophrenia patients (Park, Pschel et al.,1999; Tendolkar, Ruhrmann et al.,2002), 
and thus an episodic memory task was established in the D2R deficient mouse 
model, to investigate whether disrupted function of the D2R mediates memory 
deficits  in this task.  
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In our experiment, male and female D2R WT animals did not show any preferential 
discrimination for recency mediated object recognition (what-when). Female KO 
animals show preferential exploration of old object, but no conclusions could be 
made due to a lack of discrimination for objects in D2R WTs. However, on the 
spatio-temporal component of this task, D2R WT animals discriminated between the 
old stationary vs. the old displaced objects; as did D2R WT and KO animals show 
intact memory for the displaced object, as seen by preferential discrimination of the 
displaced object. Thus, our analysis indicates that spatial memory is intact in both 
D2R WT and KO animals. 
Our paradigm was based on the temporal element of memory that incorporates the 
relative order of recency at which the objects were seen (Dere, Huston et al.,2005) as 
opposed to  memory for novelty on a one trial object recognition task. Animals are 
exposed an object (object B) in Sample 2, which is novel in terms of its recency to 
Object A presented in Sample 1. Thus, animals receive exposure to Object B which 
occurs at a more recent point in time, and is therefore not completely novel in test. It 
is suggested, that WT control animals would show increased preference of the older 
object that indicates the older object was remembered as having occurred at an 
earlier point in time (Dere, Huston et al., 2005; Dere, Kart-Teke et al.,2006).In this 
recency -oriented task, rats and mice spend a greater proportion of time exploring the 
old objects as compared to the recent objects, and also spend a greater amount of 
time exploring the spatially displaced object compared to the stationary object. In 
tasks that measure memory for objects based on their temporal recency, the more 
recent object is explored less than the less recent (old familiar) object, as a 
representation of the less recent object still exists in memory. This increased 
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exploration of less recent objects is not consistent with theories of novel object 
recognition, and is discussed in detail in the next section. 
Secondly, female D2R KO animal show intact spatial memory, with a trend toward 
intact spatial memory in male D2R WT and KO mice indicating that this spatio 
temporal task is not impaired following D2R deletion, thus indicating that the 
consolidation of spatial memories may not be D2R dependent.  
However, spatial memory deficits have been reported in rats administered dopamine 
D2R KO antagonist raclopride (Wilkerson and Levin,1999), and delay dependent 
intervals in spatial memory tasks promote disruptions in D2R KO mice (Glickstein, 
Hof et al., 2002). D2R KO mice show slower learning of place recognition and show 
partial alterations in their coding of spatial information to an open field. 
Consequently, marked decrements in signalling for reward as reflected by slower 
acquisition of place reward associations are also seen in D2R KO mice in 
comparison to their WT littermates (Tran, Tamura et al.,2003). This indicates that 
D2R blockade disrupts spatial memory tasks as well as spatial tasks that rely on 
place-appetitive reward stimulus properties. 
 However, in our task, it is impossible to separate the temporal aspect from the 
spatial task, and obtain an absolute measure of spatial memory, as memory consists 
of the consolidation of information about an object based on both its spatial 
properties and its recency. Furthermore, recent objects are present in locations that 
once contained the old objects, making it difficult to separate recency based 
discrimination of objects from place based preference. Thus, as the context-place 
association does not change, only the objects do, it is difficult to ascertain whether 
intact spatial memory is due to displacement of an old object, a consequence of 
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preferred exploration of old vs. recent objects; or if this reflects a preference in place 
due to increased exploration of the recent object vs. the old objects (Refer to 
Appendix 4). 
Previous reports indicate that DA dissociates between novelty based object 
preference and place based preference for novel stimuli. D2R antagonist Eticlopride 
produces impairments in place related preference for a novel object, at a low dose 
that also impairs novelty based object preference. However, the D1R antagonist SCH 
23390 induces impairments in place preference for the object only(Besheer, Jensen et 
al.,1999). These studies using D1 and D2R specific antagonists indicate dissociation 
between novelty preference and spatial discrimination mediated object 
discrimination memories. This suggests that in our task these D2R mediated 
dissociations may not be apparent due to the spatio-temporal nature of our task that 
involves both place and recency mediated memories, which make it difficult to 
separate dissociations in terms of spatial discrimination or recency preference alone. 
Studies that investigate spatiotemporal memory with regard to the DA system 
suggest that the hippocampus and PFC are integral in the activation, processing and 
reconciliation of information about past and present environments (Wall and 
Messier, 2001). This activation and consolidation of memories may be mediated by 
D1R in the PFC (Glickstein and Schmauss,2002). Consequently, the PFC circuits  
are mediated by glutamatergic NMDA and AMPA channels that promote excitatory 
synaptic dopamine transmission, and mediate spatial memories (Tanaka,2002). This 
suggests differential modulation of spatio-temporal memories may not be limited to 
D1 and D2R KOs alone.  
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A lack of exploration on the whatÐwhen recency component in our task by D2R WT 
and KO animals may be a consequence of  increased exploration of the more recent 
object as opposed to the old object as indicated by our secondary analysis that 
investigated exploration rates for the old stationary object only vs. the recent objects, 
to determine if displacement of the old objects (place)  confounded exploration of the 
stationary old vs. recent objects (recency)  (See Appendix 4).Thus, our results mimic 
the pattern proposed by (Ennaceur and Delacour,1988) where animals show 
increased preference for a more recent object, which is consistent with the novel 
object recognition literature. Alternatively, it is suggested that equal amounts of 
exploration for both the old and recent/new objects is not a failure in the ability to 
discriminate between objects (Ennaceur,2010). Rather, animals recognize both 
objects as familiar or explore both as novel (as object exploration for the less recent 
object wanes over time). Animals may show a short term preference for the more 
recent object, and then go back to the exploration of the old object, thus indicating 
increased preference of the old object. Consequently, the more recent object is 
explored less than the less recently encountered object (old object) because the 
representation of the former is still available in memory, and not because there is no 
memory for the recent object (Ennaceur,2010).  
This suggests that in our task, animals show preferential exploration of the old object 
as they remember the occurrence of the old (less recent) and recent object. According 
to the literature for novelty, this is not possible as increased exploration of a less 
recent object reflects a weak or no memory of this object. It is suggested that object 
occurrence governed by recency is confused with the memory of an object at a 
particular place or time (Ennaceur,2010). This does not indicate that the memory for 
the recent object has been lost, and thus it is not possible to model the ÔwhenÕ aspect.  
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Our results indicate that D2R KOÕs show no memory for what when and intact 
memory for what and where, on the episodic memory task. Episodic memory cannot 
be limited to the sum of ÒwhatÓ, ÒwhereÓ and ÒwhenÓ that constitute an episode, as 
these can be still be indexed as individual components of memory at certain points of 
time in an episode, where past and present memories can be reconciled as they are 
reminiscent of an episode (Ennaceur,2010). In light of our results, this may be 
indicative of the D2R differentially mediating the what-where and what-when 
components of an episodic memory task; where mutants show intact memory on the 
spatio-temporal component of the task.  
8.3 Nrg-1 mutants show no impairments in LI  
LI is a model of learned inattention that is used to model schizophrenia like deficits 
governed by abnormal stimulus salience. LI is the difference in learning between the 
PE and NPE groups. As a model of attentional salience, the animal is required to 
ignore non reinforced stimuli, where pre-exposure to the stimulus retards learning 
(Lubow and Moore 1959). The suppression of drinking behaviour is an indicator of 
learning where NPE animals learn the tone-shock (CS-US) association and refrain 
from licking for water. However, animals pre exposed to the tone (PE group) do not 
make this differentiation. It is suggested that this suppression of behaviour in the 
NPE group may be due to the nature of the event itself (Estes and Skinner,1941). 
This is attributed to the presentation of a novel stimulus (tone), where animals in the 
NPE group suppress drinking behaviours in the test phase, owing to this stimulus 
novelty. Thus, leaving the group that had been pre exposed to the tone unaffected, 
and mimicking behaviour as seen in LI. This suggests that the nature of the stimulus 
itself, rather than learning to the tone-shock relationship would predispose to an LI 
like effect. 
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In order to differentiate between unconditioned suppression of behaviour and 
associative learning in LI, two sets of stimuli i.e. paired stimuli (contingent tone and 
shock) and unpaired stimuli (non contingent tone and shock) were used to show that 
the LI effect and the subsequent expression of behaviours was a consequence of this 
tone-shock association, rather than an artefact of behavioural suppression due to the 
aversive nature of the tone stimulus. LI is demonstrated as a difference between the 
PE and NPE groups only when the stimuli are paired, and the tone predicts the shock. 
Animals in the paired group learn to suppress licking behaviour, as a consequence of 
this association. The group that was exposed to non contingent stimuli however, does 
not differ from the PE group and did not show LI. Thus, animals presented with the 
non contingent stimuli did not show LI or suppress behaviour compared to animals 
that received contingent tone shock pairings.  
These findings jointly suggest that the suppression of behaviour in LI is solely 
governed by the associative CS-US relationship. As suppression of behaviour was 
only seen on exposure to paired stimuli (tone-shock), and not as a response to the 
properties of the unpaired stimulus (stimulus 1: tone, stimulus 2: shock) itself. The 
difference in learning between the PE and NPE groups cannot be attributed to 
unconditioned learning to the aversive unpaired stimulus alone. If this were the case, 
and novelty to the tone did affect behaviour, animals in the contingent group would 
mimic behaviours of the non contingent group. These results suggest that attentive 
learning occurs as a consequence of the associative relationship between two paired 
stimuli, rather than the properties of the stimulus alone. This indicates that LI is a 
standalone phenomenon of associability that is not attributable to the nature of the 
stimulus alone. These findings thus replicate other studies that show LI to be a robust 
task of inattention. 
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Neuregulin-1 (NRG1) is an at risk haplotype for schizophrenia (Harrison and Law 
2006). Mutant mice Heterozygous (Het) for the Nrg-1 gene or its receptor ErbB4 
have been shown to display cognitive deficits reminiscent of those demonstrated in 
schizophrenia in tasks of social novelty and pre-pulse inhibition (OÕ Tuathaigh et 
al.,2007; Karl,2011). Like our previous studies in D2R mutants, we wanted to 
investigate whether dampened function of the Nrg-1 gene predisposes to 
schizophrenia like deficits on a task of learned inattention, as a measure of cognitive 
impairment in schizophrenia. The results from our experiment indicate that both Nrg-
1 WT and Het animals show robust LI.  
Previous reports indicate that Nrg-1 Ig domain mutants show impairments in LI 
(Rimer, Barrett et al.,2005). However, this study did not have an NPE control group, 
thus it is difficult to make a concrete conclusion regarding LI impairment. 
Behavioural alterations in Nrg-1 mutants are differentially mediated depending on 
the Nrg-1 isoform that is targeted. Targeted deletion of ErbB2 and ErbB3 receptors 
in Heregulin Het mutants spares disruptions on the T maze, and improves 
performance on the rotarod and locomotor acitivity in an open field, indicating that 
behavioural alterations in Nrg-1 mutants are a consequence of targeted deletions at 
specific loci (Gerlai, Pisacane et al.,2000).  
Studies in TM domain mutants suggest sexually dimorphic effects in the exploration 
and habituation to a novel environment (OÕTuathaigh and Croke,2006; O' Tuathaigh, 
2007), with impairments being seen  in male Het animals only. Shifting of 
exploratory behaviour is increased in female mutants but reduced in male mutants 
(OÕTuathaigh, Harte et al.,2010). However, our study indicates intact behaviours in 
male and female mutants.  
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8.4 Nrg-1 Het mutants show impairments in Prepulse Inhibition 
To investigate the role of the Nrg1 gene in other attentional salience mediated 
cognitive phenotypes in schizophrenia; we investigated the involvement of the TM 
domain of the Nrg-1 gene in mediating sensorimotor gating in a PPI task relevant to 
schizophrenia. Our results indicate that partial deletion of the TM domain of the Nrg-
1 gene leads to attenuated PPI in Nrg-1 Het mutants compared to their WT 
littermates. No sex specific PPI disruptions were seen in Nrg-1 Het mutants. 
It has been suggested that PPI and PPI deficits may not be a robust replicable effect 
in Nrg-1 TM domain mutants. Rather deficits in PPI in Nrg-1 TM domain mutants 
are suggested to be protocol and site specific (Karl,2011).The first PPI protocol 
employed in this study consisted of a fixed vs. variable ISI protocol in one 
phenotyping facility (i.e. Garvan) and a second, with variable ISI at a different 
facility (NeuRa). Garvan consisted of the ten 90 dB ASR trials, 18 × 120 dB ASR 
trials, two prepulse alone trials per prepulse intensity (i.e. 74/78/82/86 dB), 
eight PPI response trials per prepulse intensity (prepulse followed 80 ms later by a 
120 dB startle pulse). NeuRA consisted of five 120 dB startle pulses after which four 
startle pulses (70/80/100/120 dB) were presented five times each in a pseudo-
randomised order. After this, 75 PPI response trials (prepulse intensities of 
74/82/86 dB followed by a 120 dB startle pulse) were presented five times in a quasi-
randomised order employing five different inter stimulus intensities (ISI) 
(32/64/128/256/512 ms) followed by a final five 120 dB startle pulses. The fixed ISI 
protocol produced attenuated startle responses to a 120 dB tone in mutant Nrg-
1 mice. However, in the PPI protocol with a variable ISI (Garvan/NeuRA) showed 
no differences in ASR to the 120 dB startle tone. Furthermore, no difference in PPI 
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between Nrg-1 WT and Het animals was seen. These findings strongly suggest that 
Nrg-1 mediates PPI in a protocol dependent- site specific manner. 
Our protocol consisted of twelve 120-db pulses of broadband noise, in blocks of six 
at the beginning and end of the session. Prepulse Inhibition was based on acoustic 
prepulse intensities that consisted of noise prepulses (3db, 7db, 15db and 25db above 
65 dB background noise) that were presented in a random order. Prepulse inhibition 
was measured as a magnitude of startle to the prepulse trial that consisted of a 20-ms 
noise prepulse, with a 100 ms delay which was then followed by 65 db of broadband 
noise, distributed at random throughout the task. Impairments in Nrg-1 Hets in 
baseline startle were seen in a third protocol (Karl, 2011)  that was closest to our 
protocol in terms of the magnitude of the of prepulses used (2,4,8,16 dB above 70 dB 
background noise). The ASR was attenuated in Nrg-1 Het mutants compared to 
WTs, but no differences in % PPI were seen. Thus, indicating that PPI and PPI 
disruption in Nrg-1 mutants depends both on the protocol employed and the test site.  
Previously reported Nrg-1 deficits in PPI (Stefansson H. 2002) have not been 
replicated. Moderate disruption of PPI in TM domain Nrg-1 mutants (Stefansson H. 
2002) and no disruptions in other studies (Boucher, Arnold et al.,2007) have been 
attributed to differences in the magnitude of baseline responding, which may 
promote a floor effect. In Nrg-1 WTs when baseline % PPI was reported to be 60-
65% in WTs, 50-55% PPI disruption was reported in Het mutants. Whereas when 
baseline inhibition was lower in controls, no disruptions in PPI were reported in Het 
mutants (van den Buuse 2010). These findings taken together confirm the suggestion 
that PPI and its disruption in Nrg-1 mutants depend on the protocol employed. 
Nrg-1 WTs show a trend for habituation deficits, with a trend toward intact 
habituation in Nrg1 Hets. Heregulin (type 1 neuregulin with different n terminal) Het 
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mutants show intact behavioural processes (Gerlai, Pisacane et al.,2000), which 
suggests that Nrg-1 mutants show intact habituation and this allele may dissociate for 
habituation and PPI. Previous reports indicate deficits in the exploration and 
habituation to an open field in Nrg-1 TM domain mutants (Babovic, O'Tuathaigh et 
al.,2007). However, habituation to an open field is different from habituation to 
pulses, and it may not be possible to facilitate a direct comparison between the two, 
as the former measures habituation in an exploratory modality and the latter 
measures habituation from an attentional salience perspective. Intact LI in mutants 
from our previous study indicates that Het animals may show a spared disruption of 
habituation to stimuli of attentional salience, but previous reports have only indicated 
a role for Nrg-1 in novelty driven salience (OÕ Tuathaigh et al.,2007). 
Overall, Nrg-1 mutants show robust impairments on %PPI that may be governed by 
the protocol used, whereas other behaviours such as habituation may be mediated 
distinctly by Nrg-1. 
8.5 Nrg-1 Het mutants show sex specific dissociations on the ÔwhatÕ 
and ÔwhenÕ, but not ÔwhatÕ and ÔwhereÕ components of episodic 
memory 
People with schizophrenia have been shown to have disrupted episodic memory, 
which is defined as memory for items embedded in a spatiotemporal context (Leavitt 
and Goldberg 2009). In order to investigate the translational relevance of reduced 
function of TM domain Nrg-1 behaviourally, we investigated whether mice 
Heterozygous for the TM-domain Nrg-1 gene, would display impaired episodic 
memory in a task that requires simultaneous memory for ÒwhatÓ, ÒwhenÓ and 
ÒwhereÓ. Our data indicates that male Nrg-1 Het animals show disruptions in their 
memory for what and when as indicated by no preference for old vs. a recent objects 
as compared to their WT littermates. There was an intact preference for the old vs. 
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new object in female Het animals; however it is difficult to make a conclusion as WT 
female Nrg-1 animals did not show a significant preference for either object. Both 
Nrg-1 WT and Het animals failed to show preference in memory for old displaced 
vs. an old stationary object, reflecting no spatial memory for object displacement. 
 Deletion of the TM domain in Nrg-1 mutants affects Type III Nrg-1 signalling.Nrg-
1 type III is defined by its cysteine-rich domain (CRD), which functions as a 
second transmembrane domain (Nave and Salzer,2006). CRD Nrg -1 Het mice show 
impairments in short term spatial memory on the T maze (Chen 2008), whereas TM 
domain Nrg-1 Het mutants show intact spatial memory(OÕ Tuathaigh et al.,2007). 
This may be due to Nrg1/ErbB receptor mediated function in CRD mutants, whereas 
TM domain mice are independent of ErbB signalling. 
Studies that report impairments in object recognition memory in TM domain mutants 
are based on the hypothesis that posits that exploration of the novel object reflects 
intact memory processes, where exploration of a less novel (old) object reflects 
memory impairments (Ennaceur and Delacour 1988; O' Tuathaigh 2007; Ennaceur 
2010). However, our task adapted from (Dere, Huston et al., 2005) emphasises 
increased exploration of the old object as opposed to the novel object, and these 
results may be subject to paradigmatic differences.  As the temporal component of 
recognition memory is always present in our task, it is not directly comparable to 
behaviours on a novel object recognition task, as both objects have been exposed 
prior to test, and are not ÔnovelÕ, but evaluated in terms of their relative recency, or 
on a spatial memory task, as place preference is always confounded by recency 
discrimination. Thus, reflecting object exploration in terms of recency discrimination 
for the objects, rather than a test of novelty based or spatial memories. 
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Episodic memory tested in a single day may be influenced by delays between sample 
and test phases. At short delays, it is suggested that memory for a familiar object is 
intact and at longer delays it becomes weak (Ennaceur,2010).The lack of exploratory 
preferences in the what-where component of the episodic task may be governed 
delays. Our task employed a long delay of 50 minutes. It is suggested that over a 
long delay an object loses its sense of familiarity and may appear to be less familiar 
or novel, reflecting a weakened memory for the old object, this would account for 
increased preference of an old vs. a recent object by Nrg-1 animals. The exploration 
of the more recent or ÔnovelÕ object depends on the consolidated memory for the 
familiar, old object, and therefore may promote increased exploration of the old 
object compared to the novel/recent object (Ennaceur,2010). Thus, increased 
exploration of the old object in our task may actually reflect weakened memory for 
that object. Additionally, equal or no differences in object exploration by Nrg-1 
mutants may not necessarily reflect that learning has not occurred, as it may be a 
consequence of temporary decay of memory for an object as  previously mentioned 
(Ennaceur,2010). No preference to an object indicates equal attention has been 
allocated to both the novel and familiar stimulus and is attributed to a weaker 
memory for the old object; in line with novel object recognition increased preference 
for an old object does not reflect memory for that object. In our task, even if the 
encoding and consolidation for the familiar/old object may have waned owing to a 
longer delay between the presentation of the old familiar object and test (50+50 
minutes) vs. the presentation of the recent object and test (50 minutes), as it was seen 
at a further point in time compared to the recent object, and might be reflected by 
increased exploration of the old object.  
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The lack of exploration on the spatial aspect of the task may be attributed to a decline 
of interest for object exploration in this third phase (Sample1, Sample 2, and test) of 
object exposure. Rates of exploration for what where (stationary vs. displaced) 
objects is greatly reduced, compared to exploration rates for what when objects (old 
vs. recent). Exploration rates reflect no discrimination, as they do not surpass the .5 
level of equal discrimination for either object. No preference to an object indicates 
equal attention has been allocated to both the novel and familiar stimulus. 
Alternatively, spatial discrimination memory may be subject to interaction with 
recency (Kart-Teke, De Souza Silva et al.,2006).  
A revision of the protocol in mice (Dere, Huston et al.,2005) was created to 
investigate place and recency based interactions in episodic memory in rats, where 
rats were found to respond differently to the spatial displacement component of the 
task, depending on whether the old familiar or recent familiar objects were shifted to 
locations where they had not been previously encountered (Kart-Teke, De Souza 
Silva et al.,2006). Furthermore, rats were also allowed a 5 minutes cut off point of 
exploration per trial as opposed to the 10 minutes of exploration time allocated in the 
mouse trial. Two copies of the object from sample trial 1 (old familiar objects) and 
two copies of the object known from sample trial 2 (recent familiar objects) were 
present. Two of these objects were placed in random locations, which already 
contained objects during sample trial one (as seen in our design), while the remaining 
two objects were randomly placed in locations, which were not previously occupied 
by objects in the first sample trial. An old familiar object was kept in place (old 
familiar stationary object), while another was displaced to a novel location (old 
familiar displaced object). In contrast to this, the modified task did the same for the 
recent familiar objects presented in the second sample i.e. recent 
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familiar stationary object and recent familiar displaced object (Refer to Appendix 4).  
This revision was made to ascertain whether the exploration pattern exhibited by the 
rats would indicate an interaction between recency and spatial displacement.  
It was seen, that consistent to the previous task in mice, rats made the same 
distinctions as mice in their preference for the old vs. recent objects and old 
displaced vs. old stationary objects (Dere, Huston et al.,2005). In the modified task 
however, rats preferred the displaced recent familiar object compared to the 
stationary recent familiar object. They also preferred the stationary old familiar 
object relative to the displaced old familiar object, indicating an interaction between 
recency and spatial displacement. This increased exploration of a newer, more recent 
displaced object over the old object is consistent with theories of novel object 
recognition. This indicates that the episodic memory task is subject to paradigmatic 
influences and indicates that the spatio-temporal interaction in the old protocol 
(Dere, Huston et al.,2005) may confound  recency mediated memories. 
Nrg-1 mutants show sex specific impairments on the what-when recency mediated 
component of the episodic memory task. This suggests that this Nrg-1 may have 
relevance for investigating memory dysfunction in schizophrenia, particularly in the 
context of sexually dimorphic memory impairment. Assessing Nrg-1 involvement in 
episodic memory in the revised protocol, as mentioned previously, would shed light 
whether Nrg-1 dissociates sex specifically for impairments in novelty and recency 
mediated memories.   
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8.6 Conclusions 
¥ PPI is attenuated in D2R deficient mutants, in a one day sensorimotor gating 
task. Knocking out the D2R attenuates %PPI, and leaves ASR unaffected in 
both genotypes. A trend toward amphetamine disruption of PPI in D2R null 
mutants, in a one day, single low dose injection paradigm was seen, although 
this was non significant. 
d-Amphetamine induced disruption of LI administered prior to PE and 
COND 24 h apart disrupts LI in D2R KO (Weiner, Lubow et al.,1988; 
Weiner, Bernasconi et al.,1997;Bay-Richter et al.,2009). To investigate 
whether this drug administration dependent schedule of amphetamine 
disruption generalizes to cognitive phenotypes of relevance to schizophrenia, 
a one vs. two dose PPI protocol was used. A dissociation between a single 
and double dose of amphetamine exists with regard to D2R involvement in 
PPI. Amphetamine disrupts %PPI in D2R deficient mutants when 
administered as a single low dose injection, in a two day protocol. Two low 
dose injections of amphetamine however, do not disrupt PPI in D2R KO or 
their WT littermates.  These findings demonstrate that prior conclusions 
about the requirement of the D2R for amphetamine effects in PPI does not 
generalise to all doses. Secondly, they suggest dissociation between one and 
two doses of amphetamine with respect to the D2R. Third they suggest the 
importance of protocol in phenotypic effects on PPI in mice; as the disruptive 
effects of amphetamine were only seen in a single low dose, two day (one 
injection prior to test only) protocol, and not in a double low dose protocol 
(prior to habituation and test). 
¥  D2R WT and KO animals show equal exploration of in the recency mediated 
aspect of an episodic memory task, and female KO mutants show enhanced 
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memory for old vs. recent objects.  Both D2R WT and KO mice show intact 
memory for displaced objects in the spatio-temporal aspect of the task. This 
indicates that absence of the D2R KO in these mice show intact memory for 
what and where on an episodic memory task. 
¥ Nrg-1 TM domain mutants show no impairements onLI. 
¥ Nrg-1 TM domain mutants show deficits on the schizophrenia relevant PPI 
task of sensorimotor gating. Nrg-1 Het mutants show attenuated % PPI 
compared to their WT littermates; however, this may be subject to protocol 
specificity and at certain prepulse intensities. A trend toward PPI disruptions 
in male animals was seen, suggesting that Nrg-1 mediates sex specific 
impairment in schizophrenia phenotypes, but this was not significant. 
¥ Reduced function of TM-NRG1 gene has sex-specific effects on episodic-like 
memory impairing it in males and improving it in females. This suggests that 
this model may have relevance for investigating memory dysfunction in 
schizophrenia, particularly in the context of sexually dimorphic memory 
impairment. A revised  episodic memory protocol(Kart-Teke, De Souza Silva 
et al.,2006) may help elucidate Nrg-1 involvement in novelty driven 
memories and recency.   
 
FUTURE STUDIES SUGGESTED BY THIS WORK 
¥ Future studies could involve dose response studies to investigate whether 
PPI disruption in the D2R KO as mediated by protocol is by low doses of 
amphetamine only, or whether these disruptions by the low dose are 
mediated differently by protocol when amphetamine is administered at a 
high dose. A replication of the episodic memory task in both models is 
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warranted, to demonstrate intact memory for what-where-when. 
Additionally, a modification of the task is required to determine whether 
mice do show the non- standard preference for the old objects and its 
implications for memory impairment in the knock out. Pharmacological 
models investigating the effect of amphetamine in disruption of episodic 
memory could also then be conducted in the D2R, in the new modified 
version of the task. Replicability of the schizophrenia relevant disruption 
in these three tasks in the Nrg-1 model is warranted, to determine whether 
disruptions on schizophrenia relevant phenotypes can be consistently 
reproduced in this mutant model. If PPI disruptions are protocol specific 
in Nrg-1 mutants, a one vs. two day PPI task would help elucidate this 
stance in the current literature. Additionally, the effects of a low dose of 
amphetamine in the disruption of these schizophrenia relevant phenotypes 
and the reversal of these disruptions by antipsychotic drugs could also be 
established in Nrg-1 mutants. This would help elucidate whether the 
disruptions in these behavioural phenotypes by dampened Nrg-1 function 
are mediated differently by aberrant dopamine neurotransmission, and 
have predictive validity for pharmacological models of schizophrenia 
relevant phenotypes. 
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APPENDIX 
1.1 Appendix 1: Data and analysis showing no effect of experiment 
in the AmpHetamine disruption of PPI in D2R WT and KO animals 
from two separate cohorts 
Repeated measures ANOVA indicating no effect of experiment on the dataset, thus 
permitting pooling data from two separate cohorts to show sufficient genotype and 
treatment matched animal cohorts. Between subjects effects in the ANOVA 
(Appendix 1.1) showing main effects of Experiment, Genotype and Treatment in 
Chapter 2. 
 
Between Subjects Effects 
Source Type III Sum of 
Squares 
df Mean 
Sq. 
f Sig. 
 
17.742 1 
396583.
547 
249.681 .000 
Genotype 10685.281 1 17.742 .011 .916 
Treatment 
41.775 1 
10685.2
81 
6.727 .012 
Experiment*Genotype 26.035 1 41.775 .026 .872 
Experiment * 2492.721 1 26.035 .016 .899 
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Treatment 
Genotype* Treatment 
1640.436 1 
2492.72
1 
1.569 .216 
Experiment*Genotype*
Treatment 
.000 1 
1640.43
6 
1.033 .314 
 77829.639 0 . . . 
Error 
 49 
1588.36
0 
  
Table 1.1 (Appendix 1.1) Table showing results of ANOVAs between subjects 
differences of the effects of experiment, genotype and treatment on PPI in 
Chapter 2.  
1.1.1. Repeated measures ANOVA, split by experiment (Experiment 
1 vs Experiment 2) showing raw data each experiment. 
The ANOVA was also split by experiment to look at group differences within each 
experiment. An absence of a control saline KO group and inadequate ampHetamine 
treated D2R WTs (n=3) in experiment 1, do not permit conclusive results. See Table 
1.2 
 
Within subjects Effects 
Experiment 1 
Source  Type III df Mean F Sig. 
228 
 
Sum of 
Squares 
Sq. 
PPI  Sphericity 
Assumed 
719.036 3 239.679 5.869 .001 
 Greenhouse-
Geisser 
719.036 2.420 297.114 5.869 .003 
 Huynh-Feldt 719.036 3.000 239.679 5.869 .001 
 Lower-bound 719.036 1.000 719.036 5.869 .025 
PPI * Genotype Sphericity 
Assumed 
150.348 3 50.116 1.227 .307 
 Greenhouse-
Geisser 
150.348 2.420 62.126 1.227 .306 
 Huynh-Feldt 150.348 3.000 50.116 1.227 .307 
 Lower-bound 150.348 1.000 150.348 1.227 .280 
PPI* treatment Sphericity 
Assumed 
36.448 3 12.149 .297 .827 
 Greenhouse-
Geisser 
36.448 2.420 15.061 .297 .784 
 Huynh-Feldt 36.448 3.000 12.149 .297 .827 
 Lower-bound 36.448 1.000 36.448 .297 .591 
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PPI*Genotype* 
Treatment 
Sphericity 
Assumed 
.000 0 . . . 
 Greenhouse-
Geisser 
.000 .000 . . . 
 Huynh-Feldt .000 .000 . . . 
 Lower-bound .000 .000 . . . 
Error( ppi) Sphericity 
Assumed 
2572.898 63 40.840 
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 Greenhouse-
Geisser 
2572.898 50.821 50.626 
  
 Huynh-Feldt 2572.898 63.000 40.840   
 Lower-bound 2572.898 21.000 122.519   
 
Table 1.2 (Appendix 1.1) Table showing results of within subjects 
effects of the repeated measures ANOVA as split by Experiment. 
PPI is the repeated measures factor and genotype and treatment are 
the between subjects factors.  
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Between Subjects Effects 
Experiment 1 
 
Source Type III 
Sum of 
Squares 
df Mean Sq. f Sig. 
Intercept 138336.719 1 138336.719 98.806 .000 
Genotype 
 
3795.046 1 3795.046 2.711 .115 
Treatment 1689.506 1 1689.506 1.207 .284 
Genotype * 
Treatment 
.000 0 . . . 
Error 29401.757 21 1400.084   
 
Table 1.3 (Appendix 1.1) Table showing results of ANOVAs between subjects 
differences of the effects of experiment, genotype and treatment on PPI in 
Chapter 2, as split by experiment. 
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The ANOVA split by experiment shows results of experiment 2. For within subjects 
effects in experiment 2, see Table 1.4. For between subjects effects in experiment 2, 
see Table1.5. 
Experiment  2 
Source  Type III 
Sum of 
Squares 
df Mean 
Sq. 
F Sig. 
PPI  Sphericity 
Assumed 
2476.489 3 825.496 8.919 .000 
 Greenhouse-
Geisser 
2476.489 2.088 1186.295 8.919 .000 
 Huynh-Feldt 2476.489 2.501 990.266 8.919 .000 
 Lower-bound 2476.489 1.000 2476.489 8.919 .006 
PPI * Genotype Sphericity 
Assumed 
389.930 3 129.977 1.404 .247 
 Greenhouse-
Geisser 
389.930 2.088 186.786 1.404 .254 
 Huynh-Feldt 389.930 2.501 155.920 1.404 .251 
 Lower-bound 389.930 1.000 389.930 1.404 .246 
PPI* treatment Sphericity 275.233 3 91.744 .991 .401 
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Assumed 
 Greenhouse-
Geisser 
275.233 2.088 131.843 .991 .380 
 Huynh-Feldt 275.233 2.501 110.056 .991 .391 
 Lower-bound 275.233 1.000 275.233 .991 .328 
PPI*Genotype* 
Treatment 
Sphericity 
Assumed 
112.774 3 37.591 .406 .749 
 Greenhouse-
Geisser 
112.774 2.088 54.021 .406 .677 
 Huynh-Feldt 112.774 2.501 45.095 .406 .713 
 Lower-bound 112.774 1.000 112.774 .406 .529 
Error(ppi) Sphericity 
Assumed 
7774.797 84 92.557 
  
 Greenhouse-
Geisser 
7774.797 58.452 133.011 
  
 Huynh-Feldt 7774.797 70.023 111.032   
 Lower-bound 7774.797 28.000 277.671   
 
Table 1.4(Appendix 1.1) Table showing results of within subjects effects 
of the repeated measures ANOVA as split by Experiment. PPI is the 
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repeated measures factor and genotype and treatment are the between 
subjects factors.  
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Between Groups Effects 
Experiment 2 
Source Type III 
Sum of 
Squares 
df Mean Sq. f Sig. 
Intercept 324728.293 1 324728.293 187.751 .000 
Genotype 
 
15283.712 1 15283.712 8.837 .006 
Treatment 6656.345 1 6656.345 3.849 .060 
Genotype * 
Treatment 
1640.436 1 1640.436 .948 .338 
Error 48427.882 28 1729.567   
 
Table 1.5 (Appendix 1.1) Table showing results of ANOVAs between subjects 
differences of the effects of experiment , genotype and treatment on PPI in 
Chapter 4, as split by experiment. 
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1.1.2 Appendix 2: Data and analysis showing outliers removed from 
the AmpHetamine disruption of PPI in D2R WT and KO animals 
from two cohorts in Chapter 2 
Outliers pertaining to the pooled data set consisting of two cohorts; Subject 48B1.7  
(D2R KO, saline treated) was not included in the data set, owing to very low levels 
of % PPI (See Fig. 1a-d). Studies that have used prepulse intensities, similar to ours 
above 65 dB background noise; 69 dB, 73 dB and 81 db show upto 45% PPI in D2R 
WT and 40 % PPI in D2R KO administered saline (Ralph, Varty et al., 1999; Ralph-
Williams, Lehmann-Masten et al., 2002). Neither of these studies show % PPI at or 
below 0 on the scale, in either D2R KO or WT mutants. 
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Figure 1a % PPI  in D2R WT and KO animals, at the 68 dB prepulse intensity, 
split by treatment. Outliers are indicated below 0 level of PPI responding, with 
0 being the maximum % inhibition toward the prepulse. 
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Figure 1b % PPI  in D2R WT and KO animals, at the 72 dB prepulse intensity, 
split by treatment. Outliers are indicated below 0 level of PPI responding, with 
0 being the maximum % inhibition toward the prepulse. 
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Figure 1c % PPI  in D2R WT and KO animals, at the 80 dB prepulse intensity, 
split by treatment. Outliers are indicated below 0 level of PPI responding, with 
0 being the maximum % inhibition toward the prepulse. 
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Figure 1d % PPI in D2R WT and KO animals, at the 68 dB prepulse intensity, 
split by treatment. Outliers are indicated below 0 level of PPI responding, with 
0 being the maximum % inhibition toward the prepulse. 
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2.1 Appendix 3: Data and analysis showing D2R WT and KO sample 
exploration times for animals removed from the analysis in the 
episodic memory task in Chapter 3 
Animal Id 100b1.4 showed little exploration in object A i.e. bottles as reflected by 
exploration time in sample 1. However, in test, it was seen when object A was 
displaced, exploration times increased significantly for the object displaced, and also 
for the object that occurred in the same position in the sample and test phases (See 
Table 1.6) that suggests a preference for place may interact with temporal memory 
for when the object occurred. Exploration times are dramatically increased for the 
old object, which in the sample stage had very little exploration. This makes it 
difficult to ascertain wHether increased exploration in test is due to the object being 
displaced, due to increased exploration of the more recent object, or that it is present 
in the location that was previously also occupied by this object in sample 1, See  
Table 1.8 and Figure 1e and Fig 1f. 
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Subject Sample 
Stage 
Object Total 
Exploration 
times in 
sample 
Test 
object 
Total 
Exploration 
in test 
Location 
in test 
Location 
in 
Sample 
100b1.4 1 Bottle 6 Bottle 
displaced 
39 Top right 
corner 
(NE) 
Bottom 
right (SE) 
    Bottle 
stationary 
31 Bottom 
left (SW) 
Bottom 
left (SW) 
 2 Golf Ball 36  51 Top  
right 
(NW)  
and 
bottom 
right 
(SE) 
Top  
right 
(NW)  
and 
bottom 
right 
(SE) 
99b4.1 1 Bottle 30 Bottle 
displaced 
50 Top right 
corner 
(NE) 
bottom 
right (SE) 
    Bottle 41 Bottom Bottom 
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Table 1.6 Table showing raw data for exploration times in animals that were 
removed from the analysis. 
 
 
 
 
 
stationary left (SW) left (SW) 
 2 Golf Ball 71  48 bottom 
right 
(SE) 
bottom 
right 
(SE) 
99b4.2 1 Bottle  Bottle 
displaced 
40 Top right 
corner 
(NE) 
bottom 
right (SE) 
    Bottle 
stationary 
45 Bottom 
left (SW) 
Bottom 
left  
(SW) 
 2 Golf Ball 24  42 bottom 
right 
(SE) 
bottom 
right 
(SE) 
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The same pattern is seen in subject 99b4.1 and 99b4.2. It is difficult to ascertain 
wHether exploration occurred independently of a spatial- temporal interaction 
between object, as the objects in the sample were placed in the same locations as 
they were in the test. The sample stages indicate preferences for the golf ball, but the 
test stages indicate preferences for the bottle. Here it is difficult to ascertain wHether 
object preference is due to the nature of the object (as reflected by exploration in 
sample stages), or due displacement of objects, as these objects were not explored to 
the same extent in sample 1, or due to objects being presented in the same locations 
in sample and test, thus reflecting a place preference that is independent of object 
exploration. 
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Figure 1e Schematic drawing of the what, where , when object exploration task. 
The mice received three 10-min trials with a 50-min inter-trial interval. On 
sample trial 1, 4 novel objects were presented arranged in a triangle spatial 
configuration. On sample trial 2, another 4 novel objects were presented in a 
different spatial arrangement. During the test trial, two Òold familiarÓ and two 
Òrecent familiarÓ objects known from the sample trials were presented as 
depicted. Circles and squares represent equal objects presented initially in the 
first and second sample trial respectively. Object locations: NW = north-west, 
NC = north-center, NE = north-east, SW = south-west, SC = south-center, 
SE = south-east.  
 
 
 
 
246 
 
2.1.1 Appendix 4: Analysis showing Recency Discrimination for old stationary object 
only vs recent stationary objects in D2R WT and KO animals in the episodic memory 
task in Chapter 3 
A secondary analysis investigating discrimination  of the recent objects vs the older 
stationary object only was conducted in order to explore the exploration of the old vs 
recent objects, and ascertain that increased exploration of  the old objects   was not 
due to one of the old objects being displaced, but a true measure of memory for the 
old object in a particular temporal context (sample 1) that occurred before the recent 
object (sample 2) (Dere, Huston et al., 2005).This indicates that animals genuinely 
prefer to explore the old object as they remember it occurred in sample 1, rather than 
because this object was simply displaced. However, our analysis shows that this was 
only true for female wt animals. All other animals show increased preference of the 
more recent objects in their original positions as in sample 2. However, this does not 
necessarily reflect object exploration due to recency alone, increased exploration of 
Recent object 2 at fixed locations, rather than equal exploration of recent objects 
suggests a place preference associated with the recent objects. Therefore, making it 
difficult to arrive at a conclusion about object exploration preference based on 
recency alone. See Table 1.6-1.7 and Figure 1f. 
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Source  Type 
III 
Sum 
of 
Squa
res 
df Mean 
Sq. 
F Sig. 
Recency 
Discrimina
tion 
Sphericity 
Assumed 
1923.
875 
1 
1923.87
5 
61.382 .000 
 Greenhouse
Geisser 
1923.
875 
1.000 
1923.87
5 
61.382 .000 
 Huynh-
Feldt 
1923.
875 
1.000 
1923.87
5 
61.382 .000 
 Lower-
bound 
1923.
875 
1.000 
1923.87
5 
61.382 .000 
Recency 
discrimina
tion 
*Sex 
Sphericity 
Assumed 
244.9
94 
1 244.994 7.817 .009 
 Greenhouse
-Geisser 
244.9
94 
1.000 244.994 7.817 .009 
 Huynh- 244.9
94 
1.000 244.994 7.817 .009 
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Feldt 
 Lower-
bound 
244.9
94 
1.000 244.994 7.817 .009 
Recency 
discrimina
tion*Geno
ytpe 
Sphericity 
Assumed 11.90
7 
1 11.907 .380 .543 
 Greenhouse
-Geisser 
11.90
7 
1.000 11.907 .380 .543 
 Huynh-
Feldt 
11.90
7 
1.000 11.907 .380 .543 
 Lower-
bound 
11.90
7 
1.000 11.907 .380 .543 
Recency 
discrimina
tion 
*Sex*geno
type 
 
Sphericity 
Assumed 
149.7
50 
1 149.750 4.778 .037 
 Greenhouse
-Geisser 
149.7
50 
1.000 149.750 4.778 .037 
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Table  1.6 (Appendix 4) Results of  repeated measures ANOVA for recency, 
showing Within subjects effects of the discrimination of the old stationary 
objects vs the recent objects 
 
 
 
 
 Huynh-
Feldt 
149.7
50 
1.000 149.750 4.778 .037 
 Lower-
bound 
149.7
50 
1.000 149.750 4.778 .037 
Error(ppi) Sphericity 
Assumed 
877.5
89 
28 31.342 
  
 Greenhouse
-Geisser 
877.5
89 
28.000 31.342 
  
 Huynh-
Feldt 
877.5
89 
28.000 31.342 
  
 Lower-
bound 
877.5
89 
28.000 31.342 
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Source Type III 
Sum of 
Squares 
df Mean Sq. f Sig. 
Intercept 14863.022 1 14863.022 103.626 .000 
Sex 225.478 1 225.478 1.572 .220 
genotype .156 1 .156 .001 .974 
Sex * 
genotype 
301.226 1 301.226 2.100 .158 
Error 4016.034 28 143.430   
 
Table 1.7 (Appendix 4) Results of repeated measures ANOVA for recency 
showing the between groups effects of the discrimination of the old stationary 
objects vs the recent objects 
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Figure 1f Graph showing raw means of exploration in D2R WT and KO of old 
stationary vs recent stationary objects only. Animals show increased exploration 
of the recent objects, when the raw exploration of old displaced objects is 
removed. 
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Figure 1g Graph showing raw means of exploration in D2R WT and KO of old 
stationary vs recent stationary objects 1 and recent stationary object 2 only. 
Both these recent objects were counterbalanced for place, as well as object type.  
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3.1 Appendix 5: Original episodic memory task, and its recent 
modification to segregate the influence of the spatial displacement of 
the object interacting with the temporal component of the episodic 
memory task in Chapter 8 
 The figure below shows the protocol we employed in mice as a measure of the 
episodic memory for what, where and when. As mentioned previously (Appendix 3) 
this protocol does not separate the temporal component from the spatial component, 
making it difficult to ascertain wHether object exploration is due to the memory for 
an old familiar object at a particular point in time, or simply a consequence of this 
object being displaced. See figure 1h. A recent modification of this protocol 
addresses this problem of spatio-temporal influence on objects, by displacing one of 
the recent objects in the test phase in addition to the old familiar objects. Now, a 
stationary old familiar object and a stationary recent familiar object are present in 
addition to a displaced old familiar and a displaced recent familiar object, thus 
facilitating a preference for objects solely on the basis of  their occurrence at a 
particular point in time in terms of their recency and solely, due to the displacement , 
depending on wHether the old familiar object was recognised as being displaced or 
the recent familiar object was recognized as being displaced irrespective of its 
recency See figure 1i. 
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Figure 1h Schematic drawing of the what, where and when object exploration 
task, that was used in our experiment. The mice received three 10-min trials 
with a 50-min inter-trial interval. On sample trial 1, mice recive 4 novel objects 
were presented arranged in a triangle spatial configuration. On sample trial 2, 
another 4 novel objects were presented in a different spatial arrangement. 
During the test trial, two Òold familiarÓ and two Òrecent familiarÓ objects 
known from the sample trials were presented as depicted. Circles and squares 
represent equal objects presented initially in the first and second sample trial 
respectively. Object locations: NW = north-west, NC = north-center, 
NE = north-east, SW = south-west, SC = south-center, SE = south-east.  
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Figure 1i Schematic drawing of the experimental design shows modified object 
arrangement for the what, where and when task as previously mentioned. Rats 
received three 5 min trials with a 50 min inter-trial interval. During the test 
trial, two Òold familiarÓ and two Òrecent familiarÓ objects known from the 
sample trials were presented at familiar and novel locations relative to the 
respective sample trials. A1, Òold familiar-stationaryÓ; A2, Òold familiar-
displacedÓ; B1, Òrecent familiar-stationaryÓ; and B2, Òrecent familiar-
displaced.Ó (Kart-Teke, De Souza Silva et al., 2006) 
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